
<html lang="en"     class="pb-page"  data-request-id="472f6ca7-82d4-47e4-b2e6-4183f219d33d"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm5004123;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2014.57.issue-10"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Shuttle–Cargo Fusion Molecules of Transport Peptides and the hD2/3 Receptor Antagonist Fallypride: A Feasible Approach To Preserve Ligand–Receptor Binding?" /></meta><meta name="dc.Creator" content="Carmen  Wängler" /></meta><meta name="dc.Creator" content="Shafinaz  Chowdhury" /></meta><meta name="dc.Creator" content="Georg  Höfner" /></meta><meta name="dc.Creator" content="Petia  Djurova" /></meta><meta name="dc.Creator" content="Enrico O.  Purisima" /></meta><meta name="dc.Creator" content="Peter  Bartenstein" /></meta><meta name="dc.Creator" content="Björn  Wängler" /></meta><meta name="dc.Creator" content="Gert  Fricker" /></meta><meta name="dc.Creator" content="Klaus T.  Wanner" /></meta><meta name="dc.Creator" content="Ralf  Schirrmacher" /></meta><meta name="dc.Description" content="To determine if the conjugation of a small receptor ligand to a peptidic carrier to potentially facilitate transport across the blood–brain barrier (BBB) by “molecular Trojan horse” transcytosis is..." /></meta><meta name="Description" content="To determine if the conjugation of a small receptor ligand to a peptidic carrier to potentially facilitate transport across the blood–brain barrier (BBB) by “molecular Trojan horse” transcytosis is..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 8, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm5004123" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm5004123" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm5004123" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm5004123" /></link>
        
    
    

<title>Shuttle–Cargo Fusion Molecules of Transport Peptides and the hD2/3 Receptor Antagonist Fallypride: A Feasible Approach To Preserve Ligand–Receptor Binding? | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm5004123" /></meta><meta property="og:title" content="Shuttle–Cargo Fusion Molecules of Transport Peptides and the hD2/3 Receptor Antagonist Fallypride: A Feasible Approach To Preserve Ligand–Receptor Binding?" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0013.jpeg" /></meta><meta property="og:description" content="To determine if the conjugation of a small receptor ligand to a peptidic carrier to potentially facilitate transport across the blood–brain barrier (BBB) by “molecular Trojan horse” transcytosis is feasible, we synthesized several transport peptide–fallypride fusion molecules as model systems and determined their binding affinities to the hD2 receptor. Although they were affected by conjugation, the binding affinities were found to be still in the nanomolar range (between 1.5 and 64.2 nM). In addition, homology modeling of the receptor and docking studies for the most potent compounds were performed, elucidating the binding modes of the fusion molecules and the structure elements contributing to the observed high receptor binding. Furthermore, no interaction between the hybrid compounds and P-gp, the main excretory transporter of the BBB, was found. From these results, it can be inferred that the approach to deliver small neuroreceptor ligands across the BBB by transport peptide carriers is feasible." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm5004123"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm5004123">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm5004123&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm5004123&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm5004123&amp;href=/doi/10.1021/jm5004123" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 10</span><span class="cit-fg-pageRange">, 4368-4381</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/10" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm500392t" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm5004182" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Shuttle–Cargo Fusion Molecules of Transport Peptides and the hD<sub>2/3</sub> Receptor Antagonist Fallypride: A Feasible Approach To Preserve Ligand–Receptor Binding?</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carmen++W%C3%A4ngler">Carmen Wängler</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shafinaz++Chowdhury">Shafinaz Chowdhury</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Georg++H%C3%B6fner">Georg Höfner</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Petia++Djurova">Petia Djurova</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Enrico+O.++Purisima">Enrico O. Purisima</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∇</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Bartenstein">Peter Bartenstein</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bj%C3%B6rn++W%C3%A4ngler">Björn Wängler</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gert++Fricker">Gert Fricker</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Klaus+T.++Wanner">Klaus T. Wanner</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ralf++Schirrmacher">Ralf Schirrmacher</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal H3A 2B4, Canada</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Biomedical Chemistry, Department of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim of Heidelberg University, Mannheim 68167, Germany</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Department of Nuclear Medicine, University Hospital Munich, Ludwig-Maximilians-University Munich, Munich 81377, Germany</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Lady Davis Institute, Jewish General Hospital, McGill University, Montreal H3T 1E2, Canada</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Pharmaceutical Chemistry, Ludwig-Maximilians-University Munich, Munich 81377, Germany</span></div><div class="aff-info" id="aff6"><span class="aff-symbol">#</span> <span class="aff-text">Institute of Pharmacy and Molecular Biotechnology, University of Heidelberg, Heidelberg 69120, Germany</span></div><div class="aff-info" id="aff7"><span class="aff-symbol">∇</span> <span class="aff-text">National Research Council of Canada, Montreal H4P 2R2, Canada</span></div><div class="aff-info" id="aff8"><span class="aff-symbol">○</span> <span class="aff-text">Molecular Imaging and Radiochemistry, Department of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim of Heidelberg University, Mannheim 68167, Germany</span></div><div class="corresp-info"><strong>*</strong>Phone: +49 (0)621 383 3761; Fax: +49 (0)621 383 1910; E-mail: <a href="/cdn-cgi/l/email-protection#cc8fadbea1a9a2e29bada9a2aba0a9be8ca1a9a8a1ade2b9a2a5e1a4a9a5a8a9a0aea9beabe2a8a9"><span class="__cf_email__" data-cfemail="622103100f070c4c3503070c050e0710220f07060f034c170c0b4f0a070b06070e000710054c0607">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm5004123&amp;href=/doi/10.1021%2Fjm5004123" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 10</span><span class="cit-pageRange">, 4368–4381</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 30, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>16 March 2014</li><li><span class="item_label"><b>Published</b> online</span>8 May 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 May 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm5004123" title="DOI URL">https://doi.org/10.1021/jm5004123</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4368%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DCarmen%2BW%25C3%25A4ngler%252C%2BShafinaz%2BChowdhury%252C%2BGeorg%2BH%25C3%25B6fner%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D10%26contentID%3Djm5004123%26title%3DShuttle%25E2%2580%2593Cargo%2BFusion%2BMolecules%2Bof%2BTransport%2BPeptides%2Band%2Bthe%2BhD2%252F3%2BReceptor%2BAntagonist%2BFallypride%253A%2BA%2BFeasible%2BApproach%2BTo%2BPreserve%2BLigand%25E2%2580%2593Receptor%2BBinding%253F%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4381%26publicationDate%3DMay%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm5004123"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1043</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">5</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm5004123" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Shuttle–Cargo Fusion Molecules of Transport Peptides and the hD2/3 Receptor Antagonist Fallypride: A Feasible Approach To Preserve Ligand–Receptor Binding?&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Carmen&quot;,&quot;last_name&quot;:&quot;Wängler&quot;},{&quot;first_name&quot;:&quot;Shafinaz&quot;,&quot;last_name&quot;:&quot;Chowdhury&quot;},{&quot;first_name&quot;:&quot;Georg&quot;,&quot;last_name&quot;:&quot;Höfner&quot;},{&quot;first_name&quot;:&quot;Petia&quot;,&quot;last_name&quot;:&quot;Djurova&quot;},{&quot;first_name&quot;:&quot;Enrico&quot;,&quot;last_name&quot;:&quot;O. Purisima&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Bartenstein&quot;},{&quot;first_name&quot;:&quot;Björn&quot;,&quot;last_name&quot;:&quot;Wängler&quot;},{&quot;first_name&quot;:&quot;Gert&quot;,&quot;last_name&quot;:&quot;Fricker&quot;},{&quot;first_name&quot;:&quot;Klaus&quot;,&quot;last_name&quot;:&quot;T. Wanner&quot;},{&quot;first_name&quot;:&quot;Ralf&quot;,&quot;last_name&quot;:&quot;Schirrmacher&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;08&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;4368-4381&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm5004123&quot;},&quot;abstract&quot;:&quot;To determine if the conjugation of a small receptor ligand to a peptidic carrier to potentially facilitate transport across the blood–brain barrier (BBB) by “molecular Trojan horse” transcytosis is feasible, we synthesized several transport peptide–fallypride fusion molecules as model systems and determined their binding affinities to the hD2 receptor. Although they were affected by conjugation, the binding affinities were found to be still in the nanomolar range (between 1.5 and 64.2 nM). In addition, homology modeling of the receptor and docking studies for the most potent compounds were performed, elucidating the binding modes of the fusion molecules and the structure elements contributing to the observed high receptor binding. Furthermore, no interaction between the hybrid compounds and P-gp, the main excretory transporter of the BBB, was found. From these results, it can be inferred that the approach to deliver small neuroreceptor ligands across the BBB by transport peptide carriers is feasible.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5004123&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5004123" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5004123&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5004123" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5004123&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5004123" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm5004123&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5004123&amp;href=/doi/10.1021/jm5004123" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm5004123" /></input><a href="/doi/pdf/10.1021/jm5004123" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm5004123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm5004123%26sid%3Dliteratum%253Aachs%26pmid%3D24779610%26genre%3Darticle%26aulast%3DW%25C3%25A4ngler%26date%3D2014%26atitle%3DShuttle%25E2%2580%2593Cargo%2BFusion%2BMolecules%2Bof%2BTransport%2BPeptides%2Band%2Bthe%2BhD2%252F3%2BReceptor%2BAntagonist%2BFallypride%253A%2BA%2BFeasible%2BApproach%2BTo%2BPreserve%2BLigand%25E2%2580%2593Receptor%2BBinding%253F%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D10%26spage%3D4368%26epage%3D4381%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291754" title="Molecules">Molecules</a>,</li><li><a href="/action/doSearch?ConceptID=290644" title="Molecular properties">Molecular properties</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/10" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jmcmar.2014.57.issue-10/production/jmcmar.2014.57.issue-10.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/medium/jm-2014-004123_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5004123&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">To determine if the conjugation of a small receptor ligand to a peptidic carrier to potentially facilitate transport across the blood–brain barrier (BBB) by “molecular Trojan horse” transcytosis is feasible, we synthesized several transport peptide–fallypride fusion molecules as model systems and determined their binding affinities to the hD<sub>2</sub> receptor. Although they were affected by conjugation, the binding affinities were found to be still in the nanomolar range (between 1.5 and 64.2 nM). In addition, homology modeling of the receptor and docking studies for the most potent compounds were performed, elucidating the binding modes of the fusion molecules and the structure elements contributing to the observed high receptor binding. Furthermore, no interaction between the hybrid compounds and P-gp, the main excretory transporter of the BBB, was found. From these results, it can be inferred that the approach to deliver small neuroreceptor ligands across the BBB by transport peptide carriers is feasible.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77761" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77761" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Functional diagnosis and treatment of diseases of the central nervous system (CNS) are still limited by the blood–brain barrier (BBB), a combination of endothelial tight junctions and active drug transporters, preventing the accumulation of hydrophilic as well as lipophilic drugs in the brain parenchyma (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A,B).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> While exercising the very important physiological role of protecting the CNS against potentially toxic compounds, it limits diagnostic and therapeutic opportunities in the case of disease. Thus, many efforts have been made within recent decades to overcome this barrier.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5 ref6">(2-6)</a> Most strategies use the so-called molecular Trojan horse approach, which makes use of drug conjugates combining a shuttle (a substance that is able to cross the BBB by transcytosis; Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>C,D) and a cargo (a diagnostic or therapeutic drug that is intended to be taken up into the CNS and is not able to cross the BBB on its own; Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>E).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/medium/jm-2014-004123_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic depiction of the different mechanisms of BBB function and transcytosis: hydrophilic drugs cannot enter the endothelium (A), some lipophilic drugs can enter the endothelium but get externalized by active drug transport (B), BBB crossing of receptor-binding substances such as transferrin and insulin by receptor-mediated transcytosis (C), unspecific BBB crossing of positively charged substances by adsorptive transcytosis (D), and specific or nonspecific BBB crossing of hydrophilic (blue) or lipophilic (orange) drugs using the molecular Trojan horse approach by receptor-mediated or adsorptive transcytosis (E).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5004123&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Following this approach, different substance classes have been used as shuttle vectors. So far, mostly large bioactive molecules such as antibodies directed against the transferrin receptor (TfR) (TfRmAbs, such as OX26) or the insulin receptor (IRmAbs), other proteins such as melanotransferrin, receptor associated protein, and CRM197 (a nontoxic mutant of diphtheria toxin), or liposomes functionalized with peptides or proteins have been applied.<a onclick="showRef(event, 'ref2 ref3 ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref7 ref8 ref9">(2, 3, 7-9)</a> However, although exhibiting a highly specific accumulation in the target, the use of large molecules as drug carriers is unfavorable with regard to their drug pharmacokinetics, clearance, immunogenicity, and bioavailability. Furthermore, a fusion molecule composed of a large carrier and a small neuroreceptor-binding cargo is commonly regarded as being unlikely to exhibit a preserved affinity of the ligand to its intended target.</div><div class="NLM_p">Therefore, the use of smaller peptides as shuttles across the BBB has been proposed. Peptides that are, in principle, applicable for cargo delivery to the brain are neuropeptides that are transported across the BBB by endogenous transporters (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>C), such as transferrin receptor binding peptides (transported via the TfR),<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> neurotensin (transported via neurotensin receptors NTS1, NTS2, and NTS3),<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> cholecystokinin (transported via cholecystokinin receptors CCKR1 and CCKR2),<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> neuropeptide Y (transported mostly via receptors Y1, Y2, Y4, and Y5),<a onclick="showRef(event, 'ref12 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref14">(12, 14)</a> and Substance P (transported via the neurokinin receptor)<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> as well as AngioPep-2 and other peptide derivatives that are transported via the low-density lipoprotein related receptor, LRP1.<a onclick="showRef(event, 'ref16 ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18 ref19 ref20">(16-20)</a> Furthermore, cell-penetrating peptides such as SynB,<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> Penetratin,<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a> vasoactive intestinal peptide (VIP),<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Transportan,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and TAT<a onclick="showRef(event, 'ref27 ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29 ref30">(27-30)</a> derivatives as well as polyarginines<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> that have been shown to enter the brain via different transduction mechanisms<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32, 33)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>D) are also promising peptidic carriers for transporting small molecule drugs across the BBB.</div><div class="NLM_p">The use of peptides is favorable because they are highly potent substances that display a low immunogenicity and molecular weight, resulting in fast pharmacokinetics and background clearance. Furthermore, they are easily accessible by chemical synthesis and can be site-specifically derivatized with a cargo drug. All of this makes peptides promising carriers for small drug molecules that can have a higher chance of preserving the biological activity of the drug compared to that when using larger shuttles.</div><div class="NLM_p">A successful fusion molecule consisting of a peptide and a small drug thus has to fulfill the following requirements: (i) the shuttle has to target a transcytosis receptor system with high affinity or has to be able to pass the BBB by a passive mechanism, (ii) the ability of the shuttle to cross the BBB has to be maintained after conjugation of the cargo drug, and (iii) the cargo drug has to preserve its biological activity upon conjugation to the shuttle.</div><div class="NLM_p">Because a small drug molecule is structurally altered significantly by conjugation to a peptide, it is conceivable that such a conjugation would most likely result in a fusion molecule of diminished or even eliminated binding affinity of the ligand to its target receptor. Similar effects of drastically decreased binding properties (up to 6 orders of magnitude) upon conjugation of large constructs have been shown exemplarily on the biotin–streptavidin system recently.<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34, 35)</a></div><div class="NLM_p">Thus, we intended to investigate if the conjugation of a small neuroreceptor-affine drug to a carrier peptide can, in principle, result in a hybrid compound that is potentially able to transport the small molecule while at the same time preserving its affinity to the neuroreceptor. We therefore synthesized a palette of fusion drugs, each consisting of a peptide carrier and a derivative of the hD<sub>2/3</sub> receptor-binding drug fallypride in order to test the feasibility of this approach.</div><div class="NLM_p">Fallypride was used as the model neuroreceptor-binding drug because is used in its <sup>18</sup>F-labeled form in human in vivo hD<sub>2/3</sub> receptor imaging with positron emission tomography (PET),<a onclick="showRef(event, 'ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref36 ref37 ref38">(36-38)</a> thus making it a well-studied ligand system. In addition, for its counterpart, the hD<sub>2</sub> receptor system, an in vitro receptor binding assay is available to study the hD<sub>2</sub> receptor affinities of the developed hybrid molecules.</div><div class="NLM_p last">For these fallypride and transport peptide conjugates, we determined the binding affinities to the hD<sub>2</sub> receptor in vitro and found that although a decrease in hD<sub>2</sub> receptor affinity is observed upon conjugation of fallypride to the peptides, the remaining binding affinity is still surprisingly high and remains in the nanomolar range. In order to explain and corroborate these experimental findings, we conducted homology modeling of the hD<sub>2</sub> receptor, starting from the hD<sub>3</sub> receptor as the template, and performed docking studies of the two most potent hybrid compounds, elucidating the contribution of different structure elements to receptor binding. We also conjugated structural motifs to some of the synthesized hybrid molecules, allowing for radiolabeling with <sup>68</sup>Ga and <sup>18</sup>F and future in vivo PET imaging of hD<sub>2/3</sub> receptors. Furthermore, the interaction between the most promising hybrid compounds and the main excretory transporter of the BBB, P-glycoprotein, was studied.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10858" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10858" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As peptidic carriers, different peptides with the potential to enter the brain parenchyma by receptor-mediated transcytosis (two different transferrin receptor binding peptides as well as AngioPep-2) or adsorptive transcytosis (TAT, TAT<sub>49–57</sub>, transportan, penetratin, and the nuclear localization sequence of human NF-κB) were chosen as model peptides. They strongly vary in length, structure, polarity, and geometry. This structural diversity was intended to elucidate possible influences of the peptide architecture on the hD<sub>2</sub> receptor affinity of the fallypride moiety in the resulting fusion drugs. Furthermore, the influence of linker structures and lengths between the peptide carrier and the receptor ligand was systematically evaluated.</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Synthesis of Thio-fallypride (FP-T, <b>1</b>)</h3><div class="NLM_p">The first step in the stable conjugation of fallypride to different peptidic carriers was the synthesis of a fallypride derivative containing a functional group in the terminal nonpharmacophoric position of the alkyl chain for peptide coupling. For this purpose, thiol-functionalization of fallypride was chosen because peptides can be easily modified with maleimides and subsequently reacted efficiently and site-specifically with thiol-bearing synthons, yielding a defined fusion molecule via simple and efficient click chemistry.</div><div class="NLM_p">The first attempts to obtain a thiol-functionalized fallypride molecule were made by implementing protected thiol-bearing synthons in the fallypride scaffold synthesis, resulting, however, only in the formation of byproducts. Hence, it was intended that the thiol functionality would be introduced by reacting tosyl-fallypride (FP-Tos)<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> with <i>S</i>-acetyl-thioethanolamine, 1,2-ethanedithiol, or 2,2′-dithiobis(ethylamine) dihydrochloride under mildly basic conditions. Unfortunately, the anticipated thiol-bearing products could not be isolated.</div><div class="NLM_p">We subsequently developed another method starting from FP-Tos using NaSH directly as the nucleophile in a DMF/H<sub>2</sub>O system. These reaction conditions yielded thiol-derivatized product FP-T (<b>1</b>) within short reaction times of only 10–20 min in good yields (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). As a result of the basic reaction conditions using NaSH, the dimer of FP-T was initially formed, which could subsequently be reduced efficiently using tris(2-carboxyethyl)phosphine hydrochloride (TCEP), giving the product in good overall yields of 76% after semipreparative HPLC purification.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/medium/jm-2014-004123_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0010.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of FP-T (<b>1</b>) Starting from Tosyl-fallypride<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5004123&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) NaSH, DMF/H<sub>2</sub>O 3:1, rt; (ii) TCEP, DMF/H<sub>2</sub>O, rt.</p></p></figure><div class="NLM_p last">For the first step of this reaction, an exact DMF/H<sub>2</sub>O ratio of 3:1 and a small solvent volume just sufficient to dissolve the FP-Tos were found to be critical to obtain the product in high yield and purity. In general, these conditions represent a valuable new complement to former approaches using NaSH for the conversion of tosylates into thiols.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40, 41)</a></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Synthesis of Maleimide-Comprising Peptidic Carriers <b>2a</b>–<b>22a</b> and Their Reaction with FP-T (<b>1</b>), Yielding Peptide–Fallypride Fusion Molecules <b>2</b>–<b>22</b></h3><div class="NLM_p">Carrier peptide maleimides <b>2a</b>–<b>22a</b> were synthesized by standard Fmoc-based solid-phase peptide synthesis (SPPS) using an excess of 3.9 equiv of <i>O</i>-(benzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium hexafluorophosphate (HBTU) and 4.0 equiv of amino acids and <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA) in each conjugation step. The products were obtained in yields of 11–90% after HPLC purification and lyophilization, depending on the complexity of the synthesized peptide.</div><div class="NLM_p">1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N</i>′,<i>N</i>″,<i>N</i>‴-tetraacetic acid (DOTA) is a powerful chelator for radiometals such as <sup>68</sup>Ga used for in vivo PET imaging. Thus, some DOTA-derivatized peptides were also synthesized as carriers. DOTA<sub>10</sub>–AngioPep–PEG<sub><i>x</i></sub>–maleimides <b>9a</b> and <b>17a</b>–<b>20a</b> and DOTA–TfR-P<sub>s</sub> maleimide <b>22a</b>, all comprising a lysine ε-amino-conjugated DOTA moiety, were synthesized via two different pathways. First, the standard reaction pathway was followed using Fmoc–Lys(Mtt)–OH as an amino acid derivative during the SPPS of peptides <b>9a</b> and <b>22a</b> followed by Mtt-deprotection under mildly acidic conditions and subsequent conjugation of tris-<i>t</i>-Bu-DOTA. However, this strategy gave products <b>9a</b> and <b>22a</b> in comparatively low yields of 19 and 11%, respectively. Thus, another approach was subsequently used, utilizing the amino acid building block Fmoc–Lys(tris-<i>t</i>-Bu-DOTA)–OH (<b>23</b>). This chelator-modified amino acid building block was synthesized from <i>N</i><sub>α</sub>-Fmoc-protected lysine and tris-<i>t</i>-Bu-DOTA using HBTU as an activating agent. Applying this building block in standard SPPS, the respective peptides, <b>9a</b>, <b>17a</b>–<b>20a</b>, and <b>22a</b>, could be obtained in significantly improved but still moderate yields of 20–32% after purification.</div><div class="NLM_p">Obtained peptide maleimides <b>2a</b>–<b>22a</b> were subsequently reacted with FP-T (<b>1</b>) in aqueous media at ambient temperature and neutral pH for 10 min (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Products <b>2</b>–<b>22</b> were purified by semipreparative HPLC and obtained in yields between 36 and 79%.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/medium/jm-2014-004123_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0011.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. General Reaction Pathway for the Conjugation Reactions of Peptide Maleimides <b>2a</b>–<b>22a</b> to FP-T (<b>1</b>), Yielding Peptide–FP-T conjugates <b>2</b>–<b>22</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5004123&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: PB/MeCN, pH 6.7–7.2, rt.</p></p></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Influence of Different Structural Elements in the Shuttle–Cargo Fusion Molecules on the hD<sub>2</sub> Receptor Binding Affinities of the Fallypride Moiety</h3><div class="NLM_p">In order to determine the influence of peptide architecture as well as potential linkers or other structure elements such as SiFA (silicon fluoride acceptor) and DOTA on the binding affinity of the conjugated fallypride moiety to the hD<sub>2</sub> receptor, we synthesized four different subsets of fusion molecules (<b>I</b>–<b>IV</b>) by systematically varying different structure elements. Subsequently, we determined the binding affinities of these hybrid compounds to the hD<sub>2</sub> receptor in vitro.</div><div id="sec2_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i8" class="anchor-spacer"></div><h4 class="article-section__title" id="_i8"> Hybrid Molecule Subset <b>I</b></h4><div class="NLM_p">This first subset of fusion molecules (<b>I</b>) was intended to reveal if the complexity of the carrier peptide exerts a significant influence on the binding parameters of the conjugated fallypride moiety. Thus, different peptidic carriers with the potential to cross the BBB by receptor-mediated processes (TfR-P<sub>s</sub>, TfR-P<sub>l</sub>, and AngioPep-2) or transcytosis (TAT, TAT<sub>49–57</sub>, transportan, penetratin, and nuclear localization sequence of NF-κB) of different lengths, amino acid sequence, and complexity were synthesized, derivatized with maleimides, and finally conjugated to FP-T (<b>1</b>). The resulting fusion molecules, <b>2</b>–<b>9</b>, are depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/medium/jm-2014-004123_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Schematic depiction of the synthesized shuttle–cargo fusion molecules of subset <b>I</b> (carrier peptide–FP-T fusion molecules <b>2</b>–<b>9</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5004123&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9"> Hybrid Molecule Subset <b>II</b></h4><div class="NLM_p">The second subset was based on the relatively short transferrin receptor binding peptide HAIYPRH (TfR-P<sub>s</sub>) that has been shown to be able to efficiently enter cells by specific transferrin receptor-mediated transport.<a onclick="showRef(event, 'ref10 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref10 ref42 ref43">(10, 42, 43)</a> This peptide scaffold was derivatized on a solid support with linkers of different lengths (γ-amino butyric acid, PEG<sub>1</sub>, PEG<sub>2</sub>, PEG<sub>3</sub>, PEG<sub>5</sub>, PEG<sub>7</sub>, and PEG<sub>11</sub>) in order to determine if the probable steric hindrance exerted by the peptide on the binding of the fallypride moiety to the hD<sub>2</sub> receptor could be attenuated by using an appropriate linker structure. The linker-comprising peptides were reacted on the solid support with maleimido-hexanoic acid, and after cleavage from the resin and purification they were conjugated to FP-T (<b>1</b>). The synthesized TfR-P<sub>s</sub>–PEG<sub><i>x</i></sub>–FP-T fusion molecules, <b>4</b> and <b>10</b>–<b>16</b>, comprising linkers of different length are depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/medium/jm-2014-004123_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of TfR-P<sub>s</sub>–PEG<sub><i>x</i></sub>–FP-T fusion molecules <b>4</b> and <b>10</b>–<b>16</b> (fusion molecule subset <b>II</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5004123&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10"> Hybrid Molecule Subset <b>III</b></h4><div class="NLM_p">The third subset of fusion molecules (<b>III</b>) was based on the AngioPep-2 peptide that enters the brain by specific receptor-mediated transcytosis utilizing the low-density lipoprotein related receptor LRP1.<a onclick="showRef(event, 'ref17 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref17 ref44 ref45">(17, 44, 45)</a> Because it has been shown that a derivatization in position Lys<sub>10</sub> of the peptide is well-tolerated in terms of AngioPep’s transport capacity,<a onclick="showRef(event, 'ref16 ref18'); return false;" href="javascript:void(0);" class="ref ref16 ref18">(16, 18)</a> the chelator DOTA was introduced in this position in all synthesized derivatives. For this purpose, the amino acid building block Fmoc–Lys(tris-<i>t</i>-Bu-DOTA)–OH (<b>23</b>) was synthesized and implemented into routine Fmoc-SPPS, giving improved yields compared to standard peptide scaffold synthesis, subsequent side-chain deprotection, and chelator functionalization. AngioPep-2 was further reacted on a solid support with PEG linkers of different lengths (PEG<sub>3</sub>, PEG<sub>5</sub>, PEG<sub>7</sub>, and PEG<sub>11</sub>) and maleimido-hexanoic acid. After cleavage from the resin and purification, the peptide derivatives were conjugated to FP-T (<b>1</b>). Synthesized AngioPep–PEG<sub><i>x</i></sub>–FP-T fusion molecules <b>9</b> and <b>17</b>–<b>20</b> are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/medium/jm-2014-004123_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structures of AngioPep–PEG<sub><i>x</i></sub>–FP-T fusion molecules <b>9</b> and <b>17</b>–<b>20</b> (fusion molecule subset <b>III</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5004123&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> Hybrid Molecule Subset <b>IV</b></h4><div class="NLM_p">Finally, the fourth group of fusion molecules comprised either a SiFA<a onclick="showRef(event, 'ref46 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref46 ref47 ref48">(46-48)</a> or DOTA moiety (for radiolabeling with <sup>18</sup>F or <sup>68</sup>Ga) as well as the near-infrared-emitting fluorescent dye, Py5.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> These fusion molecules could, in principle, be applicable in in vivo PET imaging or combined PET/optical imaging of hD<sub>2</sub> receptors. From these conjugates, it should be possible to determine if the binding affinity of the fallypride moiety to the hD<sub>2</sub> receptor tolerates complex structure elements essential for radiolabeling and in vivo imaging such as SiFA, DOTA, and fluorescent dyes introduced within the carrier peptide part of the molecule. Therefore, additional different conjugates based on TfR-P<sub>s</sub> and AngioPep-2 were synthesized and derivatized with a SiFA/DOTA and/or Py5 moiety. SiFA-comprising fusion molecule TfR-P<sub>s</sub>–SiFA–PEG<sub>3</sub>–FP-T (<b>21</b>) was synthesized using Fmoc–Lys(Mtt)–OH during the SPPS. The Mtt protecting group was cleaved under mildly acidic conditions before reacting with <i>bis</i>-Boc-aminooxy-acetic acid using the standard coupling protocol on solid support. The peptide was then modified with the PEG<sub>3</sub>-linker and maleimido-hexanoic acid, cleaved from the solid support, and reacted with SiFA-A, an aldehyde-bearing SiFA building block,<a onclick="showRef(event, 'ref48 ref50'); return false;" href="javascript:void(0);" class="ref ref48 ref50">(48, 50)</a> and FP-T (<b>1</b>) after purification. <b>22</b> was synthesized as described earlier. The DOTA and Py5 near-infrared fluorescent dye comprising fusion molecule <b>24</b> was obtained by reaction of DOTA<sub>10</sub>–AngioPep–FP-T (<b>9</b>) with Py5. Obtained fusion molecules <b>21</b>, <b>22</b>, and <b>24</b> are depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/medium/jm-2014-004123_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structures of TfR-P<sub>s</sub>–SiFA–PEG<sub>3</sub>–FP-T (<b>21</b>), TfR-P<sub>s</sub>–DOTA–PEG<sub>3</sub>–FP-T (<b>22</b>) and DOTA<sub>10</sub>–Py5<sub>15</sub>–AngioPep–FP-T (<b>24</b>) (fusion molecule subset <b>IV</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5004123&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> Synthesis of Control Substances</h4><div class="NLM_p">In order to exclude an unlikely but theoretically possible nonspecific interaction of the peptide/linker/2,5-dioxo-3-pyrrolidinyl-thioether/lipophilic SiFA structure of the fusion molecules with the hD<sub>2</sub> receptor, we prepared various negative control compounds that were also evaluated in vitro with regard to their binding affinities to the hD<sub>2</sub> receptor.</div><div class="NLM_p">TfR-P<sub>s</sub>–SiFA–PEG<sub>3</sub>–cysteine (<b>26</b>) was obtained by reaction of <b>21a</b> with cysteine in order to obtain a very structurally similar analogue to <b>21</b> that is, however, not able to specifically bind to the hD<sub>2</sub> receptor because it lacks the fallypride moiety, but it retains the peptide, PEG linker, SiFA moiety, and 2,5-dioxo-3-pyrrolidinyl-thioether. Furthermore, underivatized TfR-P<sub>s</sub> (<b>27</b>), TfR-P<sub>l</sub> (<b>28</b>), and TAT<sub>49–57</sub> (<b>29</b>) as well as a PEG<sub>3</sub>–FP-T (<b>25</b>, as a specific binding control) were synthesized and tested for their in vitro binding affinities to the hD<sub>2</sub> receptor together with fusion molecules <b>2</b>–<b>22</b>, <b>24</b>, and <b>26</b>. The structures of control substances <b>25</b>–<b>29</b> are presented in Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/medium/jm-2014-004123_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structures PEG<sub>3</sub>–FP-T (<b>25</b>), TfR-P<sub>s</sub>–SiFA–PEG<sub>3</sub>–cysteine (<b>26</b>), and underivatized TfR-P<sub>s</sub> (<b>27</b>), TfR-P<sub>l</sub> (<b>28</b>), and TAT<sub>49–57</sub> (<b>29</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5004123&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Radiolabeling of Fusion Molecules <b>9</b>, <b>17</b>–<b>22</b>, and <b>24</b> with <sup>18</sup>F and <sup>68</sup>Ga</h3><div class="NLM_p">In principle, the synthesized fusion molecules could be interesting candidates for in vivo imaging of the hD<sub>2/3</sub> receptor system with PET. Consequently, some of the conjugates were designed bearing a SiFA<a onclick="showRef(event, 'ref46 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref46 ref47 ref48">(46-48)</a> or DOTA moiety in order to be amenable to direct radiolabeling with <sup>18</sup>F and <sup>68</sup>Ga, respectively. In the following radiolabeling study, we investigated whether SiFA- and DOTA-comprising fusion molecules <b>9</b>,<b> 17</b>–<b>22</b>, and <b>24</b> are de facto amenable to radiolabeling with <sup>18</sup>F and <sup>68</sup>Ga.</div><div class="NLM_p">The radiolabeling of the fusion molecule DOTA<sub>10</sub>–Py5<sub>15</sub>–AngioPep–FP-T (<b>24</b>) with <sup>68</sup>Ga<sup>3+</sup> gave only poor radiolabeling results under standard reaction conditions, as several unidentified radioactive byproducts were formed that could not be easily separated by HPLC. Because labeling precursor <b>24</b> is structurally identical to <b>9</b> (apart from the near-infrared fluorescent dye Py5 being introduced into the <i>N</i><sub>ε</sub>-Lys<sub>15</sub> amino side chain functionality of the peptide), which can be labeled efficiently using standard conditions as described below, the formation of byproducts seems to be a result of the sensitivity of the large delocalized system of π electrons within the fluorescent dye. Thus, a derivative being amenable to <sup>68</sup>Ga labeling for PET imaging as well as to optical imaging simultaneously would require the use of a different, less sensitive near-infrared fluorescent dye.</div><div class="NLM_p">Also, when radiolabeling the fusion molecule TfR-P<sub>s</sub>–SiFA–PEG<sub>3</sub>–FP-T (<b>21</b>) with <sup>18</sup>F<sup>–</sup>, several unidentified radioactive byproducts were formed, resulting in only poor radiolabeling results under standard reaction conditions. Similar byproducts as those observed in the <sup>18</sup>F labeling of <b>21</b> were also observed for a structurally similar fusion molecule of TfR-P<sub>s</sub> and a SiFA moiety conjugated via a 2,5-dioxo-3-pyrrolidinyl-thioether structure (SiFA–<i>S</i>-maleimido–THRPPMWSPVWP).<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Because neither the presence of peptides comprising various side chain functionalities nor PEG linkers nor fallypride interfere with the used <sup>18</sup>F-SiFA-labeling conditions,<a onclick="showRef(event, 'ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref52 ref53">(52, 53)</a> it can be inferred from these data that the 2,5-dioxo-3-pyrrolidinyl-thioether structure element is sensitive to the slightly basic labeling conditions used, resulting in the formation of structurally similar, perhaps ring opening, byproducts. In order to circumvent the formation of these byproducts, milder <sup>18</sup>F-labeling conditions were applied, resulting in the formation of the desired product, [<sup>18</sup>F]<b>21</b>, only. These reaction conditions apply the so-called Munich method for cartridge-based [<sup>18</sup>F]fluoride drying<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> and a subsequent in part neutralization of the reaction mixture with oxalic acid, which has been shown to give excellent radiolabeling results.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Under these conditions, the only byproduct is unreacted [<sup>18</sup>F]fluoride, which can be easily removed by cartridge purification, giving final product [<sup>18</sup>F]<b>21</b> in radiochemical yields of up to 60%, radiochemical purities of ≥98%, and specific activities of up to 80 GBq/μmol (2160 mCi/μmol) in an overall synthesis time of only 25 min.</div><div class="NLM_p last">The <sup>68</sup>Ga labeling of fusion molecules <b>9</b>, <b>17</b>–<b>20</b>, and <b>22</b> proceeded efficiently, giving the radiolabeled products in high radiochemical yields and purities of 96–98% as well as in high specific activities of 19.2–28.1 GBq/μmol (519–759 mCi/μmol) using standard labeling conditions.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Determination of hD<sub>2</sub> Receptor Binding Affinities of <b>2</b>–<b>22</b> and <b>24</b>–<b>29</b></h3><div class="NLM_p">Fusion shuttle–carrier fusion molecules <b>2</b>–<b>22</b> and <b>24</b> as well as control substances <b>25</b>–<b>29</b> were tested in vitro for their hD<sub>2</sub> receptor binding affinity in an established competition binding assay by displacement of [<sup>3</sup>H]spiperone on human D<sub>2</sub> receptor-transfected HEK cells.<a onclick="showRef(event, 'ref51 ref55'); return false;" href="javascript:void(0);" class="ref ref51 ref55">(51, 55)</a> This is an established procedure, with the obtained affinities giving a valuable indication of the biological potency of the newly developed receptor ligands. All binding experiments were performed at least thrice separately, with each experiment being carried out in triplicate. The binding affinity of fallypride derivative <b>1</b> could not be determined because it showed considerable dimerization under the conditions of the in vitro binding experiment that would have falsified the results. Fallypride (FP), desmethoxy-fallypride (DMFP), raclopride (RP), haloperidol (HP), chlorpromazine (CP), and (+)-butaclamol (BC) were coevaluated as reference compounds. Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> summarizes the results of these evaluations.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. <i>K</i><sub>i</sub> Values of Compounds <b>2</b>–<b>22</b> and <b>24</b>–<b>29</b> and Internal Standards<a class="ref internalNav" href="#tbl1-fn1" aria-label="b">b</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/medium/jm-2014-004123_0012.gif" alt="" id="GRAPHIC-d863e1477-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Concentrations of up to 1 μM were studied and showed no displacement of [<sup>3</sup>H]spiperone. Abbreviations: FP, Fallypride; DMFP, desmethoxy-fallypride; RP, raclopride; HP, haloperidol; CP, chlorpromazine; and BC, (+)-butaclamol.</p></div><div class="footnote" id="tbl1-fn1"><sup>Table b</sup><p class="last">Yellow, fusion molecule subset <b>I</b>; orange, fusion molecule subset <b>II</b>; green, fusion molecule subset <b>III</b>; blue, fusion molecule subset <b>IV</b>; violet, positive and negative controls; and grey, internal standards.</p></div></div><div></div></div><div class="NLM_p">As can be seen from the in vitro data, the binding affinity of the fallypride moiety to the hD<sub>2</sub> receptor is still in the nanomolar range (between 1.5 and 64.2 nM) for all studied compounds and thus it is in a comparable range to that of raclopride (affinity: 1.2 nM) and chlorpromazine (affinity: 6.1 nM), although the affinity is markedly reduced upon conjugation to complex structural systems such as peptides. This is remarkable insofar as a more pronounced reduction of binding affinities was expected, especially in the case of large peptidic carriers that were hypothesized to considerably hamper the fallypride moiety from binding to the hD<sub>2</sub> receptor by folding effects, steric hindrance, or entropy effects.</div><div class="NLM_p">As expected, fusion molecule <b>26</b> (comprising all structure elements of high-affinity binder <b>21</b> except for the fallypride moiety: TfR-binding peptide, PEG linker, lipophilic SiFA moiety, and 2,5-dioxo-3-pyrrolidinyl-thioether) and unmodified peptides <b>27</b>–<b>29</b> showed no affinity to the hD<sub>2</sub> receptor in the studied concentration range of up to 1 μM. This conclusively demonstrates that the observed high hD<sub>2</sub> receptor binding affinities of the fusion molecules are a result of the fallypride structure element and thus specific binding.</div><div class="NLM_p">The complexity, length, and individual structure of the used peptidic carriers (studied within subset <b>I</b>; compounds <b>2</b>–<b>9</b>) seems to have no significant influence on the binding affinities of the conjugated fallypride moiety. Fusion molecules comprising very short peptides such as <b>4</b> exhibit comparable affinities (10.3 nM) as that of very complex ones such as <b>7</b> or <b>6</b> (8.1 and 12.3 nM, respectively). This is further corroborated by the results obtained for compound <b>9</b>, for which a relatively high affinity of 8.0 nM was observed (which is the highest observed affinity within this subgroup) despite the rather long peptide sequence, the variety in hydrophilic as well as lipophilic amino acid side chain functionalities, and the additional chelator structure within the peptide sequence.</div><div class="NLM_p">Regarding the linker length, whose influence was studied within the subsets <b>II</b> (compounds <b>4</b> and <b>10</b>–<b>16</b>) and <b>III</b> (compounds <b>9</b> and <b>17</b>–<b>20</b>) using the transferrin receptor-affine peptide TfR-P<sub>s</sub> and AngioPep as scaffold peptides, significant effects of linker lengths on binding affinities were observed. Within TfR-P<sub>s</sub>–PEG<sub><i>x</i></sub>–FP-T subgroup <b>II</b>, the best results were found for <b>13</b> (binding affinity of 1.5 nM), whereas shorter or longer linkers resulted in lower affinities between 10.3 and 53.9 nM, which might be attributable to suboptimal receptor penetration depths in the case of short linkers and entropy costs in the case of long linkers.</div><div class="NLM_p">However, different results were obtained within AngioPep–PEG<sub><i>x</i></sub>–FP-T series <b>III</b>, where the highest binding affinity of 8.0 nM was found for derivative <b>9</b> that does not have any linker structure at all. The introduction of a linker in this subset resulted in affinities moderately decreasing from 26.1 to 44.7 nM with increasing linker lengths.</div><div class="NLM_p">Thus, the linker length resulting in optimal binding parameters in such fusion molecules has to be determined for each peptide system independently.</div><div class="NLM_p last">A considerable influence on binding affinities was also observed for the conjugation of SiFA, DOTA, and Py5 within the peptide carrier sequence that was studied in subgroup <b>IV</b>, including fusion molecules <b>21</b>, <b>22</b>, and <b>24</b>. The conjugation of a <sup>18</sup>F-binder or NIR dye resulted in a markedly decreased binding affinity in the case of the introduction of a small lipophilic SiFA or Py5 moiety (6.0 nM for <b>21</b> instead of 1.5 nM for its lead compound, <b>13</b>, and 64.2 nM for <b>24</b> instead of 8.0 nM in the case of its lead compound, <b>9</b>) and even a significant decrease in affinity in the case of the introduction of a hydrophilic and sterically demanding DOTA moiety (52.0 nM for <b>22</b> instead of 1.5 nM in case of its lead compound, <b>13</b>). The strong reduction of affinity observed in the case of DOTA introduction into the peptide sequence of TfR-P<sub>s</sub> (<b>22</b>) interestingly does not seem to be a result of the position of conjugation (the introduction of the SiFA moiety in the same position (<b>21</b>) did not result in such a marked decrease of binding affinity) but might be a consequence of the higher hydrophilicity/charge of the DOTA moiety compared to that of the SiFA scaffold.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Molecular Modeling of the hD<sub>2</sub> Receptor and Docking Studies</h3><div class="NLM_p">As a more pronounced reduction in the binding affinities of fallypride to the human D<sub>2</sub> receptor was expected upon conjugation to large and complex peptidic carriers, we also performed homology modeling of the receptor and docking studies of selected compounds (fallypride, <b>25</b>, and <b>13</b>; detailed information is available in the <a class="ref internalNav" href="#notes-3" aria-label="Supporting Information">Supporting Information</a>). By this, we intended to determine the influence of the different structure elements of the fusion molecules on hD<sub>2</sub> receptor binding and to elucidate the reason for the experimentally observed preserved binding of the hybrid molecules.</div><div class="NLM_p">When docking hybrid molecule <b>13</b> to the modeled hD<sub>2</sub> receptor, the peptide, in contrast to the PEG linker, does not seem to contribute to the stabilization of fusion molecule binding to the hD<sub>2</sub> receptor, as it is mostly exposed to solvent. The predicted binding of <b>13</b> to the hD<sub>2</sub> receptor is depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>A,B and shows an overlay of the predicted binding modes of <b>25</b> and <b>13</b> for direct comparison.</div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/medium/jm-2014-004123_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0008.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) Predicted binding mode of <b>13</b> to the model hD<sub>2</sub> receptor obtained from 6 ns MD simulations. The fallypride part of compound <b>13</b> is depicted in original atom color, the linker part, in green, and the peptidic part (TfR-binding peptide), in yellow. (B) Overlay of the energy-minimized MD average structures of <b>25</b> (in cyan carbon atoms) and <b>13</b> (fallypride is depicted in original atom color, linker structure, in green, and peptide, in yellow) bound to the hD<sub>2</sub> receptor. The hD<sub>2</sub> receptor is displayed as a molecular surface in gray for improved clarity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5004123&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Hence, this in silico modeling shows that the fallypride moiety of the fusion molecules is still able to bind in its binding pocket of the hD<sub>2</sub> receptor and that the linker and peptide do not seem to negatively influence the ligand binding by not directly interacting with the binding pocket of the receptor. On the contrary, it indicates that the PEG linker might contribute to the observed preserved binding properties of the fallypride moiety by creating a spatial separation between the binding ligand and the peptidic carrier.</div><div class="NLM_p last">These results obtained in silico thus support the three main experimentally observed effects: (i) the retained binding affinity of the hybrid molecules to the hD<sub>2</sub> receptor, (ii) the increased affinity of PEG linker-modified hybrid molecules when optimizing linker lengths, and (iii) the missing influence of the peptide size and complexity on the fallypride binding (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Estimation of the Blood–Brain Barrier Permeability of Hybrid Compounds <b>9</b>, <b>13</b>, <b>21</b>, and <b>22</b>, Native TfR-Binding Peptide, AngioPep-2, and Fallypride</h3><div class="NLM_p">After having shown that the conjugation of a small neuroreceptor-affine drug to a transport peptide can result in a hybrid compound that is still able to bind its target receptor, we intended to estimate the potential of the developed fusion molecules to enter the brain parenchyma. The BBB is the last hurdle for the hybrid compounds in the studied molecular Trojan horse approach using covalent conjugates of receptor-affine small molecules and peptides as carriers. On the molecular level, the P-glycoprotein transporter protein (P-gp) is known to play the major role in the development of drug resistance that is associated with limited CNS permeation of drug candidates.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Because of its broad substrate spectrum and high expression level at various blood–tissue barriers, P-gp considerably affects the pharmacokinetics and bioavailability of various agents.</div><div class="NLM_p">The Calcein cell assay is a highly sensitive, specific, and reliable screening method that allows for the rapid evaluation and classification of drug candidates according to their P-gp interaction.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> A key detection component in this assay is the Calcein–acetoxymethylester (Calcein-AM) complex that is easily internalized in cells and acts as a substrate of both P-gp and intracellular esterases. In the presence of a P-gp inhibitor or substrate, the transporter binding sites are occupied, and as a result, the Calcein-AM complex cannot interact with P-gp. In this case, Calcein-AM is not transported out of the cells and is hydrolyzed to the fluorescent product, Calcein, by the activity of cellular esterases. Depending on the P-gp affinity of certain test compounds, the amount of Calcein formation reaches different levels at specific compound concentrations. The level of the fluorophore formation serves as an indicator to determine the P-gp interaction profile of the given test compounds.<a onclick="showRef(event, 'ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref56 ref57">(56, 57)</a> In this study, we used the human brain endothelial capillary cell line hCMEC/D3 that exhibits stable expression of P-gp.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> In order to verify the assay, we used known P-gp inhibitor cyclosporine A as an internal positive control.</div><div class="NLM_p">In this assay, we studied the most promising hybrid molecules, <b>9</b>, <b>13</b>, <b>21</b>, and <b>22</b>, as well as their native peptide lead structures <b>27</b>, AngioPep-2, and the receptor ligand fallypride as references and Cyclosporine A as positive control.</div><div id="sec2_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Determination of the Toxicity of the Substances</h4><div class="NLM_p last">In order to exclude the possibility that the tested compounds are toxic to the cells and thus falsifying the Calcein assay, the cytotoxicity of the compounds was evaluated in an AlamarBlue assay that identifies cytotoxic substances by their ability to decrease the metabolic activity and thus the redox potential of viable cells. The assay revealed no cytotoxic effects for any of the tested compounds on hCMEC/D3 cells (Figure S1, <a class="ref internalNav" href="#notes-3" aria-label="Supporting Information">Supporting Information</a>).</div></div><div id="sec2_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Determination of the Interaction of Hybrid Molecules and P-glycoprotein</h4><div class="NLM_p">The interaction of the substances with P-gp was studied by subjecting them to the Calcein assay, which is a highly sensitive, specific, and reliable screening method that allows for the rapid evaluation and classification of drug candidates according to their P-gp interaction.<a onclick="showRef(event, 'ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref56 ref57">(56, 57)</a> Intracellular accumulation of free Calcein corresponds to the degree of P-gp interaction of a given test compound. For this assay, the hCMEC/D3 cell line was used, which is known to stably express P-gp.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> The P-gp inhibitor, Cyclosporine A, served as an internal positive control.</div><div class="NLM_p">None of the studied substances, neither hybrid molecules nor native peptides nor fallypride, were substrates of P-gp (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>), implying that they are not transported from the abluminal to the luminal side of the endothelium by P-gp. Although this assay is not able to reproduce the complex situation in a living subject, these results indicate that the transport of the developed fusion molecules over the BBB is not prevented by the main excretory transporter of the BBB, P-gp.</div><figure id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/medium/jm-2014-004123_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0009.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Results obtained from the Calcein assay to identify the interaction of the studied substances with P-gp. Intracellular fluorescence in the absence of test compounds was set as 100%. None of the substances showed any modulation of P-gp in the concentration range of 0.1–10 μM. At higher concentrations, fallypride as well as <b>21</b> showed an interaction with the applied esterase, disturbing the assay at concentrations >10 μM and resulting in the lower fluorescence values observed, which are not consequence of P-gp modulation by these compounds. Cyclosporine A was used as a positive control and showed an IC<sub>50</sub> value of 0.94 μM under the same conditions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5004123&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26226" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26226" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">From the obtained results, it can be inferred that even a small neuroreceptor ligand such a fallypride binding to the hD<sub>2/3</sub> receptor can be conjugated to a relatively large peptidic carrier molecule while largely retaining its nanomolar binding affinity to the target receptor (specific binding affinities of up to 1.5 nM were found in this study).</div><div class="NLM_p">These promising experimental in vitro results were further substantiated by in silico molecular modeling studies that indicated that the fallypride moiety of the fusion molecules is still able to bind to its binding pocket of the hD<sub>2</sub> receptor. Despite the significant structural changes exerted by conjugation, neither linker nor peptide seem to negatively influence the ligand binding to its receptor. The linker can even slightly stabilize the ligand–receptor interaction according to the in silico modeling.</div><div class="NLM_p">Furthermore, the most promising hybrid substances were tested to determine if they possibly interact with P-gp, showing that these substances are not substrates of this transporter. This indicates that the transcytosis of the developed fusion molecules over the BBB is not prevented by its main excretory transporter, P-gp.</div><div class="NLM_p last">These findings should encourage enlarging the research focus of molecular Trojan horse drug delivery across the BBB from the generally used proteins toward transport peptides as carriers.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80154" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80154" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General</h3><div class="NLM_p">All commercially available chemicals were of analytical grade and were used without further purification. Resins for peptide synthesis, coupling reagents, and Fmoc-protected amino acids were purchased from NovaBiochem. Calcein and Cyclosporine A were purchased at the highest purity grade from Sigma-Aldrich. EBM-2 basal medium and Single-Quot Kit were obtained from Lonza, fetal bovine serum, from Biochrom, and rat-tail collagen type I, from Hoffmann-LaRoche. SiFA-A, Py5, and tosyl-fallypride were synthesized as described elsewhere.<a onclick="showRef(event, 'ref39 ref50 ref59'); return false;" href="javascript:void(0);" class="ref ref39 ref50 ref59">(39, 50, 59)</a> For analytical and semipreparative HPLC chromatography, an Agilent 1200 system or a Dionex 3000 HPLC system equipped with a Gabi-Star (Raytest) radioactivity detector was used. The columns used for chromatography were Chromolith Performance (RP-18e, 100–4.6 mm, Merck, Germany) and Chromolith (RP-18e, 100–10 mm, Merck, Germany) columns, operated with flows of 4 and 8 mL/min, respectively. The preparative HPLC system used was a Knauer Preparative Pump 1800 together with a Knauer Smartline UV detector 2600 and a Chromolith Prep (RP-18e, 100–25 mm, Merck, Germany) column, operated with a flow of 100 mL/min. ESI, MALDI, and NMR spectra were obtained with a Finnigan MAT95Q, a Bruker Daltonics Microflex, and a Jeol AS500 spectrometer, respectively.</div><div class="NLM_p">The purity of synthesized compounds <b>1</b>,<b> 2a</b>–<b>22a</b>, and <b>2</b>–<b>29</b> was ≥96% in each case, as determined by analytical HPLC.</div><div class="NLM_p">The determination of the FP-T–peptide conjugate binding affinities to the human D<sub>2</sub> receptor was performed by competition binding experiments according to a previously described procedure.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></div><div class="NLM_p last">A detailed description of homology modeling of the hD<sub>2</sub> receptor, model prediction, docking studies, and molecular dynamics simulations as well as a detailed description of the cytotoxicity and Calcein assays can be found in the <a class="ref internalNav" href="#notes-3" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Synthesis of 3-(3-((1-Allylpyrrolidin-2-yl)methylcarbamoyl)-4,5-dimethoxy-phenyl)-propyl-thiol (FP-T, <b>1</b>)</h3><div class="NLM_p last">A solution of sodium hydrosulfide (217 mg, 3.87 mmol) in DMF/H<sub>2</sub>O (3:1, 1 mL) was added to a solution of tosyl-fallypride (200 mg, 387 μmol) in DMF (650 μL). The initially dark green color of the solution bleached within 10 to 15 min, indicating the end of the reaction. After addition of H<sub>2</sub>O (1 mL), Tris(2-carboxyethyl)phosphine hydrochloride (TCEP) (∼150 mg) was added as a solid until gas formation stopped. The crude product was purified by semipreparative HPLC using a gradient of 0–40% MeCN + 0.1% FA over 6 min. The product was obtained as colorless oil after lyophilization (111 mg, 293 μmol, 76%). <sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>): δ 8.56 (bs, 1H), 7.35–7.32 (m, 1H), 7.10–7.07 (m, 1H), 6.13–6.03 (m, 1H), 5.53 (d, 1H, <i>J</i><sup>2</sup> = 16.5), 5.41 (d, 1H, <i>J</i><sup>2</sup> = 10.3), 4.06–4.02 (m, 1H), 3.92 (s, 3H), 3.90 (s, 3H), 3.89–3.70 (m, 4H), 3.23–3.16 (m, 1H, <i>J</i><sup>3</sup> = 7.7), 2.72 (t, 2H, <i>J</i><sup>3</sup> = 7.7), 2.68–2.46 (m, 4H), 2.36–2.31 (m, 1H), 2.13–2.07 (m, 2H), 2.01–1.82 (m, 2H), 1.77 (t, 1H, <i>J</i><sup>3</sup> = 7.9). <sup>13</sup>C NMR (acetone-<i>d</i><sub>6</sub>): δ 166.89, 153.68, 146.88, 138.29, 129.24, 127.48, 124.69, 122.20, 116.73, 66.82, 61.52, 58.07, 56.41, 54.41, 41.53, 36.46, 34.71, 29.11, 24.26, 23.53. ESI-MS (<i>m</i>/<i>z</i>) for [M + H]<sup>+</sup> (calcd): 379.20 (379.20).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> General Synthesis of Carrier Peptide Maleimides <b>2a</b>–<b>20a</b></h3><div class="NLM_p">Peptides were synthesized on solid support by standard Fmoc solid-phase peptide synthesis as described by Wellings et al.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> using standard commercially available resins, amino acids, Fmoc–amino−PEG–acids and Fmoc–Lys(tris-<i>t</i>-Bu-DOTA)–OH (<b>23</b>). The N-terminal modification with maleimido-hexanoic acid was accomplished using the standard coupling protocol for amino acids after cleavage of the N-terminal Fmoc protecting group. The resulting maleimide-modified peptides were cleaved from the solid support using a mixture of TFA (trifluoroacetic acid)/TIS (triisopropylsilane)/H<sub>2</sub>O (95:2.5:2.5) for 90 min, suspended in diethyl ether, and purified by semipreparative HPLC. The products were isolated as white solids after lyophilization. Gradients used for HPLC purification and overall synthesis yields are given below.</div><div class="NLM_p last"><b>2a</b>: gradient, 0–30% MeCN in 6 min; yield, 90%; MALDI-MS (<i>m</i>/<i>z</i>) for [M + H]<sup>+</sup> (calcd): 1912.2 (1912.1). <b>3a</b>: gradient, 0–30% MeCN in 6 min; yield, 72%; ESI-MS (<i>m</i>/<i>z</i>) for [M + 2H]<sup>2+</sup> (calcd): 738.92 (766.97). <b>4a</b>: gradient, 15–40% MeCN in 6 min, yield: 76%; ESI-MS (<i>m</i>/<i>z</i>) for [M + H]<sup>+</sup> (calcd): 1085.55 (1085.55), (<i>m</i>/<i>z</i>) for [M + 2H]<sup>2+</sup> (calcd): 543.28 (543.27). <b>5a</b>: gradient, 20–45% MeCN in 6 min; yield, 44%; MALDI-MS (<i>m</i>/<i>z</i>) for [M + H]<sup>+</sup> (calcd): 1683.6 (1683.8). <b>6a</b>: gradient, 30–80% MeCN in 6 min; yield, 11%; MALDI-MS (<i>m</i>/<i>z</i>) for [M + H]<sup>+</sup> (calcd): 3040.6 (3035.8). <b>7a</b>: gradient, 15–40% MeCN in 6 min; yield, 28%; ESI-MS (<i>m</i>/<i>z</i>) for [M + 3H]<sup>3+</sup> (calcd): 814.13 (832.80), (<i>m</i>/<i>z</i>) for [M + 4H]<sup>4+</sup> (calcd): 610.85 (624.85). <b>8a</b>: gradient, 15–40% MeCN in 6 min; yield, 83%; ESI-MS (<i>m</i>/<i>z</i>) for [M + H]<sup>+</sup> (calcd): 1476.84 (1476.84), (<i>m</i>/<i>z</i>) for [M + 2H]<sup>2+</sup> (calcd): 738.92 (738.92). <b>9a</b>: gradient, 0–50% MeCN in 6 min; yield, 31%; ESI-MS (<i>m</i>/<i>z</i>) for [M + H + Na + K<sub>complexed</sub>]<sup>2+</sup> (calcd): 1471.64 (1471.66), (<i>m</i>/<i>z</i>) for [M + 2H + Na + K<sub>complexed</sub>]<sup>3+</sup> (calcd): 981.10 (981.11). <b>10a</b>: gradient, 0–30% MeCN in 6 min; yield, 69%; ESI-MS (<i>m</i>/<i>z</i>) for [M + H]<sup>+</sup> (calcd): 1170.60 (1170.60), (<i>m</i>/<i>z</i>) for [M + 2H]<sup>2+</sup> (calcd): 585.80 (585.80). <b>11a</b>: gradient, 0–30% MeCN in 6 min; yield, 73%; ESI-MS (<i>m</i>/<i>z</i>) for [M + H]<sup>+</sup> (calcd): 1230.62 (1230.62), (<i>m</i>/<i>z</i>) for [M + 2H]<sup>2+</sup> (calcd): 616.31 (615.81). <b>12a</b>: gradient, 0–30% MeCN in 6 min; yield, 61%; ESI-MS (<i>m</i>/<i>z</i>) for [M + H]<sup>+</sup> (calcd): 1288.66 (1288.66), (<i>m</i>/<i>z</i>) for [M + 2H]<sup>2+</sup> (calcd): 644.83 (644.83). <b>13a</b>: gradient, 0–30% MeCN in 6 min; yield, 65%; ESI-MS (<i>m</i>/<i>z</i>) for [M + H]<sup>+</sup> (calcd): 1332.69 (1332.69), (<i>m</i>/<i>z</i>) for [M + 2H]<sup>2+</sup> (calcd): 666.85 (666.85). <b>14a</b>: gradient, 0–30% MeCN in 6 min; yield, 84%; ESI-MS (<i>m</i>/<i>z</i>) for [M + H]<sup>+</sup> (calcd): 1420.74 (1420.74), (<i>m</i>/<i>z</i>) for [M + 2H]<sup>2+</sup> (calcd): 710.87 (710.87). <b>15a</b>: gradient, 10–40% MeCN in 6 min; yield, 71%; ESI-MS (<i>m</i>/<i>z</i>) for [M + H]<sup>+</sup> (calcd): 1508.80 (1508.79), (<i>m</i>/<i>z</i>) for [M + 2H]<sup>2+</sup> (calcd): 754.90 (754.90). <b>16a</b>: gradient, 10–40% MeCN in 6 min; yield, 73%; ESI-MS (<i>m</i>/<i>z</i>) for [M + H]<sup>+</sup> (calcd): 1684.90 (1684.90), (<i>m</i>/<i>z</i>) for [M + 2H]<sup>2+</sup> (calcd): 842.95 (842.95). <b>17a</b>: gradient, 0–40% MeCN in 6 min; yield, 32%; substance was directly reacted with FP-T after reduction of solvent volume. <b>18a</b>: gradient, 0–40% MeCN in 6 min; yield, 31%; substance was directly reacted with FP-T after reduction of solvent volume. <b>19a</b>: gradient, 0–40% MeCN in 6 min; yield, 31%; substance was directly reacted with FP-T after reduction of solvent volume. <b>20a</b>: gradient, 0–40% MeCN in 6 min; yield, 22%; substance was directly reacted with FP-T after reduction of solvent volume.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Synthesis of TfR-P<sub>s</sub>–SiFA–PEG<sub>3</sub>–Maleimide <b>21a</b></h3><div class="NLM_p last">TfR-P<sub>s</sub> (50 μmol) was synthesized on solid support as described above. Fmoc–Lys(Mtt)–OH was coupled using the standard coupling protocol after removal of the N-terminal Fmoc protecting group followed by coupling of Fmoc–PEG<sub>3</sub>–OH and maleimido-hexanoic acid. For selective deprotection of the terminal lysine side chain functionality, the Mtt protecting group was cleaved using TFA (1.75%) and TIS (1%) in DCM, and the resulting charged ammonium group was converted into the amine by treatment with DIPEA in DCM (2%, 6 × 2 mL) before reacting with <i>bis</i>-Boc-aminooxy-acetic acid using the standard coupling protocol. The peptide was cleaved from the solid support, deprotected, and purified by semipreparative HPLC using a gradient of 0–40% MeCN + 0.1% FA over 6 min. The product was obtained as a white solid after lyophilization (15.6 mg, 10.2 μmol, 20%). ESI-MS (<i>m</i>/<i>z</i>) for [M + H]<sup>+</sup> (calcd): 1533.80 (1533.80), (<i>m</i>/<i>z</i>) for [M + 2H]<sup>2+</sup> (calcd): 767.40 (767.40). Subsequently, a solution of this aminooxy-functionalized intermediate (9.4 mg, 6.13 μmol) in PB (0.5 M, pH 4, 150 μL) was added to a solution of SiFA-A (3.26 mg, 12.26 μmol) in MeCN (300 μL). After 10 min, the crude product was purified by semipreparative HPLC using a gradient of 20–90% MeCN + 0.1% FA over 6 min. The product was obtained as a white solid after lyophilization (5.3 mg, 2.98 μmol, 49%). ESI-MS (<i>m</i>/<i>z</i>) for [M – H]<sup>−</sup> (calcd): 1781.92 (1781.94).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Synthesis of TfR-P<sub>s</sub>–DOTA–PEG<sub>3</sub>–Maleimide <b>22a</b></h3><div class="NLM_p last">TfR-P<sub>s</sub> (50 μmol) was synthesized on solid support as described above. Fmoc–Lys(tris-<i>t</i>-Bu-DOTA)–OH (<b>23</b>) was introduced using the standard coupling protocol after removal of the N-terminal Fmoc protecting group followed by coupling of Fmoc–PEG<sub>3</sub>–OH and maleimido-hexanoic acid. The peptide was cleaved from the solid support, deprotected, and purified by semipreparative HPLC using a gradient of 0–40% MeCN + 0.1% FA over 6 min. The product was obtained as a white solid after lyophilization (18.3 mg, 9.91 μmol, 20%). ESI-MS (<i>m</i>/<i>z</i>) for [M + H + Na<sub>salt</sub> + K<sub>complexed</sub>]<sup>+</sup> (calcd): 1909.88 (1909.93), (<i>m</i>/<i>z</i>) for [M + 2H + Na<sub>salt</sub> + K<sub>complexed</sub>]<sup>2+</sup> (calcd): 954.94 (954.97).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> General Synthesis of Carrier Peptide–FP-T Conjugates <b>2</b>–<b>22</b></h3><div class="NLM_p">To a solution of peptide maleimides <b>2a</b>–<b>22a</b> (2.5–10 μmol) in PB (phosphate buffer, 0.1 M, pH 4.0)/MeCN 1:1 (250 μL) was added a solution of FP-T (<b>1</b>, 1.25 equiv) in MeCN, and the pH of the solution was adjusted to 6.7–7.2 using PB (0.5 M, pH 7.2, ∼ 50 μL). After 10 min, the reactions were complete, and the crude products were purified by semipreparative HPLC. The products were isolated as white solids after lyophilization. Gradients used for HPLC purification and overall synthesis yields are given below.</div><div class="NLM_p last"><b>2</b>: gradient, 0–40% MeCN in 6 min; yield, 71%; MALDI-MS (<i>m</i>/<i>z</i>) for [M + H]<sup>+</sup> (calcd): 2291 (2289). <b>3</b>: gradient, 15–40% MeCN in 6 min; yield, 67%; ESI-MS (<i>m</i>/<i>z</i>) for [M + 4H]<sup>4+</sup> (calcd): 478.54 (478.53). <b>4</b>: gradient, 15–50% MeCN in 6 min; yield, 56%; ESI-MS (<i>m</i>/<i>z</i>) for [M + 2H]<sup>2+</sup> (calcd): 732.37 (732.37). <b>5</b>: gradient, 20–45% MeCN in 6 min; yield, 62%; ESI-MS (<i>m</i>/<i>z</i>) for [M + 2H]<sup>2+</sup> (calcd): 1031.51 (1031.50), (<i>m</i>/<i>z</i>) for [M + 3H]<sup>3+</sup> (calcd): 688.01 (688.00). <b>6</b>: gradient, 30–80% MeCN in 6 min; yield, 36%; MALDI-MS (<i>m</i>/<i>z</i>) for [M + H]<sup>+</sup> (calcd): 3414.8 (3413.9). <b>7</b>: gradient, 15–40% MeCN in 6 min; yield, 69%; ESI-MS (<i>m</i>/<i>z</i>) for [M + 4H]<sup>4+</sup> (calcd): 733.64 (719.40), (<i>m</i>/<i>z</i>) for [M + 5H]<sup>5+</sup> (calcd): 564.52 (575.72). <b>8</b>: gradient, 15–40% MeCN in 6 min; yield, 66%; ESI-MS (<i>m</i>/<i>z</i>) for [M + 3H]<sup>3+</sup> (calcd): 619.02 (619.01). <b>9</b>: gradient, 10–50% MeCN in 6 min; yield, 46%; ESI-MS (<i>m</i>/<i>z</i>) for [M + 3H]<sup>3+</sup> (calcd): 1086.86 (1086.85), (<i>m</i>/<i>z</i>) for [M + 4H]<sup>4+</sup> (calcd): 815.39 (815.39). <b>10</b>: gradient, 0–40% MeCN in 6 min; yield, 65%; MALDI-MS (<i>m</i>/<i>z</i>) for [M + H]<sup>+</sup> (calcd): 1550.4 (1548.8). <b>11</b>: gradient, 0–40% MeCN in 6 min; yield, 64%; MALDI-MS (<i>m</i>/<i>z</i>) for [M + H]<sup>+</sup> (calcd): 1610.7 (1608.8). <b>12</b>: gradient, 0–40% MeCN in 6 min; yield, 56%; MALDI-MS (<i>m</i>/<i>z</i>) for [M + H]<sup>+</sup> (calcd): 1669.0 (1666.9). <b>13</b>: gradient, 0–40% MeCN in 6 min; yield, 69%; MALDI-MS (<i>m</i>/<i>z</i>) for [M + H]<sup>+</sup> (calcd): 1713.1 (1710.9). <b>14</b>: gradient, 10–40% MeCN in 6 min; yield, 57%; ESI-MS (<i>m</i>/<i>z</i>) for [M + 2H]<sup>2+</sup> (calcd): 899.97 (899.97), (<i>m</i>/<i>z</i>) for [M + 3H]<sup>3+</sup> (calcd): 600.32 (600.31). <b>15</b>: purification performed using a Kromasil C8 preparative column, gradient, 0–50% MeCN in 6 min; yield, 72%; ESI-MS (<i>m</i>/<i>z</i>) for [M + 2H]<sup>2+</sup> (calcd): 944.00 (944.00); (<i>m</i>/<i>z</i>) for [M + 3H]<sup>3+</sup> (calcd): 630.00 (629.66). <b>16</b>: purification performed using a Kromasil C8 preparative column, gradient, 0–50% MeCN in 6 min; yield, 64%; ESI-MS (<i>m</i>/<i>z</i>) for [M + 2H]<sup>2+</sup> (calcd): 1032.05 (1032.05), (<i>m</i>/<i>z</i>) for [M + 3H]<sup>3+</sup> (calcd): 688.70 (688.37). <b>17</b>: gradient, 0–50% MeOH in 6 min; yield, 40%; MALDI-MS (<i>m</i>/<i>z</i>) for [M + H]<sup>+</sup> (calcd): 3507.8 (3505.7). <b>18</b>: gradient, 0–50% MeOH in 6 min; yield, 70%; MALDI-MS (<i>m</i>/<i>z</i>) for [M + H]<sup>+</sup> (calcd): 3598.0 (3593.7). <b>19</b>: gradient, 0–50% MeOH in 6 min; yield, 74%; MALDI-MS (<i>m</i>/<i>z</i>) for [M + H]<sup>+</sup> (calcd): 3682.8 (3681.8). <b>20</b>: gradient, 0–50% MeOH in 6 min; yield, 75%; MALDI-MS (<i>m</i>/<i>z</i>) for [M + H]<sup>+</sup> (calcd): 3859.3 (3857.9). <b>21</b>: gradient, 10–65% MeCN in 6 min; yield, 79%; ESI-MS (<i>m</i>/<i>z</i>) for [M + 2H]<sup>2+</sup> (calcd): 1080.66 (1080.57), (<i>m</i>/<i>z</i>) for [M + 3H]<sup>3+</sup> (calcd): 721.05 (720.71). <b>22</b>: gradient, 10–40% MeCN in 6 min; yield, 42%; ESI-MS (<i>m</i>/<i>z</i>) for [M + 2H]<sup>2+</sup> (calcd): 1113.04 (1113.08), (<i>m</i>/<i>z</i>) for [M + 3H]<sup>3+</sup> (calcd): 742.73 (742.39).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Synthesis of Fmoc–Lys(tris-<i>t</i>-Bu-DOTA)–OH (<b>23</b>)</h3><div class="NLM_p last">To a solution of <i><i>N,N</i>,N</i>′<i>,N</i>′-tetramethyl-<i>O-</i>(1<i>H</i>-benzotriazol-1-yl)uronium hexafluorophosphate (HBTU, 1.0 g, 2.65 mmol) and tris-<i>t</i>-Bu-DOTA (1.56 g, 2.72 mmol) in DMF (6 mL) was added diisopropylethylamine (DIPEA, 464 μL, 2.72 mmol). After 2 min reaction time, the mixture was added to a suspension of Fmoc–lysine (1.0 g, 2.72 mmol) in DMF (2 mL) and reacted for 30 min. Afterward, the nonreacted Fmoc–lysine was filtered off, and the solvent was removed. The crude product was purified by preparative HPLC using a gradient of 15–70% MeCN + 0.1% TFA over 10 min. The product was obtained as light yellow solid oil after lyophilization (815 mg, 883 μmol, 33%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.52 (bs, 1H), 7.91 (d, 2H, <i>J</i><sup>3</sup> = 7.6), 7.75–7.72 (m, 2H), 7.69 (d, 1H, <i>J</i><sup>3</sup> = 8.3), 7.43 (t, 2H, <i>J</i><sup>3</sup> = 7.5), 7.33 (t, 2H, <i>J</i><sup>3</sup> = 7.5), 4.33–4.20 (m, 2H), 3.96–3.90 (m, 2H), 3.61–2.87 (bm, 18H), 1.74–1.23 (m, 6H), 1.47 (s, 9H), 1.39 (s, 18H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 175.57, 173.86, 158.70, 158.35, 158.01, 156.11, 143.69, 140.65, 127.59, 126.30, 125.21, 120.08, 65.52, 54.56, 54.46, 53.54, 53.21, 53.19, 50.79, 50.69, 50.61, 46.57, 27.59, 23.07. ESI-MS (<i>m</i>/<i>z</i>) for [M + Na]<sup>+</sup> (calcd): 923.55 (923.54).</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Synthesis of DOTA<sub>10</sub>–Py5<sub>15</sub>–AngioPep–FP-T (<b>24</b>)</h3><div class="NLM_p last">To a solution of DOTA<sub>10</sub>–AngioPep–maleimide–FP-T conjugate (<b>9</b>, 3.1 mg, 0.95 μmol) and Py5 (0.7 mg, 1.90 μmol) in DMF (250 μL) was added DIPEA (0.32 μL, 1.90 μmol), and the mixture was reacted for 10 min. The crude product was purified by semipreparative HPLC using a gradient of 10–40% MeCN + 0.1% FA over 6 min. The product was obtained as a dark red solid after lyophilization (1.37 mg, 0.38 μmol, 40%). ESI-MS (<i>m</i>/<i>z</i>) for [M + 2H]<sup>3+</sup> (calcd): 1173.91 (1173.90), (<i>m</i>/<i>z</i>) for [M + 3H]<sup>4+</sup> (calcd): 880.68 (880.68).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Synthesis of PEG<sub>3</sub>–FP-T (<b>25</b>)</h3><div class="NLM_p last">To a commercially available Rink Amide resin (50 μmol) were subsequently coupled Fmoc–PEG<sub>3</sub>–OH and maleimido-hexanoic acid using standard amino acid coupling conditions. The product was cleaved from the resin as described before and purified by semipreparative HPLC using a gradient of 10–40% MeCN + 0.1% FA over 6 min. The product was obtained as colorless crystallizing oil after lyophilization (19 mg, 41.6 μmol, 83%). ESI-MS (<i>m</i>/<i>z</i>) for [M + H]<sup>+</sup> (calcd): 480.23 (480.23). Subsequently, a solution of this maleimide intermediate (4.8 mg, 10.5 μmol) in PB (phosphate buffer, 0.1 M, pH 4.0)/MeCN 1:1 (250 μL) was added to a solution of FP-T (<b>1</b>, 3.0 mg, 7.9 μmol), and the pH of the solution was adjusted to 7.0 using PB (0.5 M, pH 7.2, ∼ 50 μL). After 10 min, the product was purified by semipreparative HPLC using a gradient of 10–50% MeCN + 0.1% FA over 6 min. The product was isolated as colorless oil after lyophilization (2.72 mg, 3.26 μmol, 41%). ESI-MS (<i>m</i>/<i>z</i>) for [M + H]<sup>+</sup> (calcd): 836.45 (836.44).</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Synthesis of TfR-P<sub>s</sub>–SiFA–PEG<sub>3</sub>–Cysteine (<b>26</b>)</h3><div class="NLM_p last">To a solution of TfR-P<sub>s</sub>–SiFA–PEG<sub>3</sub>–maleimide (<b>21a</b>, 6.2 mg, 3.48 μmol) in MeCN/PB (0.1M, pH 5.0) 1:1 (300 μL) was added a solution of cysteine (1.0 mg, 8.26 μmol) in H<sub>2</sub>O (100 μL), and the pH of the mixture was adjusted to 7.0 using PB (0.5 M, pH 7.2, ∼25 μL). After 5 min, the crude product was purified by semipreparative HPLC using a gradient of 10–65% MeCN + 0.1% FA over 6 min. The product was obtained as white solid after lyophilization (3.54 mg, 1.86 μmol, 53%). ESI-MS (<i>m</i>/<i>z</i>) for [M + H]<sup>+</sup> (calcd): 1903.96 (1902.96), (<i>m</i>/<i>z</i>) for [M + 2H]<sup>2+</sup> (calcd): 952.48 (951.98).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Synthesis of Nonmodified Peptides TfR-P<sub>s</sub> (<b>27</b>), NTP (<b>28</b>), and TAT<sub>49–57</sub> (<b>29</b>)</h3><div class="NLM_p">The peptides were synthesized on solid support, deprotected, and cleaved using standard protocols as described before. The products were purified by semipreparative HPLC and isolated as white solids after lyophilization. Gradients used for HPLC purification, synthesis yields, and analytical data are given below.</div><div class="NLM_p last"><b>27</b>: gradient, 0–40% MeCN in 6 min; yield, 86%; ESI-MS (<i>m</i>/<i>z</i>) for [M + H]<sup>+</sup> (calcd): 892.47 (892.47). <b>28</b>: gradient, 0–30% MeCN in 6 min; yield, 73%; ESI-MS (<i>m</i>/<i>z</i>) for [M + 2H]<sup>2+</sup> (calcd): 642.39 (642.39). <b>29</b>: gradient, 0–30% MeCN in 6 min; yield, 71%; ESI-MS (<i>m</i>/<i>z</i>) for [M + 4H]<sup>4+</sup> (calcd): 335.72 (335.72); MALDI-MS (<i>m</i>/<i>z</i>) for [M + H]<sup>+</sup> (calcd): 1340.2 (1339.9).</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <sup>18</sup>F Radiolabeling of <b>21</b></h3><div class="NLM_p last">Standard radiolabeling conditions: To a solution of dried [<i>n</i>-Bu<sub>4</sub>N]<sup>18</sup>F complex (4.1–6.2 GBq) in DMSO (500 μL), obtained as described elsewhere,<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> was added a solution of <b>21</b> (25 nmol, 54 μg) in dry DMSO (2.5 μL), and the mixture was reacted for 5 min at ambient temperature without stirring. Subsequently, the reaction mixture was added to HEPES buffer (0.1 M, pH 4, 9 mL) and loaded on a Waters SepPak C-18 light cartridge, previously conditioned with ethanol (5 mL) and water (10 mL). The trapped product was washed with water (5 mL), eluted from the cartridge with ethanol (200 μL), and diluted with isotonic saline solution (2 mL). The purified product solution was subjected to analytical radio-HPLC, which showed an insufficient radiochemical purity of the product of 81–85%. Optimized radiolabeling conditions: Aqueous [<sup>18</sup>F]fluoride in target water was passed through a SAX cartridge (Sep-Pak Accell Plus QMA Carbonate light (46 mg)) followed by 20 mL of air, 5 mL of anhydrous acetonitrile, and again 20 mL of air. The [<sup>18</sup>F]fluoride was eluted with a solution of [K<sup>+</sup>⊂K2.2.2]OH<sup>–</sup> in anhydrous acetonitrile (0.5 mL) containing 110 μmol Kryptofix 2.2.2 and 100 μmol KOH. To this solution were added first a solution of oxalic acid (1M, 21 μL) and subsequently a solution of <b>21</b> (25 nmol, 54 μg) in anhydrous DMSO (2.5 μL), and the mixture was reacted for 5 min at ambient temperature without stirring. Subsequently, the reaction mixture was added to HEPES buffer (0.1 M, pH 2, 9 mL) and loaded on a Waters SepPak C-18 light cartridge. The trapped product was washed with water (5 mL), eluted from the cartridge with ethanol (200 μL), and finally diluted with isotonic saline solution (2 mL). The purified product solution was subjected to analytical radio-HPLC. The radiolabeled product, [<sup>18</sup>F]<b>21</b>, was found to be ≥98% pure and was obtained in specific activities of up to 80 GBq/μmol and radiochemical yields of up to 60% in a total synthesis time of 25 min.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> <sup>68</sup>Ga Radiolabeling of <b>9</b>, <b>17</b>–<b>20</b>, <b>22</b>, and <b>24</b></h3><div class="NLM_p last">A solution of the respective fusion molecule (10–12.5 nmol) in HEPES buffer (0.025 M, pH 4.0, 100 μL) was added to 170–290 MBq of <sup>68</sup>Ga<sup>3+</sup> in sodium acetate solution obtained by fractioned elution of a <sup>68</sup>Ge/<sup>68</sup>Ga generator (IGG100, Eckert & Ziegler, Berlin, Germany) with HCl (0.1 M, 1.2 mL) and subsequent titration to pH 3.5–4.0 by addition of sodium acetate solution (1.25 M, 90–95 μL). After reaction for 10 min at 99 °C, the reaction mixtures were cooled to ambient temperature and analyzed by analytical radio-HPLC. The radiolabeled products, [<sup>68</sup>Ga]<b>9</b>, [<sup>68</sup>Ga]<b>17</b>–[<sup>68</sup>Ga]<b>20</b>, and [<sup>68</sup>Ga]<b>22</b> were found to be 96–98% pure and obtained in specific activities of 19.2–28.1 GBq/μmol.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35"><a href="/doi/suppl/10.1021/jm5004123">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08773" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08773" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Detailed description of the homology modeling of the hD<sub>2</sub> receptor; the model prediction, docking studies, molecular dynamics simulations, and results of these in silico studies; and a detailed description of the cytotoxicity and Calcein assays. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm5004123/suppl_file/jm5004123_si_001.pdf">jm5004123_si_001.pdf (877.56 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB ID for protein hD<sub>3</sub> receptor in complex with antagonist eticlopride: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBL">3PBL</a>.</p><div class="testing" data-doi="10.1021/jm5004123" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50202" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50202" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carmen Wängler</span> - <span class="hlFld-Affiliation affiliation">McConnell
Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal H3A 2B4, Canada</span>; 
    <span class="hlFld-Affiliation affiliation">Biomedical
Chemistry, Department of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim of Heidelberg University, Mannheim 68167, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Nuclear Medicine, University Hospital
Munich, Ludwig-Maximilians-University Munich, Munich 81377, Germany</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#460527342b23286811272328212a2334062b23222b276833282f6b2e232f22232a24233421682223"><span class="__cf_email__" data-cfemail="db98baa9b6beb5f58cbabeb5bcb7bea99bb6bebfb6baf5aeb5b2f6b3beb2bfbeb7b9bea9bcf5bfbe">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shafinaz Chowdhury</span> - <span class="hlFld-Affiliation affiliation">Lady
Davis Institute, Jewish General Hospital, McGill University, Montreal H3T 1E2, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Georg Höfner</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical
Chemistry, Ludwig-Maximilians-University
Munich, Munich 81377, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Petia Djurova</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmacy and Molecular Biotechnology, University of Heidelberg, Heidelberg 69120, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Enrico O. Purisima</span> - <span class="hlFld-Affiliation affiliation">National
Research Council of Canada, Montreal H4P 2R2, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Bartenstein</span> - <span class="hlFld-Affiliation affiliation">Department
of Nuclear Medicine, University Hospital
Munich, Ludwig-Maximilians-University Munich, Munich 81377, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Björn Wängler</span> - <span class="hlFld-Affiliation affiliation">Molecular
Imaging and Radiochemistry, Department of Clinical Radiology and Nuclear
Medicine, Medical Faculty Mannheim of Heidelberg
University, Mannheim 68167, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gert Fricker</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmacy and Molecular Biotechnology, University of Heidelberg, Heidelberg 69120, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Klaus T. Wanner</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical
Chemistry, Ludwig-Maximilians-University
Munich, Munich 81377, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ralf Schirrmacher</span> - <span class="hlFld-Affiliation affiliation">McConnell
Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal H3A 2B4, Canada</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d863e3161-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13231" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13231" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">C.W. thanks the Fonds der Chemischen Industrie for financial support. R.S. thanks the Natural Sciences and Engineering Council (NSERC) Canada and the FRSQ funded Quebec Bio-Imaging Network for financial support.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i38" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i38"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i39" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i39"> Abbreviations Used</h2><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">BC</td><td class="NLM_def"><p class="first last">(+)-butaclamol</p></td></tr><tr><td class="NLM_term">Calcein-AM</td><td class="NLM_def"><p class="first last">calcein–acetoxymethylester complex</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">CP</td><td class="NLM_def"><p class="first last">chlorpromazine</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DOTA</td><td class="NLM_def"><p class="first last">1,4,7,10-tetraaza-cyclododecane-<i>N</i>,<i>N</i>′,<i>N</i>″,<i>N</i>‴-tetraacetic acid</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">DMFP</td><td class="NLM_def"><p class="first last">desmethoxy-fallypride</p></td></tr><tr><td class="NLM_term">ESI</td><td class="NLM_def"><p class="first last">electrospray ionization</p></td></tr><tr><td class="NLM_term">FP</td><td class="NLM_def"><p class="first last">fallypride</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G protein-coupled receptor</p></td></tr><tr><td class="NLM_term">HBTU</td><td class="NLM_def"><p class="first last"><i>O</i>-(benzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">HP</td><td class="NLM_def"><p class="first last">haloperidol</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">KRB</td><td class="NLM_def"><p class="first last">Krebs ringer buffer</p></td></tr><tr><td class="NLM_term">MALDI</td><td class="NLM_def"><p class="first last">matrix-assisted laser desorption/ionization</p></td></tr><tr><td class="NLM_term">NIR</td><td class="NLM_def"><p class="first last">near-infrared</p></td></tr><tr><td class="NLM_term">PEG</td><td class="NLM_def"><p class="first last">poly(ethylene glycol)</p></td></tr><tr><td class="NLM_term">PET</td><td class="NLM_def"><p class="first last">positron emission tomography</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">RP</td><td class="NLM_def"><p class="first last">raclopride</p></td></tr><tr><td class="NLM_term">SIE</td><td class="NLM_def"><p class="first last">solvated interaction energy</p></td></tr><tr><td class="NLM_term">SiFA</td><td class="NLM_def"><p class="first last">silicon fluoride acceptor</p></td></tr><tr><td class="NLM_term">SPPS</td><td class="NLM_def"><p class="first last">solid-phase peptide synthesis</p></td></tr><tr><td class="NLM_term">TfR</td><td class="NLM_def"><p class="first last">transferrin receptor</p></td></tr><tr><td class="NLM_term">VIP</td><td class="NLM_def"><p class="first last">vasoactive intestinal peptide</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67356" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67356" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 61 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Schirrmacher, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard-Gauthier, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reader, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soucy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirrmacher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wängler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wängler, C.</span><span> </span><span class="NLM_article-title">Design of brain imaging agents for positron emission tomography: do large bioconjugates provide an opportunity for in vivo brain imaging?</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1621</span><span class="NLM_x">–</span> <span class="NLM_lpage">1634</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.4155%2Ffmc.13.128" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVOgsb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=1621-1634&author=R.+Schirrmacherauthor=V.+Bernard-Gauthierauthor=A.+Readerauthor=J.+P.+Soucyauthor=E.+Schirrmacherauthor=B.+W%C3%A4nglerauthor=C.+W%C3%A4ngler&title=Design+of+brain+imaging+agents+for+positron+emission+tomography%3A+do+large+bioconjugates+provide+an+opportunity+for+in+vivo+brain+imaging%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Design of brain imaging agents for positron emission tomography: do large bioconjugates provide an opportunity for in vivo brain imaging?</span></div><div class="casAuthors">Schirrmacher, Ralf; Bernard-Gauthier, Vadim; Reader, Andrew; Soucy, Jean-Paul; Schirrmacher, Esther; Waengler, Bjoern; Waengler, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1621-1634</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">The development of brain imaging agents for positron emission tomog. and other in vivo imaging modalities mostly relies on small compds. of low MW as a result of the restricted transport of larger mols., such as peptides and proteins, across the blood-brain barrier.  Besides passive transport, only a few active carrier mechanisms, such as glucose transporters and amino acid transporters, have so far been exploited to mediate the accumulation of imaging probes in the brain.  An important question for the future is whether some of the abundant active carrier systems located at the blood-brain barrier can be used to shuttle potential, but non-crossing, imaging agents into the brain.  What are the biol. and chem. constrictions toward such bioconjugates and is it worthwhile to persue such a delivery strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4Z2wOe_zhr7Vg90H21EOLACvtfcHk0lgHhIRIQO3kPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVOgsb7I&md5=1831933d19d453600d692d58ce7803c2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.4155%2Ffmc.13.128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.13.128%26sid%3Dliteratum%253Aachs%26aulast%3DSchirrmacher%26aufirst%3DR.%26aulast%3DBernard-Gauthier%26aufirst%3DV.%26aulast%3DReader%26aufirst%3DA.%26aulast%3DSoucy%26aufirst%3DJ.%2BP.%26aulast%3DSchirrmacher%26aufirst%3DE.%26aulast%3DW%25C3%25A4ngler%26aufirst%3DB.%26aulast%3DW%25C3%25A4ngler%26aufirst%3DC.%26atitle%3DDesign%2520of%2520brain%2520imaging%2520agents%2520for%2520positron%2520emission%2520tomography%253A%2520do%2520large%2520bioconjugates%2520provide%2520an%2520opportunity%2520for%2520in%2520vivo%2520brain%2520imaging%253F%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2013%26volume%3D5%26spage%3D1621%26epage%3D1634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Pardridge, W. M.</span><span> </span><span class="NLM_article-title">Re-engineering biopharmaceuticals for delivery to brain with molecular trojan horses</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1327</span><span class="NLM_x">–</span> <span class="NLM_lpage">1338</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc800148t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntVymsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=1327-1338&author=W.+M.+Pardridge&title=Re-engineering+biopharmaceuticals+for+delivery+to+brain+with+molecular+trojan+horses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Re-Engineering Biopharmaceuticals for Delivery to Brain with Molecular Trojan Horses</span></div><div class="casAuthors">Pardridge, William M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1327-1338</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Biopharmaceuticals, including recombinant proteins, monoclonal antibody therapeutics, and antisense or RNA interference drugs, cannot be developed as drugs for the brain, because these large mols. do not cross the blood-brain barrier (BBB).  Biopharmaceuticals must be re-engineered to cross the BBB, and this is possible with genetically engineered mol. Trojan horses.  A mol. Trojan horse is an endogenous peptide, or peptidomimetic monoclonal antibody (mAb), which enters brain from blood via receptor-mediated transport on endogenous BBB transporters.  Recombinant neurotrophins, single chain Fv antibodies, or therapeutic enzymes may be re-engineered as IgG fusion proteins.  The engineering of IgG-avidin fusion proteins enables the BBB delivery of biotinylated drugs.  The IgG fusion proteins are new chem. entities that are dual or triple function mols. that bind multiple receptors.  The fusion proteins are able both to enter the brain, by binding an endogenous BBB receptor, and to induce the desired pharmacol. effect in brain, by binding target receptors in the brain behind the BBB.  The development of mol. Trojan horses for BBB drug delivery allows the re-engineering of biopharmaceuticals that, owing to the BBB problem, could not otherwise be developed as new drugs for the human brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWMtDrX08sBLVg90H21EOLACvtfcHk0lgHhIRIQO3kPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntVymsr8%253D&md5=33a66171dd5ee634a5270169e9b28669</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fbc800148t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc800148t%26sid%3Dliteratum%253Aachs%26aulast%3DPardridge%26aufirst%3DW.%2BM.%26atitle%3DRe-engineering%2520biopharmaceuticals%2520for%2520delivery%2520to%2520brain%2520with%2520molecular%2520trojan%2520horses%26jtitle%3DBioconjugate%2520Chem.%26date%3D2008%26volume%3D19%26spage%3D1327%26epage%3D1338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Pardridge, W. M.</span><span> </span><span class="NLM_article-title">Drug transport across the blood-brain barrier</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1959</span><span class="NLM_x">–</span> <span class="NLM_lpage">1972</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1038%2Fjcbfm.2012.126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=22929442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1akurfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=1959-1972&author=W.+M.+Pardridge&title=Drug+transport+across+the+blood-brain+barrier"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Drug transport across the blood-brain barrier</span></div><div class="casAuthors">Pardridge, William M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow & Metabolism</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1959-1972</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The blood-brain barrier (BBB) prevents the brain uptake of most pharmaceuticals.  This property arises from the epithelial-like tight junctions within the brain capillary endothelium.  The BBB is anatomically and functionally distinct from the blood-cerebrospinal fluid barrier at the choroid plexus.  Certain small mol. drugs may cross the BBB via lipid-mediated free diffusion, providing the drug has a mol. wt. <400 Da and forms <8 hydrogen bonds.  These chem. properties are lacking in the majority of small mol. drugs, and all large mol. drugs.  Nevertheless, drugs can be reengineered for BBB transport, based on the knowledge of the endogenous transport systems within the BBB.  Small mol. drugs can be synthesized that access carrier-mediated transport (CMT) systems within the BBB.  Large mol. drugs can be reengineered with mol. Trojan horse delivery systems to access receptor-mediated transport (RMT) systems within the BBB.  Peptide and antisense radiopharmaceuticals are made brain-penetrating with the combined use of RMT-based delivery systems and avidin-biotin technol.  Knowledge on the endogenous CMT and RMT systems expressed at the BBB enable new solns. to the problem of BBB drug transport.  Journal of Cerebral Blood Flow & Metab. (2012) 32, 1959-1972; doi:10.1038/jcbfm.2012.126; published online 29 August 2012.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8BKNlB45nSrVg90H21EOLACvtfcHk0lgHhIRIQO3kPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1akurfJ&md5=f05b190f1e4373fdaf8e3cba794a587c</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fjcbfm.2012.126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjcbfm.2012.126%26sid%3Dliteratum%253Aachs%26aulast%3DPardridge%26aufirst%3DW.%2BM.%26atitle%3DDrug%2520transport%2520across%2520the%2520blood-brain%2520barrier%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2012%26volume%3D32%26spage%3D1959%26epage%3D1972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Pardridge, W. M.</span><span> </span><span class="NLM_article-title">Biopharmaceutical drug targeting to the brain</span> <span class="citation_source-journal">J. Drug Targeting</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">167</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.3109%2F10611860903548354" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=20064077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivFeks78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=157-167&author=W.+M.+Pardridge&title=Biopharmaceutical+drug+targeting+to+the+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Biopharmaceutical drug targeting to the brain</span></div><div class="casAuthors">Pardridge, William M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Targeting</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">157-167</span>CODEN:
                <span class="NLM_cas:coden">JDTAEH</span>;
        ISSN:<span class="NLM_cas:issn">1061-186X</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Biopharmaceuticals are large mol. drugs that do not cross the blood-brain barrier (BBB).  The limiting factor in the drug development of biopharmaceuticals as new drugs for the human brain is the engineering of effective brain drug targeting technol. platforms.  Recombinant proteins, enzymes, and monoclonal antibodies can be re-engineered for transport across the human BBB with the mol. Trojan horse technol.  The most active BBB mol. Trojan horse is a monoclonal antibody to the human insulin receptor.  The genetic engineering of IgG fusion proteins was demonstrated for neurotrophic factors, decoy receptors, therapeutic enzymes, single chain Fv antibodies, and avidin.  The IgG fusion proteins are not toxic on repeated administration in high doses to primates and do not interfere with glycemic control in plasma or brain.  IgG fusion proteins contain amino acid sequences that induce immune tolerance, and show low immunogenicity in primates.  The IgG fusion proteins are new bifunctional biopharmaceuticals that are both targeted to brain via transport on endogenous BBB receptors, and exert pharmacol. effects in brain at the cognate receptor, ligand, or enzyme substrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRWOOTMvV4QbVg90H21EOLACvtfcHk0liv0Dr99mU-fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivFeks78%253D&md5=d043c468777e8ed37cba3e08708faf96</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.3109%2F10611860903548354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10611860903548354%26sid%3Dliteratum%253Aachs%26aulast%3DPardridge%26aufirst%3DW.%2BM.%26atitle%3DBiopharmaceutical%2520drug%2520targeting%2520to%2520the%2520brain%26jtitle%3DJ.%2520Drug%2520Targeting%26date%3D2010%26volume%3D18%26spage%3D157%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Patel, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goyal, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhadada, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatt, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amin, A. F.</span><span> </span><span class="NLM_article-title">Getting into the brain: approaches to enhance brain drug delivery</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2009&pages=35-58&author=M.+M.+Patelauthor=B.+R.+Goyalauthor=S.+V.+Bhadadaauthor=J.+S.+Bhattauthor=A.+F.+Amin&title=Getting+into+the+brain%3A+approaches+to+enhance+brain+drug+delivery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DM.%2BM.%26aulast%3DGoyal%26aufirst%3DB.%2BR.%26aulast%3DBhadada%26aufirst%3DS.%2BV.%26aulast%3DBhatt%26aufirst%3DJ.%2BS.%26aulast%3DAmin%26aufirst%3DA.%2BF.%26atitle%3DGetting%2520into%2520the%2520brain%253A%2520approaches%2520to%2520enhance%2520brain%2520drug%2520delivery%26jtitle%3DCNS%2520Drugs%26date%3D2009%26volume%3D23%26spage%3D35%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Smith, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gumbleton, M.</span><span> </span><span class="NLM_article-title">Endocytosis at the blood–brain barrier: from basic understanding to drug delivery strategies</span> <span class="citation_source-journal">J. Drug Targeting</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">–</span> <span class="NLM_lpage">214</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1080%2F10611860600650086" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=16777679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsFyru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=191-214&author=M.+W.+Smithauthor=M.+Gumbleton&title=Endocytosis+at+the+blood%E2%80%93brain+barrier%3A+from+basic+understanding+to+drug+delivery+strategies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Endocytosis at the blood-brain barrier: from basic understanding to drug delivery strategies</span></div><div class="casAuthors">Smith, Mathew W.; Gumbleton, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Targeting</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">191-214</span>CODEN:
                <span class="NLM_cas:coden">JDTAEH</span>;
        ISSN:<span class="NLM_cas:issn">1061-186X</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  The blood-brain barrier (BBB) protects the central nervous system (CNS) from potentially harmful xenobiotics and endogenous mols.  Anatomically, it comprises the brain microvasculature whose functionality is nevertheless influenced by assocd. astrocyte, pericyte and neuronal cells.  The highly restrictive paracellular pathway within brain microvasculature restricts significant CNS penetration to only those drugs whose physicochem. properties afford ready penetration into hydrophobic cell membranes or are capable of exploiting endogenous active transport processes such as solute carriers or endocytosis pathways.  Endocytosis at the BBB is an essential pathway by which the brain obtains its nutrients and affords communication with the periphery.  The development of strategies to exploit these endocytic pathways for the purposes of drug delivery to the CNS is still an immature field although some impressive results were documented with the targeting of particular receptors.  This current article initially provides an overview of general endocytosis processes and pathways showing evidence of their functional existence within the BBB.  Subsequent sections provide, in an entity-specific manner, comprehensive reviews on BBB transport investigations of endocytosis involving: transferrin and the targeting of the transferrin receptor; hormones; cytokines; cell penetrating peptides; microorganisms and toxins, and nanoparticles aimed at more effectively delivering drugs to the CNS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzIwFBgV4FlLVg90H21EOLACvtfcHk0liv0Dr99mU-fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsFyru7o%253D&md5=31776a86a3b6ca21c5540b131457786f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1080%2F10611860600650086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10611860600650086%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DM.%2BW.%26aulast%3DGumbleton%26aufirst%3DM.%26atitle%3DEndocytosis%2520at%2520the%2520blood%25E2%2580%2593brain%2520barrier%253A%2520from%2520basic%2520understanding%2520to%2520drug%2520delivery%2520strategies%26jtitle%3DJ.%2520Drug%2520Targeting%26date%3D2006%26volume%3D14%26spage%3D191%26epage%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Pardridge, W. M.</span><span> </span><span class="NLM_article-title">Blood–brain barrier delivery of protein and non-viral gene therapeutics with molecular trojan horses</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">345</span><span class="NLM_x">–</span> <span class="NLM_lpage">348</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2007&pages=345-348&author=W.+M.+Pardridge&title=Blood%E2%80%93brain+barrier+delivery+of+protein+and+non-viral+gene+therapeutics+with+molecular+trojan+horses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPardridge%26aufirst%3DW.%2BM.%26atitle%3DBlood%25E2%2580%2593brain%2520barrier%2520delivery%2520of%2520protein%2520and%2520non-viral%2520gene%2520therapeutics%2520with%2520molecular%2520trojan%2520horses%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2007%26volume%3D122%26spage%3D345%26epage%3D348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Pardridge, W. M.</span><span> </span><span class="NLM_article-title">Drug targeting to the brain</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1733</span><span class="NLM_x">–</span> <span class="NLM_lpage">1744</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1007%2Fs11095-007-9324-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=17554607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BD2sXosVKgtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2007&pages=1733-1744&author=W.+M.+Pardridge&title=Drug+targeting+to+the+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Drug Targeting to the Brain</span></div><div class="casAuthors">Pardridge, William M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1733-1744</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The goal of brain drug targeting technol. is the delivery of therapeutics across the blood-brain barrier (BBB), including the human BBB.  This is accomplished by re-engineering pharmaceuticals to cross the BBB via specific endogenous transporters localized within the brain capillary endothelium.  Certain endogenous peptides, such as insulin or transferrin, undergo receptor-mediated transport across the BBB in vivo.  In addn., peptidomimetic monoclonal antibodies (MAb) may also cross the BBB via RMT on the endogenous transporters.  The MAb may be used as a mol. Trojan horse to ferry across the BBB large mol. pharmaceuticals, including recombinant proteins, antibodies, RNA interference drugs, or non-viral gene medicines.  Fusion proteins of the mol. Trojan horse and either neurotrophins or single chain Fv antibodies have been genetically engineered.  The fusion proteins retain bi-functional properties, and both bind the BBB receptor, to trigger transport into brain, and bind the cognate receptor inside brain to induce the pharmacol. effect.  Trojan horse liposome technol. enables the brain targeting of non-viral plasmid DNA.  Mol. Trojan horses may be formulated with fusion protein technol., avidin-biotin technol., or Trojan horse liposomes to target to brain virtually any large mol. pharmaceutical.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuz680fGNiBLVg90H21EOLACvtfcHk0lj823bbTQcpDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXosVKgtrk%253D&md5=1240d9a47eb361850e8a76ee76ce0413</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs11095-007-9324-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-007-9324-2%26sid%3Dliteratum%253Aachs%26aulast%3DPardridge%26aufirst%3DW.%2BM.%26atitle%3DDrug%2520targeting%2520to%2520the%2520brain%26jtitle%3DPharm.%2520Res.%26date%3D2007%26volume%3D24%26spage%3D1733%26epage%3D1744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Gabathuler, R.</span><span> </span><span class="NLM_article-title">Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1016%2Fj.nbd.2009.07.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=19664710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGms7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2010&pages=48-57&author=R.+Gabathuler&title=Approaches+to+transport+therapeutic+drugs+across+the+blood%E2%80%93brain+barrier+to+treat+brain+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases</span></div><div class="casAuthors">Gabathuler, Reinhard</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-57</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The central nervous system is protected by barriers which control the entry of compds. into the brain, thereby regulating brain homeostasis.  The blood-brain barrier, formed by the endothelial cells of the brain capillaries, restricts access to brain cells of blood-borne compds. and facilitates nutrients essential for normal metab. to reach brain cells.  This very tight regulation of the brain homeostasis results in the inability of some small and large therapeutic compds. to cross the blood-brain barrier (BBB).  Therefore, various strategies are being developed to enhance the amt. and concn. of therapeutic compds. in the brain.  In this review, we will address the different approaches used to increase the transport of therapeutics from blood into the brain parenchyma.  We will mainly conc. on the physiol. approach which takes advantage of specific receptors already expressed on the capillary endothelial cells forming the BBB and necessary for the survival of brain cells.  Among all the approaches used for increasing brain delivery of therapeutics, the most accepted method is the use of the physiol. approach which takes advantage of the transcytosis capacity of specific receptors expressed at the BBB.  The low d. lipoprotein receptor related protein (LRP) is the most adapted for such use with the engineered peptide compd. (EPiC) platform incorporating the Angiopep peptide in new therapeutics the most advanced with promising data in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXnM4hn2vGGrVg90H21EOLACvtfcHk0lj823bbTQcpDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGms7jE&md5=ede4d80cd5fabc1080289b5446072d07</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2009.07.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2009.07.028%26sid%3Dliteratum%253Aachs%26aulast%3DGabathuler%26aufirst%3DR.%26atitle%3DApproaches%2520to%2520transport%2520therapeutic%2520drugs%2520across%2520the%2520blood%25E2%2580%2593brain%2520barrier%2520to%2520treat%2520brain%2520diseases%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2010%26volume%3D37%26spage%3D48%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engler, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collawn, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, B. A.</span><span> </span><span class="NLM_article-title">Receptor mediated uptake of peptides that bind the human transferrin receptor</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">2004</span><span class="NLM_x">–</span> <span class="NLM_lpage">2012</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1046%2Fj.1432-1327.2001.02073.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=11277922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivVarsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=2001&pages=2004-2012&author=J.+H.+Leeauthor=J.+A.+Englerauthor=J.+F.+Collawnauthor=B.+A.+Moore&title=Receptor+mediated+uptake+of+peptides+that+bind+the+human+transferrin+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor mediated uptake of peptides that bind the human transferrin receptor</span></div><div class="casAuthors">Lee, Jae H.; Engler, Jeffrey A.; Collawn, James F.; Moore, Bryan A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2004-2012</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">A biopanning process designed to find peptide epitopes specific for cell surface receptors has been used in this study to select seven- and 12-amino-acid peptides capable of binding to and internalizing with the human transferrin receptor (hTfR).  Through sequential rounds of neg. and pos. selection, two peptide sequences were identified that specifically bind to the hTfR.  Phage contg. the sequences HAIYPRH or THRPPMWSPVWP were inhibited from binding the hTfR in a dose-dependent fashion when peptides of the same sequence were present in a competition assay.  Interestingly, transferrin did not compete with either of these sequences for receptor binding, suggesting that these peptides bind a site on the hTfR distinct from the transferrin binding site.  When either of these sequences was expressed as a fusion to green fluorescent protein (GFP), the recombinant GFP mol. was internalized in cells expressing the hTfR.  These studies suggest that the two peptides can be used to target other proteins into the endosomal pathway.  Further, they provide a strategy for identifying peptides that bind to other cell surface receptors that can be used for both diagnostic and therapeutic purposes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZqmkWYuxavbVg90H21EOLACvtfcHk0lgjGPcZrmmYPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivVarsrc%253D&md5=8071d3918d869523d8693c68b7056637</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1327.2001.02073.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1327.2001.02073.x%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DEngler%26aufirst%3DJ.%2BA.%26aulast%3DCollawn%26aufirst%3DJ.%2BF.%26aulast%3DMoore%26aufirst%3DB.%2BA.%26atitle%3DReceptor%2520mediated%2520uptake%2520of%2520peptides%2520that%2520bind%2520the%2520human%2520transferrin%2520receptor%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2001%26volume%3D268%26spage%3D2004%26epage%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Boules, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredrickson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richelson, E.</span><span> </span><span class="NLM_article-title">Bioactive analogs of neurotensin: focus on CNS effects</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">2523</span><span class="NLM_x">–</span> <span class="NLM_lpage">2533</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1016%2Fj.peptides.2005.12.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=16882457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvV2gs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=2523-2533&author=M.+Boulesauthor=P.+Fredricksonauthor=E.+Richelson&title=Bioactive+analogs+of+neurotensin%3A+focus+on+CNS+effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactive analogs of neurotensin: Focus on CNS effects</span></div><div class="casAuthors">Boules, Mona; Fredrickson, Paul; Richelson, Elliott</div><div class="citationInfo"><span class="NLM_cas:title">Peptides (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2523-2533</span>CODEN:
                <span class="NLM_cas:coden">PPTDD5</span>;
        ISSN:<span class="NLM_cas:issn">0196-9781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Neurotensin (NT) is a 13-amino acid neuropeptide found in the central nervous system and in the gastrointestinal tract.  It is closely assocd. anatomically with dopaminergic and other neurotransmitter systems, and evidence supports a role for NT agonists in the treatment of various neuropsychiatric disorders.  However, NT is readily degraded by peptidases, so there is much interest in the development of stable NT agonists, that can be injected systemically, cross the blood-brain barrier (BBB), yet retains the pharmacol. characteristics of native NT for therapeutic use in the treatment of diseases such as schizophrenia, Parkinson's disease and addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUdzePDOc0p7Vg90H21EOLACvtfcHk0lgjGPcZrmmYPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvV2gs7k%253D&md5=a78d008b6c62190144780ad3c4c667d5</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.peptides.2005.12.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.peptides.2005.12.018%26sid%3Dliteratum%253Aachs%26aulast%3DBoules%26aufirst%3DM.%26aulast%3DFredrickson%26aufirst%3DP.%26aulast%3DRichelson%26aufirst%3DE.%26atitle%3DBioactive%2520analogs%2520of%2520neurotensin%253A%2520focus%2520on%2520CNS%2520effects%26jtitle%3DPeptides%26date%3D2006%26volume%3D27%26spage%3D2523%26epage%3D2533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">McGonigle, P.</span><span> </span><span class="NLM_article-title">Peptide therapeutics for CNS indications</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">559</span><span class="NLM_x">–</span> <span class="NLM_lpage">566</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2012&pages=559-566&author=P.+McGonigle&title=Peptide+therapeutics+for+CNS+indications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcGonigle%26aufirst%3DP.%26atitle%3DPeptide%2520therapeutics%2520for%2520CNS%2520indications%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D83%26spage%3D559%26epage%3D566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Cano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merino, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ezquerra, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somoza, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz-Gayo, M.</span><span> </span><span class="NLM_article-title">A cholecystokinin-1 receptor agonist (CCK-8) mediates increased permeability of brain barriers to leptin</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">1009</span><span class="NLM_x">–</span> <span class="NLM_lpage">1015</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1038%2Fbjp.2008.149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=18587446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvVGrurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2008&pages=1009-1015&author=V.+Canoauthor=B.+Merinoauthor=L.+Ezquerraauthor=B.+Somozaauthor=M.+Ruiz-Gayo&title=A+cholecystokinin-1+receptor+agonist+%28CCK-8%29+mediates+increased+permeability+of+brain+barriers+to+leptin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A cholecystokinin-1 receptor agonist (CCK-8) mediates increased permeability of brain barriers to leptin</span></div><div class="casAuthors">Cano, V.; Merino, B.; Ezquerra, L.; Somoza, B.; Ruiz-Gayo, M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1009-1015</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background and purpose: Leptin regulates energy expenditure and body wt. by acting both on the hypothalamus and on peripheral targets.  Central actions of leptin are enhanced by cholecystokinin (CCK).  The interaction between leptin and CCK makes physiol. sense, as rats lacking CCK1 receptors are resistant to peripheral leptin but not to leptin directly infused into the brain.  We have recently reported that CCK enhances leptin effects by increasing the entry of leptin into the CNS.  The aim of this work was to further characterize the effect of CCK (10 μg/kg) on leptin kinetics as well as the CCK receptor subtype involved in the interaction between CCK and leptin.  Exptl. approach: Expts. were carried out both in free-feeding and in fasted rats receiving a single dose of leptin (100 μg/kg; i.p.).  Parameters analyzed over the next 6 h were plasma and cerebrospinal fluid concns. of leptin.  Key results: We obsd. that CCK-8 depressed the increase in plasma leptin that followed the i.p. injection and simultaneously increased leptin concn. in the cerebrospinal fluid from 92 to 230 pg/mL.  The effect of CCK-8 was totally prevented by the CCK1 receptor antagonist, SR-27897 (0.3 mg/kg, s.c.), but not by the CCK2 receptor antagonist, L-365260 (1 mg/kg).  Conclusions and implications: These results show that CCK plays a role in regulating the access of leptin to the brain and suggest that CCK analogs, acting on CCK1 receptors, might be useful drugs in improving leptin actions within the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr03XGmm0KQybVg90H21EOLACvtfcHk0limXxVHPb90Lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvVGrurk%253D&md5=3bc77eb9d0a6eb06943d903a82077b3e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fbjp.2008.149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjp.2008.149%26sid%3Dliteratum%253Aachs%26aulast%3DCano%26aufirst%3DV.%26aulast%3DMerino%26aufirst%3DB.%26aulast%3DEzquerra%26aufirst%3DL.%26aulast%3DSomoza%26aufirst%3DB.%26aulast%3DRuiz-Gayo%26aufirst%3DM.%26atitle%3DA%2520cholecystokinin-1%2520receptor%2520agonist%2520%2528CCK-8%2529%2520mediates%2520increased%2520permeability%2520of%2520brain%2520barriers%2520to%2520leptin%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D154%26spage%3D1009%26epage%3D1015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Kastin, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akerstrom, V.</span><span> </span><span class="NLM_article-title">Nonsaturable entry of neuropeptide Y into brain</span> <span class="citation_source-journal">Am. J. Physiol.: Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">E479</span><span class="NLM_x">–</span> <span class="NLM_lpage">E482</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=1999&pages=E479-E482&author=A.+J.+Kastinauthor=V.+Akerstrom&title=Nonsaturable+entry+of+neuropeptide+Y+into+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKastin%26aufirst%3DA.%2BJ.%26aulast%3DAkerstrom%26aufirst%3DV.%26atitle%3DNonsaturable%2520entry%2520of%2520neuropeptide%2520Y%2520into%2520brain%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Endocrinol.%2520Metab.%26date%3D1999%26volume%3D276%26spage%3DE479%26epage%3DE482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Chappa, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audus, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunte, S. M.</span><span> </span><span class="NLM_article-title">Characteristics of substance P transport across the blood–brain barrier</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1201</span><span class="NLM_x">–</span> <span class="NLM_lpage">1208</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2006&pages=1201-1208&author=A.+K.+Chappaauthor=K.+L.+Audusauthor=S.+M.+Lunte&title=Characteristics+of+substance+P+transport+across+the+blood%E2%80%93brain+barrier"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChappa%26aufirst%3DA.%2BK.%26aulast%3DAudus%26aufirst%3DK.%2BL.%26aulast%3DLunte%26aufirst%3DS.%2BM.%26atitle%3DCharacteristics%2520of%2520substance%2520P%2520transport%2520across%2520the%2520blood%25E2%2580%2593brain%2520barrier%26jtitle%3DPharm.%2520Res.%26date%3D2006%26volume%3D23%26spage%3D1201%26epage%3D1208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Thomas, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taskar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudraraju, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorsheim, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaasch, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mittapalli, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmieri, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steeg, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockman, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, Q. R.</span><span> </span><span class="NLM_article-title">Uptake of ANG1005, a novel paclitaxel derivative, through the blood–brain barrier into brain and experimental brain metastases of breast cancer</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">2486</span><span class="NLM_x">–</span> <span class="NLM_lpage">2494</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2009&pages=2486-2494&author=F.+C.+Thomasauthor=K.+Taskarauthor=V.+Rudrarajuauthor=S.+Godaauthor=H.+R.+Thorsheimauthor=J.+A.+Gaaschauthor=R.+K.+Mittapalliauthor=D.+Palmieriauthor=P.+S.+Steegauthor=P.+R.+Lockmanauthor=Q.+R.+Smith&title=Uptake+of+ANG1005%2C+a+novel+paclitaxel+derivative%2C+through+the+blood%E2%80%93brain+barrier+into+brain+and+experimental+brain+metastases+of+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DF.%2BC.%26aulast%3DTaskar%26aufirst%3DK.%26aulast%3DRudraraju%26aufirst%3DV.%26aulast%3DGoda%26aufirst%3DS.%26aulast%3DThorsheim%26aufirst%3DH.%2BR.%26aulast%3DGaasch%26aufirst%3DJ.%2BA.%26aulast%3DMittapalli%26aufirst%3DR.%2BK.%26aulast%3DPalmieri%26aufirst%3DD.%26aulast%3DSteeg%26aufirst%3DP.%2BS.%26aulast%3DLockman%26aufirst%3DP.%2BR.%26aulast%3DSmith%26aufirst%3DQ.%2BR.%26atitle%3DUptake%2520of%2520ANG1005%252C%2520a%2520novel%2520paclitaxel%2520derivative%252C%2520through%2520the%2520blood%25E2%2580%2593brain%2520barrier%2520into%2520brain%2520and%2520experimental%2520brain%2520metastases%2520of%2520breast%2520cancer%26jtitle%3DPharm.%2520Res.%26date%3D2009%26volume%3D26%26spage%3D2486%26epage%3D2494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Bertrand, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Currie, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demeule, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abulrob, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fatehi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartelet, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabathuler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaigne, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanimirovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beliveau, R.</span><span> </span><span class="NLM_article-title">Transport characteristics of a novel peptide platform for CNS therapeutics</span> <span class="citation_source-journal">J. Cell. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2827</span><span class="NLM_x">–</span> <span class="NLM_lpage">2839</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1111%2Fj.1582-4934.2009.00930.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=19818094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlansrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2010&pages=2827-2839&author=Y.+Bertrandauthor=J.+C.+Currieauthor=M.+Demeuleauthor=A.+Reginaauthor=C.+Cheauthor=A.+Abulrobauthor=D.+Fatehiauthor=H.+Sarteletauthor=R.+Gabathulerauthor=J.+P.+Castaigneauthor=D.+Stanimirovicauthor=R.+Beliveau&title=Transport+characteristics+of+a+novel+peptide+platform+for+CNS+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Transport characteristics of a novel peptide platform for CNS therapeutics</span></div><div class="casAuthors">Bertrand, Yanick; Currie, Jean-Christophe; Demeule, Michel; Regina, Anthony; Che, Christian; Abulrob, Abedelnasser; Fatehi, Dorothy; Sartelet, Herve; Gabathuler, Reinhard; Castaigne, Jean-Paul; Stanimirovic, Danica; Beliveau, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular and Molecular Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2827-2839</span>CODEN:
                <span class="NLM_cas:coden">JCMMC9</span>;
        ISSN:<span class="NLM_cas:issn">1582-1838</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">New and effective therapeutics that cross the blood-brain barrier (BBB) are critically needed for treatment of many brain diseases.  We characterize here a novel drug development platform that is broadly applicable for the development of new therapeutics with increased brain penetration.  The platform is based on the Angiopep-2 peptide, a sequence derived from ligands that bind to low-d. lipoprotein receptor-related protein-1 (LRP-1), a receptor expressed on the BBB.  Fluorescent imaging studies of a Cy5.5 Angiopep-2 conjugate and immunohistochem. studies of injected Angiopep-2 in mice demonstrated efficient transport across the BBB into brain parenchyma and subsequent co-localization with the neuronal nuclei-selective marker NeuN and the glial marker glial fibrillary acidic protein (GFAP).  Uptake of [125I]-Angiopep-2 into brain endothelial cells occurred by a saturable mechanism involving LRP-1.  The primary sequence and charge of Angiopep-2 were crucial for its passage across the BBB.  Overall, the results demonstrate the significant potential of this platform for the development of novel neurotherapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorb_5glvZU4LVg90H21EOLACvtfcHk0lhGbKQhKzHpng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlansrk%253D&md5=8a934864d86940a15d203cc7228fa00e</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1111%2Fj.1582-4934.2009.00930.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1582-4934.2009.00930.x%26sid%3Dliteratum%253Aachs%26aulast%3DBertrand%26aufirst%3DY.%26aulast%3DCurrie%26aufirst%3DJ.%2BC.%26aulast%3DDemeule%26aufirst%3DM.%26aulast%3DRegina%26aufirst%3DA.%26aulast%3DChe%26aufirst%3DC.%26aulast%3DAbulrob%26aufirst%3DA.%26aulast%3DFatehi%26aufirst%3DD.%26aulast%3DSartelet%26aufirst%3DH.%26aulast%3DGabathuler%26aufirst%3DR.%26aulast%3DCastaigne%26aufirst%3DJ.%2BP.%26aulast%3DStanimirovic%26aufirst%3DD.%26aulast%3DBeliveau%26aufirst%3DR.%26atitle%3DTransport%2520characteristics%2520of%2520a%2520novel%2520peptide%2520platform%2520for%2520CNS%2520therapeutics%26jtitle%3DJ.%2520Cell.%2520Mol.%2520Med.%26date%3D2010%26volume%3D14%26spage%3D2827%26epage%3D2839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Che, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacoste, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Currie, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demeule, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beliveau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaigne, J. P.</span><span> </span><span class="NLM_article-title">New angiopep-modified doxorubicin (ANG1007) and etoposide (ANG1009) chemotherapeutics with increased brain penetration</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2814</span><span class="NLM_x">–</span> <span class="NLM_lpage">2824</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9016637" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2814-2824&author=C.+Cheauthor=G.+Q.+Yangauthor=C.+Thiotauthor=M.+C.+Lacosteauthor=J.+C.+Currieauthor=M.+Demeuleauthor=A.+Reginaauthor=R.+Beliveauauthor=J.+P.+Castaigne&title=New+angiopep-modified+doxorubicin+%28ANG1007%29+and+etoposide+%28ANG1009%29+chemotherapeutics+with+increased+brain+penetration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm9016637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9016637%26sid%3Dliteratum%253Aachs%26aulast%3DChe%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DG.%2BQ.%26aulast%3DThiot%26aufirst%3DC.%26aulast%3DLacoste%26aufirst%3DM.%2BC.%26aulast%3DCurrie%26aufirst%3DJ.%2BC.%26aulast%3DDemeule%26aufirst%3DM.%26aulast%3DRegina%26aufirst%3DA.%26aulast%3DBeliveau%26aufirst%3DR.%26aulast%3DCastaigne%26aufirst%3DJ.%2BP.%26atitle%3DNew%2520angiopep-modified%2520doxorubicin%2520%2528ANG1007%2529%2520and%2520etoposide%2520%2528ANG1009%2529%2520chemotherapeutics%2520with%2520increased%2520brain%2520penetration%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2814%26epage%3D2824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Regina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demeule, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavallee, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabathuler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beliveau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaigne, J. P.</span><span> </span><span class="NLM_article-title">Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector angiopep-2</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1038%2Fbjp.2008.260" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=18574456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVygtL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2008&pages=185-197&author=A.+Reginaauthor=M.+Demeuleauthor=C.+Cheauthor=I.+Lavalleeauthor=J.+Poirierauthor=R.+Gabathulerauthor=R.+Beliveauauthor=J.+P.+Castaigne&title=Antitumour+activity+of+ANG1005%2C+a+conjugate+between+paclitaxel+and+the+new+brain+delivery+vector+angiopep-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2</span></div><div class="casAuthors">Regina, A.; Demeule, M.; Che, C.; Lavallee, I.; Poirier, J.; Gabathuler, R.; Beliveau, R.; Castaigne, J-P.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-197</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background and purpose: Paclitaxel is highly efficacious in the treatment of breast, head and neck, non-small cell lung cancers and ovarian carcinoma.  For malignant gliomas, paclitaxel is prevented from reaching its target by the presence of the efflux pump P-glycoprotein (P-gp) at the blood-brain barrier.  We investigated the utilization of a new drug delivery system to increase brain delivery of paclitaxel.  Exptl. approach: Paclitaxel mols. were conjugated to a brain peptide vector, Angiopep-2, to provide a paclitaxel-Angiopep-2 conjugate named ANG1005.  We detd. the brain uptake capacity, intracellular effects and antitumor properties of ANG1005 in vitro against human tumor cell lines and in vivo in human xenografts.  We then detd. ANG1005 activity on brain tumors with intracerebral human tumor models in nude mice.  Key results: We show by in situ brain perfusion that ANG1005 enters the brain to a greater extent than paclitaxel and bypasses the P-gp.  ANG1005 has an antineoplastic potency similar to that of paclitaxel against human cancer cell lines.  We also demonstrate that ANG1005 caused a more potent inhibition of human tumor xenografts than paclitaxel.  Finally, ANG1005 administration led to a significant increase in the survival of mice with intracerebral implantation of U87 MG glioblastoma cells or NCI-H460 lung carcinoma cells.  Conclusions and implications: These results demonstrate the antitumor potential of a new drug, ANG1005, and establish that conjugation of anticancer agents with the Angiopep-2 peptide vector could increase their efficacy in the treatment of brain cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf7gdI2T8jHbVg90H21EOLACvtfcHk0ljRHP8l54hWiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVygtL3N&md5=3c86b5d1a64c5754d439dfa787f16637</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fbjp.2008.260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjp.2008.260%26sid%3Dliteratum%253Aachs%26aulast%3DRegina%26aufirst%3DA.%26aulast%3DDemeule%26aufirst%3DM.%26aulast%3DChe%26aufirst%3DC.%26aulast%3DLavallee%26aufirst%3DI.%26aulast%3DPoirier%26aufirst%3DJ.%26aulast%3DGabathuler%26aufirst%3DR.%26aulast%3DBeliveau%26aufirst%3DR.%26aulast%3DCastaigne%26aufirst%3DJ.%2BP.%26atitle%3DAntitumour%2520activity%2520of%2520ANG1005%252C%2520a%2520conjugate%2520between%2520paclitaxel%2520and%2520the%2520new%2520brain%2520delivery%2520vector%2520angiopep-2%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D155%26spage%3D185%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Malcor, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payrot, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faucon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abouzid, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacquot, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floquet, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debarbieux, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rougon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khrestchatisky, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlieghe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lisowski, V.</span><span> </span><span class="NLM_article-title">Chemical optimization of new ligands of the low-density lipoprotein receptor as potential vectors for central nervous system targeting</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2227</span><span class="NLM_x">–</span> <span class="NLM_lpage">2241</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2014919" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2227-2241&author=J.+D.+Malcorauthor=N.+Payrotauthor=M.+Davidauthor=A.+Fauconauthor=K.+Abouzidauthor=G.+Jacquotauthor=N.+Floquetauthor=F.+Debarbieuxauthor=G.+Rougonauthor=J.+Martinezauthor=M.+Khrestchatiskyauthor=P.+Vliegheauthor=V.+Lisowski&title=Chemical+optimization+of+new+ligands+of+the+low-density+lipoprotein+receptor+as+potential+vectors+for+central+nervous+system+targeting"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm2014919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2014919%26sid%3Dliteratum%253Aachs%26aulast%3DMalcor%26aufirst%3DJ.%2BD.%26aulast%3DPayrot%26aufirst%3DN.%26aulast%3DDavid%26aufirst%3DM.%26aulast%3DFaucon%26aufirst%3DA.%26aulast%3DAbouzid%26aufirst%3DK.%26aulast%3DJacquot%26aufirst%3DG.%26aulast%3DFloquet%26aufirst%3DN.%26aulast%3DDebarbieux%26aufirst%3DF.%26aulast%3DRougon%26aufirst%3DG.%26aulast%3DMartinez%26aufirst%3DJ.%26aulast%3DKhrestchatisky%26aufirst%3DM.%26aulast%3DVlieghe%26aufirst%3DP.%26aulast%3DLisowski%26aufirst%3DV.%26atitle%3DChemical%2520optimization%2520of%2520new%2520ligands%2520of%2520the%2520low-density%2520lipoprotein%2520receptor%2520as%2520potential%2520vectors%2520for%2520central%2520nervous%2520system%2520targeting%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2227%26epage%3D2241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Tian, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, L.</span><span> </span><span class="NLM_article-title">In vitro and in vivo studies on gelatin–siloxane nanoparticles conjugated with SynB peptide to increase drug delivery to the brain</span> <span class="citation_source-journal">Int. J. Nanomed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1031</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=22403486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BC38XjvFWrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1031-41&author=X.+H.+Tianauthor=F.+Weiauthor=T.+X.+Wangauthor=P.+Wangauthor=X.+N.+Linauthor=J.+Wangauthor=D.+Wangauthor=L.+Ren&title=In+vitro+and+in+vivo+studies+on+gelatin%E2%80%93siloxane+nanoparticles+conjugated+with+SynB+peptide+to+increase+drug+delivery+to+the+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo studies on gelatin-siloxane nanoparticles conjugated with SynB peptide to increase drug delivery to the brain</span></div><div class="casAuthors">Tian, Xin-Hua; Wei, Feng; Wang, Tian-Xiao; Wang, Peng; Lin, Xiao-Ning; Wang, Jun; Wang, Dong; Ren, Lei</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Nanomedicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1031-1041</span>CODEN:
                <span class="NLM_cas:coden">IJNNHQ</span>;
        ISSN:<span class="NLM_cas:issn">1178-2013</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Background: Nanobiotechnol. can provide more efficient tools for diagnosis, targeted and personalized therapy, and increase the chances of brain tumor treatment being successful.  Use of nanoparticles is a promising strategy for overcoming the blood-brain barrier and delivering drugs to the brain.  Gelatin-siloxane (GS) nanoparticles modified with Tat peptide can enhance plasmid DNA transfection efficiency compared with a com. reagent.  Methods: SynB-PEG-GS nanoparticles are membrane-penetrable, and can cross the blood-brain barrier and deliver a drug to its target site in the brain.  The efficiency of delivery was investigated in vivo and in vitro using brain capillary endothelial cells, a cocultured blood-brain barrier model, and a normal mouse model.  Results: Our study demonstrated that both SynB-PEG-GS and PEG-GS nanoparticles had a spherical shape and an av. diam. of 150-200 nm.  It was shown by MTT assay that SynB-PEG-GS nanoparticles had good biocompatibility with brain capillary endothelial cells.  Cellular uptake by SynB-PEG-GS nanoparticles was higher than that for PEG-GS nanoparticles for all incubation periods.  The amt. of SynB-PEG-GS nanoparticles crossing the cocultured blood-brain barrier model was significantly higher than that of PEG-GS nanoparticles at all time points measured (P < 0.05).  In animal testing, SynB-PEG-GS nanoparticle levels in the brain were significantly higher than those of PEG-GS nanoparticles at all time points measured (P < 0.01).  In contrast with localization in the brain, PEG-GS nanoparticle levels were significantly higher than those of SynB-PEG-GS nanoparticles (P < 0.01) in the liver.  Conclusion: This study indicates that SynB-PEG-GS nanoparticles have favorable properties with regard to morphol., size distribution, and toxicity.  Moreover, the SynB-PEG-GS nanoparticles exhibited more efficient brain capillary endothelial cell uptake and improved crossing of the blood-brain barrier.  Further, biodistribution studies of rhodamine-loaded nanoparticles demonstrated that modification with the SynB peptide could not only improve the ability of PEG-GS nanoparticles to evade capture in the reticuloendothelial system but also enhance their efficiency in crossing the blood-brain barrier.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQoFHPbbbugLVg90H21EOLACvtfcHk0ljSfu_79lvJIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjvFWrsLc%253D&md5=12c3b0832b6f1ec93b2d528349dc413d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DX.%2BH.%26aulast%3DWei%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DT.%2BX.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DX.%2BN.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DRen%26aufirst%3DL.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520studies%2520on%2520gelatin%25E2%2580%2593siloxane%2520nanoparticles%2520conjugated%2520with%2520SynB%2520peptide%2520to%2520increase%2520drug%2520delivery%2520to%2520the%2520brain%26jtitle%3DInt.%2520J.%2520Nanomed.%26date%3D2012%26volume%3D7%26spage%3D1031%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Temsamani, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnafous, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rousselle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraisse, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clair, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Granier, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaczorek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherrmann, J. M.</span><span> </span><span class="NLM_article-title">Improved brain uptake and pharmacological activity profile of morphine-6-glucuronide using a peptide vector-mediated strategy</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">313</span><span class="NLM_x">, </span> <span class="NLM_fpage">712</span><span class="NLM_x">–</span> <span class="NLM_lpage">719</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1124%2Fjpet.104.081000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=15647327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktFemsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2005&pages=712-719&author=J.+Temsamaniauthor=C.+Bonnafousauthor=C.+Rousselleauthor=Y.+Fraisseauthor=P.+Clairauthor=L.+A.+Granierauthor=A.+R.+Reesauthor=M.+Kaczorekauthor=J.+M.+Scherrmann&title=Improved+brain+uptake+and+pharmacological+activity+profile+of+morphine-6-glucuronide+using+a+peptide+vector-mediated+strategy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Improved brain uptake and pharmacological activity profile of Morphine-6-glucuronide using a peptide vector-mediated strategy</span></div><div class="casAuthors">Temsamani, Jamal; Bonnafous, Cecile; Rousselle, Christophe; Fraisse, Yannik; Clair, Philippe; Granier, Luc-Andre; Rees, Anthony R.; Kaczorek, Michel; Scherrmann, Jean-Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">712-719</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Morphine-6-glucuronide (M6G), an active metabolite of morphine, has been shown to have significantly attenuated brain penetration relative to that of morphine.  Recently, we have demonstrated that conjugation of various drugs to peptide vectors significantly enhances their brain uptake.  In this study, we have conjugated morphine-6-glucuronide to a peptide vector SynB3 to enhance its brain uptake and its analgesic potency after systemic administration.  We show by in situ brain perfusion that vectorization of M6G (Syn1001) markedly enhances the brain uptake of M6G.  This enhancement results in a significant improvement in the pharmacol. activity of M6G in several models of nociception.  Syn1001 was about 4 times more potent than free M6G (ED50 of 1.87 vs. 8.74 μmol/kg).  Syn1001 showed also a prolonged duration of action compared with free M6G (300 and 120 min, resp.).  Furthermore, the conjugation of M6G results in a lowered respiratory depression, as measured in a rat model.  Taken together, these data strongly support the utility of peptide-mediated strategies for improving the efficacy of drugs such as M6G for the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrrHR8h0dYyrVg90H21EOLACvtfcHk0lgwAhoWPNIvKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktFemsLY%253D&md5=436b2ad8faf1339f4b459fdac1f6c416</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.081000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.081000%26sid%3Dliteratum%253Aachs%26aulast%3DTemsamani%26aufirst%3DJ.%26aulast%3DBonnafous%26aufirst%3DC.%26aulast%3DRousselle%26aufirst%3DC.%26aulast%3DFraisse%26aufirst%3DY.%26aulast%3DClair%26aufirst%3DP.%26aulast%3DGranier%26aufirst%3DL.%2BA.%26aulast%3DRees%26aufirst%3DA.%2BR.%26aulast%3DKaczorek%26aufirst%3DM.%26aulast%3DScherrmann%26aufirst%3DJ.%2BM.%26atitle%3DImproved%2520brain%2520uptake%2520and%2520pharmacological%2520activity%2520profile%2520of%2520morphine-6-glucuronide%2520using%2520a%2520peptide%2520vector-mediated%2520strategy%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D313%26spage%3D712%26epage%3D719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Mazel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clair, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rousselle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherrmann, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Temsamani, J.</span><span> </span><span class="NLM_article-title">Doxorubicin–peptide conjugates overcome multidrug resistance</span> <span class="citation_source-journal">Anticancer Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2001&pages=107-16&author=M.+Mazelauthor=P.+Clairauthor=C.+Rousselleauthor=P.+Vidalauthor=J.+M.+Scherrmannauthor=D.+Mathieuauthor=J.+Temsamani&title=Doxorubicin%E2%80%93peptide+conjugates+overcome+multidrug+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMazel%26aufirst%3DM.%26aulast%3DClair%26aufirst%3DP.%26aulast%3DRousselle%26aufirst%3DC.%26aulast%3DVidal%26aufirst%3DP.%26aulast%3DScherrmann%26aufirst%3DJ.%2BM.%26aulast%3DMathieu%26aufirst%3DD.%26aulast%3DTemsamani%26aufirst%3DJ.%26atitle%3DDoxorubicin%25E2%2580%2593peptide%2520conjugates%2520overcome%2520multidrug%2520resistance%26jtitle%3DAnticancer%2520Drugs%26date%3D2001%26volume%3D12%26spage%3D107%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Rousselle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clair, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefauconnier, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaczorek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherrmann, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Temsamani, J.</span><span> </span><span class="NLM_article-title">New advances in the transport of doxorubicin through the blood–brain barrier by a peptide vector-mediated strategy</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">679</span><span class="NLM_x">–</span> <span class="NLM_lpage">686</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2000&pages=679-686&author=C.+Rousselleauthor=P.+Clairauthor=J.+M.+Lefauconnierauthor=M.+Kaczorekauthor=J.+M.+Scherrmannauthor=J.+Temsamani&title=New+advances+in+the+transport+of+doxorubicin+through+the+blood%E2%80%93brain+barrier+by+a+peptide+vector-mediated+strategy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRousselle%26aufirst%3DC.%26aulast%3DClair%26aufirst%3DP.%26aulast%3DLefauconnier%26aufirst%3DJ.%2BM.%26aulast%3DKaczorek%26aufirst%3DM.%26aulast%3DScherrmann%26aufirst%3DJ.%2BM.%26aulast%3DTemsamani%26aufirst%3DJ.%26atitle%3DNew%2520advances%2520in%2520the%2520transport%2520of%2520doxorubicin%2520through%2520the%2520blood%25E2%2580%2593brain%2520barrier%2520by%2520a%2520peptide%2520vector-mediated%2520strategy%26jtitle%3DMol.%2520Pharmacol.%26date%3D2000%26volume%3D57%26spage%3D679%26epage%3D686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Dogrukol-Ak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuncel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuncel, M.</span><span> </span><span class="NLM_article-title">Passage of vasoactive intestinal peptide across the blood–brain barrier</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">–</span> <span class="NLM_lpage">444</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2003&pages=437-444&author=D.+Dogrukol-Akauthor=W.+A.+Banksauthor=N.+Tuncelauthor=M.+Tuncel&title=Passage+of+vasoactive+intestinal+peptide+across+the+blood%E2%80%93brain+barrier"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDogrukol-Ak%26aufirst%3DD.%26aulast%3DBanks%26aufirst%3DW.%2BA.%26aulast%3DTuncel%26aufirst%3DN.%26aulast%3DTuncel%26aufirst%3DM.%26atitle%3DPassage%2520of%2520vasoactive%2520intestinal%2520peptide%2520across%2520the%2520blood%25E2%2580%2593brain%2520barrier%26jtitle%3DPeptides%26date%3D2003%26volume%3D24%26spage%3D437%26epage%3D444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Lindgren, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallbrink, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmquist, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langel, U.</span><span> </span><span class="NLM_article-title">Passage of cell-penetrating peptides across a human epithelial cell layer in vitro</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">377</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=2004&pages=69-76&author=M.+E.+Lindgrenauthor=M.+M.+Hallbrinkauthor=A.+M.+Elmquistauthor=U.+Langel&title=Passage+of+cell-penetrating+peptides+across+a+human+epithelial+cell+layer+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLindgren%26aufirst%3DM.%2BE.%26aulast%3DHallbrink%26aufirst%3DM.%2BM.%26aulast%3DElmquist%26aufirst%3DA.%2BM.%26aulast%3DLangel%26aufirst%3DU.%26atitle%3DPassage%2520of%2520cell-penetrating%2520peptides%2520across%2520a%2520human%2520epithelial%2520cell%2520layer%2520in%2520vitro%26jtitle%3DBiochem.%2520J.%26date%3D2004%26volume%3D377%26spage%3D69%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Qin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Q.</span><span> </span><span class="NLM_article-title">Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery</span> <span class="citation_source-journal">Int. J. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">419</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1016%2Fj.ijpharm.2011.07.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=21807083" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1CltbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=419&publication_year=2011&pages=85-95&author=Y.+Qinauthor=H.+L.+Chenauthor=W.+M.+Yuanauthor=R.+Kuaiauthor=Q.+Y.+Zhangauthor=F.+L.+Xieauthor=L.+Zhangauthor=Z.+R.+Zhangauthor=J.+Liuauthor=Q.+He&title=Liposome+formulated+with+TAT-modified+cholesterol+for+enhancing+the+brain+delivery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery</span></div><div class="casAuthors">Qin, Yao; Chen, Huali; Yuan, Wenmin; Kuai, Rui; Zhang, Qianyu; Xie, Fulan; Zhang, Li; Zhang, Zhirong; Liu, Ji; He, Qin</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">419</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">85-95</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Delivery of drugs to the brain is a major challenge due to the presence of the blood-brain barrier (BBB).  The cell penetrating peptide TAT, which appears to enter cells with alacrity, can pass through the BBB efficiently.  With this in mind, a novel TAT-modified liposome (TAT-LIP) was developed for overcoming the ineffective delivery of normal drug formulation to the brain.  Targeting liposomal formulations are always composed of modified phospholipids as an anchor.  However, cholesterol, another liposomal component, which was more stable and cheaper, has not been fully investigated as an alternative anchor.  In this study, TAT was covalently conjugated with the cholesterol to prep. the liposome.  The cellular uptake by brain capillary endothelial cells (BCECs) of rats and the mechanism of TAT-LIP pathway of endocytosis was explored.  The blood brain barrier model in vitro was established to evaluate the transendothelial ability crossing the BBB and its transport mechanism.  The biodistribution of each formulation was further identified.  The results showed that the pos. charge of the TAT-LIP played an important role in enhancing its brain delivery.  The absorptive endocytosis might be one of the mechanisms of TAT-LIP crossing the BBB.  In conclusion, the exptl. data in vitro and in vivo indicated that the TAT-LIP was a promising brain drug delivery system due to its high delivery efficiency across the BBB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7Vs9iIz7ezLVg90H21EOLACvtfcHk0lgS8PiQ5ak0GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1CltbbF&md5=2044ef7c599023479256fb53963253b2</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2011.07.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2011.07.021%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%2BL.%26aulast%3DYuan%26aufirst%3DW.%2BM.%26aulast%3DKuai%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DQ.%2BY.%26aulast%3DXie%26aufirst%3DF.%2BL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DZ.%2BR.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DQ.%26atitle%3DLiposome%2520formulated%2520with%2520TAT-modified%2520cholesterol%2520for%2520enhancing%2520the%2520brain%2520delivery%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2011%26volume%3D419%26spage%3D85%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Qin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Q.</span><span> </span><span class="NLM_article-title">Liposome formulated with TAT-modified cholesterol for improving brain delivery and therapeutic efficacy on brain glioma in animals</span> <span class="citation_source-journal">Int. J. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">420</span><span class="NLM_x">, </span> <span class="NLM_fpage">304</span><span class="NLM_x">–</span> <span class="NLM_lpage">312</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1016%2Fj.ijpharm.2011.09.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=21945185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlWmtL3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=420&publication_year=2011&pages=304-312&author=Y.+Qinauthor=H.+L.+Chenauthor=Q.+Y.+Zhangauthor=X.+X.+Wangauthor=W.+M.+Yuanauthor=R.+Kuaiauthor=J.+Tangauthor=L.+Zhangauthor=Z.+R.+Zhangauthor=Q.+Zhangauthor=J.+Liuauthor=Q.+He&title=Liposome+formulated+with+TAT-modified+cholesterol+for+improving+brain+delivery+and+therapeutic+efficacy+on+brain+glioma+in+animals"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Liposome formulated with TAT-modified cholesterol for improving brain delivery and therapeutic efficacy on brain glioma in animals</span></div><div class="casAuthors">Qin, Yao; Chen, Huali; Zhang, Qianyu; Wang, Xiaoxiao; Yuan, Wenmin; Kuai, Rui; Tang, Jie; Zhang, Li; Zhang, Zhirong; Zhang, Qiang; Liu, Ji; He, Qin</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">420</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">304-312</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The treatment of central nervous system diseases such as brain glioma is a major challenge due to the presence of the blood-brain barrier (BBB).  A cell-penetrating peptide TAT (AYGRKKRRQRRR), which appears to enter cells with alacrity, was employed to enhance the delivery efficiency of normal drug formulation to the brain.  Targeting liposomal formulations often apply modified phospholipids as anchors.  However, cholesterol, another liposomal component more stable and cheaper, has not been fully investigated as an alternative anchor.  In our study, TAT was covalently conjugated with cholesterol for prepg. doxorubicin-loaded liposome for brain glioma therapy.  Cellular uptake by brain capillary endothelial cells (BCECs) and C6 glioma cells was explored.  The anti-proliferative activity against C6s confirmed strong inhibitory effect of the liposomes modified with doxorubicin-loaded TAT.  The bio-distribution findings in brains and hearts were evident of higher efficiency of brain delivery and lower cardiotoxic risk.  The results on survival of the brain glioma-bearing animals indicate that survival time of the glioma-bearing rats treated with TAT-modified liposome was much longer than in the other groups.  In conclusion, the potency of the TAT-modified liposome to enter the BBB appears to be related with the TAT on the liposome's surface.  The TAT-modified liposome may improve the therapeutic efficacy on brain glioma in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3xqE3ThQsrVg90H21EOLACvtfcHk0lhs93D9xn_rLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlWmtL3P&md5=bf97e2dd3d8ed11f0fe7e467653315ff</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2011.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2011.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%2BL.%26aulast%3DZhang%26aufirst%3DQ.%2BY.%26aulast%3DWang%26aufirst%3DX.%2BX.%26aulast%3DYuan%26aufirst%3DW.%2BM.%26aulast%3DKuai%26aufirst%3DR.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DZ.%2BR.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DQ.%26atitle%3DLiposome%2520formulated%2520with%2520TAT-modified%2520cholesterol%2520for%2520improving%2520brain%2520delivery%2520and%2520therapeutic%2520efficacy%2520on%2520brain%2520glioma%2520in%2520animals%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2011%26volume%3D420%26spage%3D304%26epage%3D312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Rao, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horning, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labhasetwar, V.</span><span> </span><span class="NLM_article-title">TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs</span> <span class="citation_source-journal">Biomaterials</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">4429</span><span class="NLM_x">–</span> <span class="NLM_lpage">4438</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=4429-4438&author=K.+S.+Raoauthor=M.+K.+Reddyauthor=J.+L.+Horningauthor=V.+Labhasetwar&title=TAT-conjugated+nanoparticles+for+the+CNS+delivery+of+anti-HIV+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DK.%2BS.%26aulast%3DReddy%26aufirst%3DM.%2BK.%26aulast%3DHorning%26aufirst%3DJ.%2BL.%26aulast%3DLabhasetwar%26aufirst%3DV.%26atitle%3DTAT-conjugated%2520nanoparticles%2520for%2520the%2520CNS%2520delivery%2520of%2520anti-HIV%2520drugs%26jtitle%3DBiomaterials%26date%3D2008%26volume%3D29%26spage%3D4429%26epage%3D4438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Nam, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, I. S.</span><span> </span><span class="NLM_article-title">Intracellular drug delivery using poly(<span class="smallcaps smallerCapital">d</span>,<span class="smallcaps smallerCapital">l</span>-lactide-co-glycolide) nanoparticles derivatized with a peptide from a transcriptional activator protein of HIV-1</span> <span class="citation_source-journal">Biotechnol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2093</span><span class="NLM_x">–</span> <span class="NLM_lpage">2098</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2002&pages=2093-2098&author=Y.+S.+Namauthor=J.+Y.+Parkauthor=S.+H.+Hanauthor=I.+S.+Chang&title=Intracellular+drug+delivery+using+poly%28d%2Cl-lactide-co-glycolide%29+nanoparticles+derivatized+with+a+peptide+from+a+transcriptional+activator+protein+of+HIV-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNam%26aufirst%3DY.%2BS.%26aulast%3DPark%26aufirst%3DJ.%2BY.%26aulast%3DHan%26aufirst%3DS.%2BH.%26aulast%3DChang%26aufirst%3DI.%2BS.%26atitle%3DIntracellular%2520drug%2520delivery%2520using%2520poly%2528d%252Cl-lactide-co-glycolide%2529%2520nanoparticles%2520derivatized%2520with%2520a%2520peptide%2520from%2520a%2520transcriptional%2520activator%2520protein%2520of%2520HIV-1%26jtitle%3DBiotechnol.%2520Lett.%26date%3D2002%26volume%3D24%26spage%3D2093%26epage%3D2098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Sharma, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modgil, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, J.</span><span> </span><span class="NLM_article-title">Grafting of cell-penetrating peptide to receptor-targeted liposomes improves their transfection efficiency and transport across blood–brain barrier model</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">2468</span><span class="NLM_x">–</span> <span class="NLM_lpage">2478</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2012&pages=2468-2478&author=G.+Sharmaauthor=A.+Modgilauthor=C.+W.+Sunauthor=J.+Singh&title=Grafting+of+cell-penetrating+peptide+to+receptor-targeted+liposomes+improves+their+transfection+efficiency+and+transport+across+blood%E2%80%93brain+barrier+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DG.%26aulast%3DModgil%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DC.%2BW.%26aulast%3DSingh%26aufirst%3DJ.%26atitle%3DGrafting%2520of%2520cell-penetrating%2520peptide%2520to%2520receptor-targeted%2520liposomes%2520improves%2520their%2520transfection%2520efficiency%2520and%2520transport%2520across%2520blood%25E2%2580%2593brain%2520barrier%2520model%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2012%26volume%3D101%26spage%3D2468%26epage%3D2478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Meade, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meloni, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mastaglia, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knuckey, N. W.</span><span> </span><span class="NLM_article-title">The application of cell penetrating peptides for the delivery of neuroprotective peptides/proteins in experimental cerebral ischemia studies</span> <span class="citation_source-journal">J. Exp. Stroke Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.6030%2F1939-067X-2.1.21" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVKjs7zF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2009&pages=22-40&author=A.+J.+Meadeauthor=B.+P.+Meloniauthor=F.+L.+Mastagliaauthor=N.+W.+Knuckey&title=The+application+of+cell+penetrating+peptides+for+the+delivery+of+neuroprotective+peptides%2Fproteins+in+experimental+cerebral+ischemia+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The application of cell penetrating peptides for the delivery of neuroprotective peptides/proteins in experimental cerebral ischaemia studies</span></div><div class="casAuthors">Meade, Amanda J.; Meloni, Bruno P.; Mastaglia, Frank L.; Knuckey, Neville W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Stroke & Translational Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-40</span>CODEN:
                <span class="NLM_cas:coden">JESTD7</span>;
        ISSN:<span class="NLM_cas:issn">1939-067X</span>.
    
            (<span class="NLM_cas:orgname">Society for Experimental Stroke</span>)
        </div><div class="casAbstract">A review.  The restricted ability of most proteins and peptides to cross the blood-brain barrier and/or plasma membrane limits their use as therapeutics following cerebral ischemia.  However, the discovery of cell-penetrating peptides has provided a means by which such mols. can be transported across the blood-brain barrier and plasma membrane.  Many proteins/peptides have already been shown to have neuroprotective properties, and, due to their ability to block protein-protein interactions, provide a potentially rich source of new therapeutic compds. to prevent cell death following cerebral ischemia.  In this review, we give an overview of cell-penetrating peptides and their use exptl. to deliver neuroprotectant proteins/peptides into the brain following cerebral ischemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyZ4xC7kvAXLVg90H21EOLACvtfcHk0ljcdaolWqA6ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVKjs7zF&md5=dde3d406d73fc3223ac74deab19600e7</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.6030%2F1939-067X-2.1.21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.6030%252F1939-067X-2.1.21%26sid%3Dliteratum%253Aachs%26aulast%3DMeade%26aufirst%3DA.%2BJ.%26aulast%3DMeloni%26aufirst%3DB.%2BP.%26aulast%3DMastaglia%26aufirst%3DF.%2BL.%26aulast%3DKnuckey%26aufirst%3DN.%2BW.%26atitle%3DThe%2520application%2520of%2520cell%2520penetrating%2520peptides%2520for%2520the%2520delivery%2520of%2520neuroprotective%2520peptides%252Fproteins%2520in%2520experimental%2520cerebral%2520ischemia%2520studies%26jtitle%3DJ.%2520Exp.%2520Stroke%2520Transl.%2520Med.%26date%3D2009%26volume%3D2%26spage%3D22%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Malakotikhah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teixido, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giralt, E.</span><span> </span><span class="NLM_article-title">Toward an optimal blood–brain barrier shuttle by synthesis and evaluation of peptide libraries</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4881</span><span class="NLM_x">–</span> <span class="NLM_lpage">4889</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4881-4889&author=M.+Malakotikhahauthor=M.+Teixidoauthor=E.+Giralt&title=Toward+an+optimal+blood%E2%80%93brain+barrier+shuttle+by+synthesis+and+evaluation+of+peptide+libraries"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalakotikhah%26aufirst%3DM.%26aulast%3DTeixido%26aufirst%3DM.%26aulast%3DGiralt%26aufirst%3DE.%26atitle%3DToward%2520an%2520optimal%2520blood%25E2%2580%2593brain%2520barrier%2520shuttle%2520by%2520synthesis%2520and%2520evaluation%2520of%2520peptide%2520libraries%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4881%26epage%3D4889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Swift, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cramb, D. T.</span><span> </span><span class="NLM_article-title">Nanoparticles as fluorescence labels: Is size all that matters?</span> <span class="citation_source-journal">Biophys. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">865</span><span class="NLM_x">–</span> <span class="NLM_lpage">876</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2008&pages=865-876&author=J.+L.+Swiftauthor=D.+T.+Cramb&title=Nanoparticles+as+fluorescence+labels%3A+Is+size+all+that+matters%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwift%26aufirst%3DJ.%2BL.%26aulast%3DCramb%26aufirst%3DD.%2BT.%26atitle%3DNanoparticles%2520as%2520fluorescence%2520labels%253A%2520Is%2520size%2520all%2520that%2520matters%253F%26jtitle%3DBiophys.%2520J.%26date%3D2008%26volume%3D95%26spage%3D865%26epage%3D876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Swift, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heuff, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cramb, D. T.</span><span> </span><span class="NLM_article-title">A two-photon excitation fluorescence cross-correlation assay for a model ligand–receptor binding system using quantum dots</span> <span class="citation_source-journal">Biophys. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">1396</span><span class="NLM_x">–</span> <span class="NLM_lpage">1410</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2006&pages=1396-1410&author=J.+L.+Swiftauthor=R.+Heuffauthor=D.+T.+Cramb&title=A+two-photon+excitation+fluorescence+cross-correlation+assay+for+a+model+ligand%E2%80%93receptor+binding+system+using+quantum+dots"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwift%26aufirst%3DJ.%2BL.%26aulast%3DHeuff%26aufirst%3DR.%26aulast%3DCramb%26aufirst%3DD.%2BT.%26atitle%3DA%2520two-photon%2520excitation%2520fluorescence%2520cross-correlation%2520assay%2520for%2520a%2520model%2520ligand%25E2%2580%2593receptor%2520binding%2520system%2520using%2520quantum%2520dots%26jtitle%3DBiophys.%2520J.%26date%3D2006%26volume%3D90%26spage%3D1396%26epage%3D1410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Ceccarini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrieze, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koole, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muylle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bormans, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Laere, K.</span><span> </span><span class="NLM_article-title">Optimized in vivo detection of dopamine release using F-18-fallypride PET</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1565</span><span class="NLM_x">–</span> <span class="NLM_lpage">1572</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=1565-1572&author=J.+Ceccariniauthor=E.+Vriezeauthor=M.+Kooleauthor=T.+Muylleauthor=G.+Bormansauthor=S.+Claesauthor=K.+Van+Laere&title=Optimized+in+vivo+detection+of+dopamine+release+using+F-18-fallypride+PET"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCeccarini%26aufirst%3DJ.%26aulast%3DVrieze%26aufirst%3DE.%26aulast%3DKoole%26aufirst%3DM.%26aulast%3DMuylle%26aufirst%3DT.%26aulast%3DBormans%26aufirst%3DG.%26aulast%3DClaes%26aufirst%3DS.%26aulast%3DVan%2BLaere%26aufirst%3DK.%26atitle%3DOptimized%2520in%2520vivo%2520detection%2520of%2520dopamine%2520release%2520using%2520F-18-fallypride%2520PET%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2012%26volume%3D53%26spage%3D1565%26epage%3D1572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Rominger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koller, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boning, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wulff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwergal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forster, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilhac, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munk, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soyka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wangler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenstein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">la Fougere, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pogarell, O.</span><span> </span><span class="NLM_article-title">[F-18]fallypride PET measurement of striatal and extrastriatal dopamine D-2/3 receptor availability in recently abstinent alcoholics</span> <span class="citation_source-journal">Addict. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">490</span><span class="NLM_x">–</span> <span class="NLM_lpage">503</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1111%2Fj.1369-1600.2011.00355.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=22023291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BC38XltV2ktbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=490-503&author=A.+Romingerauthor=P.+Cummingauthor=G.+M.+Xiongauthor=G.+Kollerauthor=G.+Boningauthor=M.+Wulffauthor=A.+Zwergalauthor=S.+Forsterauthor=A.+Reilhacauthor=O.+Munkauthor=M.+Soykaauthor=B.+Wanglerauthor=P.+Bartensteinauthor=C.+la+Fougereauthor=O.+Pogarell&title=%5BF-18%5Dfallypride+PET+measurement+of+striatal+and+extrastriatal+dopamine+D-2%2F3+receptor+availability+in+recently+abstinent+alcoholics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">[18F]fallypride PET measurement of striatal and extrastriatal dopamine D2/3 receptor availability in recently abstinent alcoholics</span></div><div class="casAuthors">Rominger, Axel; Cumming, Paul; Xiong, Guoming; Koller, Gabriele; Boening, Guido; Wulff, Melanie; Zwergal, Andreas; Foerster, Stefan; Reilhac, Anthonin; Munk, Ole; Soyka, Michael; Waengler, Bjoern; Bartenstein, Peter; La Fougere, Christian; Pogarell, Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Addiction Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">490-503</span>CODEN:
                <span class="NLM_cas:coden">ADBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1369-1600</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Positron emission tomog. (PET) shows reduced binding of the dopamine D2/3 antagonist [11C]raclopride in striatum of withdrawn psychostimulant abusers, but not consistently in patients with alc. dependence (AD).  We make first use of the high affinity ligand [18F]fallypride to obtain serial measures of D2/3 receptor availability in striatal and extrastriatal regions of AD patients undergoing detoxification.  Seventeen patients (mean age 44 ± 5y) with AD and 14 age-matched healthy volunteers participated.  Each patient underwent [18F]fallypride PET upon hospital admission, and again 1-2 wk later: two patients achieving abstinence, and two with substantial harm redn. had addnl. PET follow-up at 1 yr.  Dynamic 180-min PET recordings were used for vol. of interest (VOI)-based and voxel-wise anal. of [18F]fallypride binding potential (BPND).  Mean baseline BPND in striatum of the AD patients (15.7 ± 3.6) was unaltered during short-term follow-up, and did not differ from that in healthy controls (16.8 ± 3.0); however, BPND was 10-20% lower in thalamus, hippocampus, and insular and temporal cortex of the AD patients (P < 0.05).  Age-dependent declines in BPND were very small in controls, but more pronounced and widespread in the AD group.  Striatal and thalamic BPND increased by 30% in four patients with long-term abstinence or reduced alc. consumption.  VOI-based [18F]fallypride PET analyses revealed group differences in D2/3 receptor availability primarily in extra-striatal regions.  Age-related loss of dopamine D2/3 receptors was more pronounced in AD patients.  Receptor availability was unaltered by acute withdrawal, but increased in the subgroup of patients with long-term follow-up, suggesting reversibility of receptor changes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4E_AxSPnZfbVg90H21EOLACvtfcHk0lgVv2ts_4mdnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltV2ktbk%253D&md5=052784627f551b0281d70a377986709b</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1111%2Fj.1369-1600.2011.00355.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1369-1600.2011.00355.x%26sid%3Dliteratum%253Aachs%26aulast%3DRominger%26aufirst%3DA.%26aulast%3DCumming%26aufirst%3DP.%26aulast%3DXiong%26aufirst%3DG.%2BM.%26aulast%3DKoller%26aufirst%3DG.%26aulast%3DBoning%26aufirst%3DG.%26aulast%3DWulff%26aufirst%3DM.%26aulast%3DZwergal%26aufirst%3DA.%26aulast%3DForster%26aufirst%3DS.%26aulast%3DReilhac%26aufirst%3DA.%26aulast%3DMunk%26aufirst%3DO.%26aulast%3DSoyka%26aufirst%3DM.%26aulast%3DWangler%26aufirst%3DB.%26aulast%3DBartenstein%26aufirst%3DP.%26aulast%3Dla%2BFougere%26aufirst%3DC.%26aulast%3DPogarell%26aufirst%3DO.%26atitle%3D%255BF-18%255Dfallypride%2520PET%2520measurement%2520of%2520striatal%2520and%2520extrastriatal%2520dopamine%2520D-2%252F3%2520receptor%2520availability%2520in%2520recently%2520abstinent%2520alcoholics%26jtitle%3DAddict.%2520Biol.%26date%3D2012%26volume%3D17%26spage%3D490%26epage%3D503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Kegeles, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slifstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moadel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harkavy-Friedman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gil, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laruelle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abi-Dargham, A.</span><span> </span><span class="NLM_article-title">Striatal and extrastriatal dopamine D-2/D-3 receptors in schizophrenia evaluated with [F-18]fallypride positron emission tomography</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">634</span><span class="NLM_x">–</span> <span class="NLM_lpage">641</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1016%2Fj.biopsych.2010.05.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=20673873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFOntb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2010&pages=634-641&author=L.+S.+Kegelesauthor=M.+Slifsteinauthor=X.+Y.+Xuauthor=N.+Urbanauthor=J.+L.+Thompsonauthor=T.+Moadelauthor=J.+M.+Harkavy-Friedmanauthor=R.+Gilauthor=M.+Laruelleauthor=A.+Abi-Dargham&title=Striatal+and+extrastriatal+dopamine+D-2%2FD-3+receptors+in+schizophrenia+evaluated+with+%5BF-18%5Dfallypride+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Striatal and Extrastriatal Dopamine D2/D3 Receptors in Schizophrenia Evaluated With [18F]fallypride Positron Emission Tomography</span></div><div class="casAuthors">Kegeles, Lawrence S.; Slifstein, Mark; Xu, Xiaoyan; Urban, Nina; Thompson, Judy L.; Moadel, Tiffany; Harkavy-Friedman, Jill M.; Gil, Roberto; Laruelle, Marc; Abi-Dargham, Anissa</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">634-641</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Alterations in dopamine D2/D3 receptor binding have been reported in schizophrenia, and a meta-anal. of imaging studies has shown a modest elevation in striatum.  Newer radioligands now allow the assessment of these receptors in extrastriatal regions.  We used positron emission tomog. with [18F]fallypride to evaluate D2/D3 receptors in both striatal and extrastriatal regions in schizophrenia.  21 Patients with schizophrenia and 22 matched healthy control subjects were scanned with an ECAT EXACT HR+ camera.  Two-tissue compartment modeling and the ref. tissue method gave binding potentials relative to nondisplaceable uptake, total plasma concn., and free plasma concn.  These were compared between groups in five striatal and eight extrastriatal regions.  Several regional vols. were lower in the patient group, and positron emission tomog. data were cor. for partial vol. effects.  Binding potential values differed in three regions between groups.  Values for binding potential relative to nondisplaceable uptake from two-tissue compartment modeling in patients and control subjects, resp., were 28.7 ± 6.8 and 25.3 ± 4.3 in postcommissural caudate, 2.9 ± .7 and 2.6 ± .4 in thalamus, and 1.8 ± .5 and 2.1 ± .7 in uncus.  Loss of D2/D3 receptors with age was found in striatal and extrastriatal regions and was greater in neocortex.  Our study found selective alterations in D2/D3 receptors in striatal and extrastriatal regions, consistent with some but not all previously published reports.  As previously shown for the striatum, a more sensitive imaging approach for studying the role of dopamine in the pathophysiol. of schizophrenia might be assessment of neurotransmitter levels rather than D2/D3 receptor levels in extrastriatal regions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTExw0oYsWerVg90H21EOLACvtfcHk0lgNKzQQzLxoAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFOntb%252FN&md5=699f4816ad045009c1679fd95f52b6f3</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2010.05.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2010.05.027%26sid%3Dliteratum%253Aachs%26aulast%3DKegeles%26aufirst%3DL.%2BS.%26aulast%3DSlifstein%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DX.%2BY.%26aulast%3DUrban%26aufirst%3DN.%26aulast%3DThompson%26aufirst%3DJ.%2BL.%26aulast%3DMoadel%26aufirst%3DT.%26aulast%3DHarkavy-Friedman%26aufirst%3DJ.%2BM.%26aulast%3DGil%26aufirst%3DR.%26aulast%3DLaruelle%26aufirst%3DM.%26aulast%3DAbi-Dargham%26aufirst%3DA.%26atitle%3DStriatal%2520and%2520extrastriatal%2520dopamine%2520D-2%252FD-3%2520receptors%2520in%2520schizophrenia%2520evaluated%2520with%2520%255BF-18%255Dfallypride%2520positron%2520emission%2520tomography%26jtitle%3DBiol.%2520Psychiatry%26date%3D2010%26volume%3D68%26spage%3D634%26epage%3D641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Gao, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mock, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glick-Wilson, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoder, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchins, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Q. H.</span><span> </span><span class="NLM_article-title">An improved synthesis of dopamine D-2/D-3 receptor radioligands [C-11]fallypride and [F-18]fallypride</span> <span class="citation_source-journal">Appl. Radiat. Isot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">1079</span><span class="NLM_x">–</span> <span class="NLM_lpage">1086</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1016%2Fj.apradiso.2009.09.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=20167502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtFGqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2010&pages=1079-1086&author=M.+Z.+Gaoauthor=M.+Wangauthor=B.+H.+Mockauthor=B.+E.+Glick-Wilsonauthor=K.+K.+Yoderauthor=G.+D.+Hutchinsauthor=Q.+H.+Zheng&title=An+improved+synthesis+of+dopamine+D-2%2FD-3+receptor+radioligands+%5BC-11%5Dfallypride+and+%5BF-18%5Dfallypride"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">An improved synthesis of dopamine D2/D3 receptor radioligands [11C]fallypride and [18F]fallypride</span></div><div class="casAuthors">Gao, Mingzhang; Wang, Min; Mock, Bruce H.; Glick-Wilson, Barbara E.; Yoder, Karmen K.; Hutchins, Gary D.; Zheng, Qi-Huang</div><div class="citationInfo"><span class="NLM_cas:title">Applied Radiation and Isotopes</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1079-1086</span>CODEN:
                <span class="NLM_cas:coden">ARISEF</span>;
        ISSN:<span class="NLM_cas:issn">0969-8043</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Improved syntheses of dopamine D2/D3 receptor radioligands [11C]Fallypride and [18F]Fallypride are reported.  The phenolic precursor (9) for C-11 labeling and the Fallypride (10) ref. std. were synthesized from the starting material 2-hydroxy-3-methoxy-5-(2-propenyl)benzoic acid Me ester (1) in 7 and 8 steps with 16% and 5% overall chem. yields, resp.  The tosylated precursor (15) for F-18 labeling was synthesized from compd. 1 in 5 steps with 32% overall chem. yield.  An alternate synthetic approach for Fallypride has been developed using the same starting material 1 in 5 steps with 26% overall chem. yield. [11C]Fallypride ([11C]10) was prepd. by O-[11C]methylation of the phenolic precursor with [11C]methyl triflate and purified with a semi-preparative HPLC method in 50-60% radiochem. yield, decay cor. to end of bombardment (EOB), based on [11C]CO2, and 370±185 GBq/μmol specific radioactivity at EOB. [18F]Fallypride ([18F]10) was prepd. by nucleophilic substitution of the tosylated precursor with K[18F]F/Kryptofix 2.2.2 and HPLC combined with solid-phase extn. (SPE) purifn. in variable (up to 50%) decay cor. radiochem. yield from K[18F]F and 111-222 GBq/μmol specific activity at EOB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXobetfyLezrVg90H21EOLACvtfcHk0lgNKzQQzLxoAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtFGqsbk%253D&md5=ba0dc8a4c0ff13c93873742a4afb47e0</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.apradiso.2009.09.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apradiso.2009.09.071%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DM.%2BZ.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DMock%26aufirst%3DB.%2BH.%26aulast%3DGlick-Wilson%26aufirst%3DB.%2BE.%26aulast%3DYoder%26aufirst%3DK.%2BK.%26aulast%3DHutchins%26aufirst%3DG.%2BD.%26aulast%3DZheng%26aufirst%3DQ.%2BH.%26atitle%3DAn%2520improved%2520synthesis%2520of%2520dopamine%2520D-2%252FD-3%2520receptor%2520radioligands%2520%255BC-11%255Dfallypride%2520and%2520%255BF-18%255Dfallypride%26jtitle%3DAppl.%2520Radiat.%2520Isot.%26date%3D2010%26volume%3D68%26spage%3D1079%26epage%3D1086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Majumdar, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muhuri, S.</span><span> </span><span class="NLM_article-title">Regioselective synthesis of pyrone-annulated sulfur heterocycles by aryl radical cyclization</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">2725</span><span class="NLM_x">–</span> <span class="NLM_lpage">2730</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1055%2Fs-2006-942499" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1SisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=2725-2730&author=K.+C.+Majumdarauthor=S.+Muhuri&title=Regioselective+synthesis+of+pyrone-annulated+sulfur+heterocycles+by+aryl+radical+cyclization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Regioselective synthesis of pyrone-annulated sulfur heterocycles by aryl radical cyclization</span></div><div class="casAuthors">Majumdar, K. C.; Muhuri, S.</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2725-2730</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">The tributyltin hydride-mediated cyclization of a no. of 4-(2-bromophenoxymethyl)-7-methylthiopyrano[3,2-c]pyran-5-ones was carried out to afford tetracyclic [6,6]pyranothiopyrans I [R, R1, R2 = H; R = Me, R1 = R2 = H; R1 = OMe, R = R2 = H; RR1 = (CH)4, R2 = H; R1 = Me, R = R2 = H; R = H, R1 = R2 = Me] in 70-80% yield and with good to excellent diastereoselectivity.  The substrate ethers were obtained by a thio-Claisen rearrangement of the corresponding 4-(4-aryloxybut-2-ynyl)-6-methylpyran-2-ones.  The cis stereochem. of the predominant diastereomer was corroborated by single crystal x-ray anal. of I [R1 = Me, R = R2 = H: monoclinic, space group, P21/c, a 8.2785(7), b 10.7418(9), c 16.3304(14) Å, β 101.008(2)°, V 1425.5(2) Å3, Z 4].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdyUtQ7EjGqrVg90H21EOLACvtfcHk0liy3TeHneSGMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1SisLk%253D&md5=4720c055449d9e0c860b7f8c9be70246</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1055%2Fs-2006-942499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2006-942499%26sid%3Dliteratum%253Aachs%26aulast%3DMajumdar%26aufirst%3DK.%2BC.%26aulast%3DMuhuri%26aufirst%3DS.%26atitle%3DRegioselective%2520synthesis%2520of%2520pyrone-annulated%2520sulfur%2520heterocycles%2520by%2520aryl%2520radical%2520cyclization%26jtitle%3DSynthesis%26date%3D2006%26spage%3D2725%26epage%3D2730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Majumdar, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafique-ul-Islam</span><span> </span><span class="NLM_article-title">Chemoselective synthesis of thieno [3,2-c] [1,8]naphthyridin-4(5H-ones by tandem cyclization</span> <span class="citation_source-journal">Heteroat. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1002%2Fhc.20234" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsVymtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=87-92&author=K.+C.+Majumdarauthor=+Rafique-ul-Islam&title=Chemoselective+synthesis+of+thieno+%5B3%2C2-c%5D+%5B1%2C8%5Dnaphthyridin-4%285H-ones+by+tandem+cyclization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoselective synthesis of thieno[3,2-c][1,8]naphthyridin-4(5H)-ones by tandem cyclization</span></div><div class="casAuthors">Majumdar, Krishna C.; Rafique-ul-Islam</div><div class="citationInfo"><span class="NLM_cas:title">Heteroatom Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-92</span>CODEN:
                <span class="NLM_cas:coden">HETCE8</span>;
        ISSN:<span class="NLM_cas:issn">1042-7163</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A no. of the thieno[3,2-c][1,8]naphthyridin-4(5H)-ones are chemoselectively synthesized from 4-(4'-aryloxybut-2'-ynylthio)-1-phenyl-1,8-naphthyridin-2(1H)-ones in 82-90% yield by the formation of sulfoxide, followed by [2,3] and [3,3]sigmatropic rearrangement and an intramol. Michael addn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDYFbS7CgRC7Vg90H21EOLACvtfcHk0liy3TeHneSGMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsVymtA%253D%253D&md5=63801e2719d5c5d1c75a5dd1ce1b1668</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fhc.20234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhc.20234%26sid%3Dliteratum%253Aachs%26aulast%3DMajumdar%26aufirst%3DK.%2BC.%26aulast%3DRafique-ul-Islam%26atitle%3DChemoselective%2520synthesis%2520of%2520thieno%2520%255B3%252C2-c%255D%2520%255B1%252C8%255Dnaphthyridin-4%25285H-ones%2520by%2520tandem%2520cyclization%26jtitle%3DHeteroat.%2520Chem.%26date%3D2007%26volume%3D18%26spage%3D87%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Liu, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, R. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuang, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, C.</span><span> </span><span class="NLM_article-title">Gene and doxorubicin co-delivery system for targeting therapy of glioma</span> <span class="citation_source-journal">Biomaterials</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">4907</span><span class="NLM_x">–</span> <span class="NLM_lpage">4916</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1016%2Fj.biomaterials.2012.03.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=22484049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1aht7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=4907-4916&author=S.+H.+Liuauthor=Y.+B.+Guoauthor=R.+Q.+Huangauthor=J.+F.+Liauthor=S.+X.+Huangauthor=Y.+Y.+Kuangauthor=L.+Hanauthor=C.+Jiang&title=Gene+and+doxorubicin+co-delivery+system+for+targeting+therapy+of+glioma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Gene and doxorubicin co-delivery system for targeting therapy of glioma</span></div><div class="casAuthors">Liu, Shuhuan; Guo, Yubo; Huang, Rongqin; Li, Jianfeng; Huang, Shixian; Kuang, Yuyang; Han, Liang; Jiang, Chen</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4907-4916</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The combination of gene therapy and chemotherapy is a promising treatment strategy for brain gliomas.  In this paper, we designed a co-delivery system (DGDPT/pORF-hTRAIL) loading chemotherapeutic drug doxorubicin and gene agent pORF-hTRAIL, and with functions of pH-trigger and cancer targeting.  Peptide HAIYPRH (T7), a transferrin receptor-specific peptide, was chosen as the ligand to target the co-delivery system to the tumor cells expressing transferrin receptors.  T7-modified co-delivery system showed higher efficiency in cellular uptake and gene expression than unmodified co-delivery system in U87 MG cells, and accumulated in tumor more efficiently in vivo.  DOX was covalently conjugated to carrier though pH-triggered hydrazone bond.  In vitro incubation of the conjugates in buffers led to a fast DOX release at pH 5.0 (intracellular environment) while at pH 7.4 (blood) the conjugates are relatively stable.  The combination treatment resulted in a synergistic growth inhibition (combination index, CI < 1) in U87 MG cells.  The synergism effect of DGDPT/pORF-hTRAIL was verified in vitro and in vivo.  In vivo anti-glioma efficacy study confirmed that DGDPT/pORF-hTRAIL displayed anti-glioma activity but was less toxic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVV0K9FZSitbVg90H21EOLACvtfcHk0ljNU--lBPEvwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1aht7w%253D&md5=16941e794801046db903e62779932e79</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2012.03.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2012.03.031%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DS.%2BH.%26aulast%3DGuo%26aufirst%3DY.%2BB.%26aulast%3DHuang%26aufirst%3DR.%2BQ.%26aulast%3DLi%26aufirst%3DJ.%2BF.%26aulast%3DHuang%26aufirst%3DS.%2BX.%26aulast%3DKuang%26aufirst%3DY.%2BY.%26aulast%3DHan%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DC.%26atitle%3DGene%2520and%2520doxorubicin%2520co-delivery%2520system%2520for%2520targeting%2520therapy%2520of%2520glioma%26jtitle%3DBiomaterials%26date%3D2012%26volume%3D33%26spage%3D4907%26epage%3D4916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Oh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, T.</span><span> </span><span class="NLM_article-title">Synthesis and anti-cancer activity of covalent conjugates of artemisinin and a transferrin-receptor targeting peptide</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1016%2Fj.canlet.2008.08.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=18838215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFCmsLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=2009&pages=33-39&author=S.+Ohauthor=B.+J.+Kimauthor=N.+P.+Singhauthor=H.+Laiauthor=T.+Sasaki&title=Synthesis+and+anti-cancer+activity+of+covalent+conjugates+of+artemisinin+and+a+transferrin-receptor+targeting+peptide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and anti-cancer activity of covalent conjugates of artemisinin and a transferrin-receptor targeting peptide</span></div><div class="casAuthors">Oh, Steve; Kim, Byung Ju; Singh, Narendra P.; Lai, Henry; Sasaki, Tomikazu</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-39</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Artemisinin, a natural product isolated from Artemisia annua L., shows a unique anti-cancer activity by an iron dependent mechanism.  Artemisinin was covalently conjugated to a transferrin-receptor targeting peptide, HAIYPRH that binds to a cavity on the surface of transferrin receptor.  This enables artemisinin to be co-internalized with receptor-bound transferrin.  The iron released from transferrin can activate artemisinin to generate toxic radical species to kill cells.  The artemisinin-peptide conjugates showed potent anti-cancer activity against Molt-4 leukemia cells with a significantly improved cancer/normal cells selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfTf4ms6hIp7Vg90H21EOLACvtfcHk0ljNU--lBPEvwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFCmsLrL&md5=00d017bc7bd19a5846984c6f75fcc634</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2008.08.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2008.08.031%26sid%3Dliteratum%253Aachs%26aulast%3DOh%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DB.%2BJ.%26aulast%3DSingh%26aufirst%3DN.%2BP.%26aulast%3DLai%26aufirst%3DH.%26aulast%3DSasaki%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520anti-cancer%2520activity%2520of%2520covalent%2520conjugates%2520of%2520artemisinin%2520and%2520a%2520transferrin-receptor%2520targeting%2520peptide%26jtitle%3DCancer%2520Lett.%26date%3D2009%26volume%3D274%26spage%3D33%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Demeule, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Currie, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabathuler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaigne, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beliveau, R.</span><span> </span><span class="NLM_article-title">Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector aAngiopep-2</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">1534</span><span class="NLM_x">–</span> <span class="NLM_lpage">1544</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1111%2Fj.1471-4159.2008.05492.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=18489712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVegtL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2008&pages=1534-1544&author=M.+Demeuleauthor=J.+C.+Currieauthor=Y.+Bertrandauthor=C.+Cheauthor=T.+Nguyenauthor=A.+Reginaauthor=R.+Gabathulerauthor=J.+P.+Castaigneauthor=R.+Beliveau&title=Involvement+of+the+low-density+lipoprotein+receptor-related+protein+in+the+transcytosis+of+the+brain+delivery+vector+aAngiopep-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2</span></div><div class="casAuthors">Demeule, Michel; Currie, Jean-Christophe; Bertrand, Yanick; Che, Christian; Nguyen, Tran; Regina, Anthony; Gabathuler, Reinhard; Castaigne, Jean-Paul; Beliveau, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1534-1544</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The blood-brain barrier (BBB) restricts the entry of proteins as well as potential drugs to cerebral tissues.  We previously reported that a family of Kunitz domain-derived peptides called Angiopeps can be used as a drug delivery system for the brain.  Here, we further characterize the transcytosis ability of these peptides using an in vitro model of the BBB and in situ brain perfusion.  These peptides, and in particular Angiopep-2, exhibited higher transcytosis capacity and parenchymal accumulation than do transferrin, lactoferrin, and avidin.  Angiopep-2 transport and accumulation in brain endothelial cells were unaffected by the P-glycoprotein inhibitor, cyclosporin A, indicating that this peptide is not a substrate for the efflux pump P-glycoprotein.  However, competition studies show that activated α2-macroglobulin, a specific ligand for the low-d. lipoprotein receptor-related protein-1 (LRP1) and Angiopep-2 can share the same receptor.  In addn., LRP1 was detected in glioblastomas and brain metastases from lung and skin cancers.  Fluorescent microscopy also revealed that Alexa488-Angiopep-2 co-localized with LRP1 in brain endothelial cell monolayers.  Overall, these results suggest that Angiopep-2 transport across the BBB is, in part, mediated by LRP1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMFu69WDcG1bVg90H21EOLACvtfcHk0li_8arNdwbtoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVegtL3L&md5=c36a424070e833dfc60329e397065a3b</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2008.05492.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2008.05492.x%26sid%3Dliteratum%253Aachs%26aulast%3DDemeule%26aufirst%3DM.%26aulast%3DCurrie%26aufirst%3DJ.%2BC.%26aulast%3DBertrand%26aufirst%3DY.%26aulast%3DChe%26aufirst%3DC.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DRegina%26aufirst%3DA.%26aulast%3DGabathuler%26aufirst%3DR.%26aulast%3DCastaigne%26aufirst%3DJ.%2BP.%26aulast%3DBeliveau%26aufirst%3DR.%26atitle%3DInvolvement%2520of%2520the%2520low-density%2520lipoprotein%2520receptor-related%2520protein%2520in%2520the%2520transcytosis%2520of%2520the%2520brain%2520delivery%2520vector%2520aAngiopep-2%26jtitle%3DJ.%2520Neurochem.%26date%3D2008%26volume%3D106%26spage%3D1534%26epage%3D1544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Bertrand, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Currie, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demeule, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abulrob, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fatehi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanimirovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartelet, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaigne, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beliveau, R.</span><span> </span><span class="NLM_article-title">Influence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">1697</span><span class="NLM_x">–</span> <span class="NLM_lpage">1707</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1038%2Fbjc.2011.427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=22027709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFWqs7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2011&pages=1697-1707&author=Y.+Bertrandauthor=J.+C.+Currieauthor=J.+Poirierauthor=M.+Demeuleauthor=A.+Abulrobauthor=D.+Fatehiauthor=D.+Stanimirovicauthor=H.+Sarteletauthor=J.+P.+Castaigneauthor=R.+Beliveau&title=Influence+of+glioma+tumour+microenvironment+on+the+transport+of+ANG1005+via+low-density+lipoprotein+receptor-related+protein+1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1</span></div><div class="casAuthors">Bertrand, Y.; Currie, J.-C.; Poirier, J.; Demeule, M.; Abulrob, A.; Fatehi, D.; Stanimirovic, D.; Sartelet, H.; Castaigne, J.-P.; Beliveau, R.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1697-1707</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: ANG1005 consists of three mols. of paclitaxel conjugated via ester bonds to the 19-amino-acid peptide Angiopep-2.  The new chem. agent has been shown to cross the blood-brain barrier (BBB) by receptor-mediated transcytosis via low-d. lipoprotein receptor-related protein 1 (LRP1).  The expts. here examd. the role of LRP1 in the subsequent endocytosis of drug into cancer cells.  Methods: Localisation of ANG1005 and Angiopep-2 was examd. by immunohistochem. and in-vivo near-IR fluorescence imaging in mice carrying orthotopic glioma tumors.  Transport of ANG1005 and Angiopep-2 was examd. in U87 glioblastoma cell lines.  Results: Systemically administered ANG1005 and Cy5.5Angiopep-2 localized to orthotopic glioma tumors in mice.  The glioma transplants correlated with high expression levels of LRP1.  Decreasing LRP1 activity, by RNA silencing or LRP1 competitors, decreased uptake of ANG1005 and Angiopep-2 into U87 glioblastoma cells.  Conversely, LRP1 expression and endocytosis rates for ANG1005 and Angiopep-2 increased in U87 cells under conditions that mimicked the microenvironment near aggressive tumors, i.e., hypoxic and acidic conditions.  Conclusion: ANG1005 might be a particularly effective chemotherapeutic agent for the wide array of known LRP1-expressing brain and non-brain cancers, in particular those with an aggressive phenotype.  British Journal of Cancer (2011) 105, 1697-1707; doi:10.1038/bjc.2011.427; published online 25 Oct. 2011; www.bjcancer.com.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGm0tJMDHmObVg90H21EOLACvtfcHk0li_8arNdwbtoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFWqs7fN&md5=4c4fe96279d122af99a53d0f72f71c30</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2011.427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2011.427%26sid%3Dliteratum%253Aachs%26aulast%3DBertrand%26aufirst%3DY.%26aulast%3DCurrie%26aufirst%3DJ.%2BC.%26aulast%3DPoirier%26aufirst%3DJ.%26aulast%3DDemeule%26aufirst%3DM.%26aulast%3DAbulrob%26aufirst%3DA.%26aulast%3DFatehi%26aufirst%3DD.%26aulast%3DStanimirovic%26aufirst%3DD.%26aulast%3DSartelet%26aufirst%3DH.%26aulast%3DCastaigne%26aufirst%3DJ.%2BP.%26aulast%3DBeliveau%26aufirst%3DR.%26atitle%3DInfluence%2520of%2520glioma%2520tumour%2520microenvironment%2520on%2520the%2520transport%2520of%2520ANG1005%2520via%2520low-density%2520lipoprotein%2520receptor-related%2520protein%25201%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2011%26volume%3D105%26spage%3D1697%26epage%3D1707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Kostikov, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orchowski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirrmacher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niedermoser, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurkschat, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iovkova-Berends, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wängler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wängler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirrmacher, R.</span><span> </span><span class="NLM_article-title">Synthesis of [F-18]SiFB: a prosthetic group for direct protein radiolabeling for application in positron emission tomography</span> <span class="citation_source-journal">Nat. Protoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1956</span><span class="NLM_x">–</span> <span class="NLM_lpage">1963</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1956-1963&author=A.+P.+Kostikovauthor=J.+S.+Chinauthor=K.+Orchowskiauthor=E.+Schirrmacherauthor=S.+Niedermoserauthor=K.+Jurkschatauthor=L.+Iovkova-Berendsauthor=C.+W%C3%A4nglerauthor=B.+W%C3%A4nglerauthor=R.+Schirrmacher&title=Synthesis+of+%5BF-18%5DSiFB%3A+a+prosthetic+group+for+direct+protein+radiolabeling+for+application+in+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKostikov%26aufirst%3DA.%2BP.%26aulast%3DChin%26aufirst%3DJ.%2BS.%26aulast%3DOrchowski%26aufirst%3DK.%26aulast%3DSchirrmacher%26aufirst%3DE.%26aulast%3DNiedermoser%26aufirst%3DS.%26aulast%3DJurkschat%26aufirst%3DK.%26aulast%3DIovkova-Berends%26aufirst%3DL.%26aulast%3DW%25C3%25A4ngler%26aufirst%3DC.%26aulast%3DW%25C3%25A4ngler%26aufirst%3DB.%26aulast%3DSchirrmacher%26aufirst%3DR.%26atitle%3DSynthesis%2520of%2520%255BF-18%255DSiFB%253A%2520a%2520prosthetic%2520group%2520for%2520direct%2520protein%2520radiolabeling%2520for%2520application%2520in%2520positron%2520emission%2520tomography%26jtitle%3DNat.%2520Protoc.%26date%3D2012%26volume%3D7%26spage%3D1956%26epage%3D1963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Wängler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostikov, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niedermoser, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orchowski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirrmacher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iovkova-Berends, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurkschat, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wängler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirrmacher, R.</span><span> </span><span class="NLM_article-title">Protein labeling with the labeling precursor [F-18]SiFA-SH for positron emission tomography</span> <span class="citation_source-journal">Nat. Protoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1964</span><span class="NLM_x">–</span> <span class="NLM_lpage">1969</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1964-1969&author=B.+W%C3%A4nglerauthor=A.+P.+Kostikovauthor=S.+Niedermoserauthor=J.+S.+Chinauthor=K.+Orchowskiauthor=E.+Schirrmacherauthor=L.+Iovkova-Berendsauthor=K.+Jurkschatauthor=C.+W%C3%A4nglerauthor=R.+Schirrmacher&title=Protein+labeling+with+the+labeling+precursor+%5BF-18%5DSiFA-SH+for+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DW%25C3%25A4ngler%26aufirst%3DB.%26aulast%3DKostikov%26aufirst%3DA.%2BP.%26aulast%3DNiedermoser%26aufirst%3DS.%26aulast%3DChin%26aufirst%3DJ.%2BS.%26aulast%3DOrchowski%26aufirst%3DK.%26aulast%3DSchirrmacher%26aufirst%3DE.%26aulast%3DIovkova-Berends%26aufirst%3DL.%26aulast%3DJurkschat%26aufirst%3DK.%26aulast%3DW%25C3%25A4ngler%26aufirst%3DC.%26aulast%3DSchirrmacher%26aufirst%3DR.%26atitle%3DProtein%2520labeling%2520with%2520the%2520labeling%2520precursor%2520%255BF-18%255DSiFA-SH%2520for%2520positron%2520emission%2520tomography%26jtitle%3DNat.%2520Protoc.%26date%3D2012%26volume%3D7%26spage%3D1964%26epage%3D1969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Wängler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niedermoser, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orchowski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirrmacher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurkschat, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iovkova-Berends, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostikov, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirrmacher, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wängler, B.</span><span> </span><span class="NLM_article-title">One-step F-18-labeling of peptides for positron emission tomography imaging using the SiFA methodology</span> <span class="citation_source-journal">Nat. Protoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1946</span><span class="NLM_x">–</span> <span class="NLM_lpage">1955</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1946-1955&author=C.+W%C3%A4nglerauthor=S.+Niedermoserauthor=J.+S.+Chinauthor=K.+Orchowskiauthor=E.+Schirrmacherauthor=K.+Jurkschatauthor=L.+Iovkova-Berendsauthor=A.+P.+Kostikovauthor=R.+Schirrmacherauthor=B.+W%C3%A4ngler&title=One-step+F-18-labeling+of+peptides+for+positron+emission+tomography+imaging+using+the+SiFA+methodology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DW%25C3%25A4ngler%26aufirst%3DC.%26aulast%3DNiedermoser%26aufirst%3DS.%26aulast%3DChin%26aufirst%3DJ.%2BS.%26aulast%3DOrchowski%26aufirst%3DK.%26aulast%3DSchirrmacher%26aufirst%3DE.%26aulast%3DJurkschat%26aufirst%3DK.%26aulast%3DIovkova-Berends%26aufirst%3DL.%26aulast%3DKostikov%26aufirst%3DA.%2BP.%26aulast%3DSchirrmacher%26aufirst%3DR.%26aulast%3DW%25C3%25A4ngler%26aufirst%3DB.%26atitle%3DOne-step%2520F-18-labeling%2520of%2520peptides%2520for%2520positron%2520emission%2520tomography%2520imaging%2520using%2520the%2520SiFA%2520methodology%26jtitle%3DNat.%2520Protoc.%26date%3D2012%26volume%3D7%26spage%3D1946%26epage%3D1955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Wetzl, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarmoluk, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craig, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfbeis, O. S.</span><span> </span><span class="NLM_article-title">Chameleon labels for staining and quantifying proteins</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">5400</span><span class="NLM_x">–</span> <span class="NLM_lpage">5402</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1002%2Fanie.200460508" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptValu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=5400-5402&author=B.+K.+Wetzlauthor=S.+M.+Yarmolukauthor=D.+B.+Craigauthor=O.+S.+Wolfbeis&title=Chameleon+labels+for+staining+and+quantifying+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Chameleon labels for staining and quantifying proteins</span></div><div class="casAuthors">Wetzl, Bianca K.; Yarmoluk, Sergiy M.; Craig, Douglas B.; Wolfbeis, Otto S.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">5400-5402</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Glowing marks: A new class of protein stains, the pyrylium dyes, undergo a strong color change (typically from blue to red) on covalently binding to proteins.  While the free stains are almost nonfluorescent, the protein-conjugated forms are highly fluorescent.  The dyes do not alter the charge of a protein, and thus do not change its electrophoretic properties.  The stains also can be used in quant. protein assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYw-9981yr5rVg90H21EOLACvtfcHk0liG621zcAfRng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptValu74%253D&md5=b63ed2a572d46b54d72fa9e667de80ac</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1002%2Fanie.200460508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200460508%26sid%3Dliteratum%253Aachs%26aulast%3DWetzl%26aufirst%3DB.%2BK.%26aulast%3DYarmoluk%26aufirst%3DS.%2BM.%26aulast%3DCraig%26aufirst%3DD.%2BB.%26aulast%3DWolfbeis%26aufirst%3DO.%2BS.%26atitle%3DChameleon%2520labels%2520for%2520staining%2520and%2520quantifying%2520proteins%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2004%26volume%3D43%26spage%3D5400%26epage%3D5402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Iovkova, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wängler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirrmacher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirrmacher, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quandt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boening, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schurmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurkschat, K.</span><span> </span><span class="NLM_article-title">Para-functionalized aryl-di-tert-butylfluorosilanes as potential labeling synthons for F-18 radiopharmaceuticals</span> <span class="citation_source-journal">Chem.—Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2140</span><span class="NLM_x">–</span> <span class="NLM_lpage">2147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1002%2Fchem.200802266" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=19156812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisVagurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=2140-2147&author=L.+Iovkovaauthor=B.+W%C3%A4nglerauthor=E.+Schirrmacherauthor=R.+Schirrmacherauthor=G.+Quandtauthor=G.+Boeningauthor=M.+Schurmannauthor=K.+Jurkschat&title=Para-functionalized+aryl-di-tert-butylfluorosilanes+as+potential+labeling+synthons+for+F-18+radiopharmaceuticals"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">para-functionalized aryl-di-tert-butylfluorosilanes as potential labeling synthons for 18F radiopharmaceuticals</span></div><div class="casAuthors">Iovkova, Ljuba; Waengler, Bjoern; Schirrmacher, Esther; Schirrmacher, Ralf; Quandt, Gabriele; Boening, Buido; Schuermann, Markus; Jurkschat, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry--A European Journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2140-2147</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The syntheses of the functionalized triorganofluorosilanes tBu2-(p-XC6H4)SiF (3a, X = SH; 4a, X = NCS; 4b, X = NCO; 5, X = NC4H2O2; 7, X = COOH; 8a, X = COONC4H4O2; 8b, X = COOC6F5) are reported.  These compds. display potential as silicon-based fluoride acceptors (SiFAs).  The mol. structures of compds. 5, 7, and 8a have been detd. by single-crystal X-ray diffraction studies.  With the exception of compds. 8a and 8b, all of the compds. could be 18F-labeled by isotopic exchange in good to high radiochem. yields (RCY) with good to excellent specific activities.  As proof of applicability, the maleimido-functionalized SiFA deriv. 5, which is specific for thiol groups, has been used for the labeling of rat serum albumin (RSA) that had been derivatized with 2-iminothiolane.  The incorporation of [18F]5 into the derivatized RSA reached a max. yield after 30 min at ambient temp.  After purifn., the [18F]RSA was evaluated in a healthy rat by means of μPET and displayed an expedient in vivo stability over 180 min.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_35-B6hKV3rVg90H21EOLACvtfcHk0liG621zcAfRng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisVagurc%253D&md5=f365f79d276db6b12d2ff7228f91089e</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1002%2Fchem.200802266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.200802266%26sid%3Dliteratum%253Aachs%26aulast%3DIovkova%26aufirst%3DL.%26aulast%3DW%25C3%25A4ngler%26aufirst%3DB.%26aulast%3DSchirrmacher%26aufirst%3DE.%26aulast%3DSchirrmacher%26aufirst%3DR.%26aulast%3DQuandt%26aufirst%3DG.%26aulast%3DBoening%26aufirst%3DG.%26aulast%3DSchurmann%26aufirst%3DM.%26aulast%3DJurkschat%26aufirst%3DK.%26atitle%3DPara-functionalized%2520aryl-di-tert-butylfluorosilanes%2520as%2520potential%2520labeling%2520synthons%2520for%2520F-18%2520radiopharmaceuticals%26jtitle%3DChem.%25E2%2580%2594Eur.%2520J.%26date%3D2009%26volume%3D15%26spage%3D2140%26epage%3D2147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Wängler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nada, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofner, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maschauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wängler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirrmacher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanner, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirrmacher, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prante, O.</span><span> </span><span class="NLM_article-title">In vitro and initial in vivo evaluation of <sup>68</sup>Ga-labeled transferrin receptor (TfR) binding peptides as potential carriers for enhanced drug transport into TfR expressing cells</span> <span class="citation_source-journal">Mol. Imaging Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">332</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1007%2Fs11307-010-0329-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=20473573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A280%3ADC%252BC3M3kvVOluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=332-341&author=C.+W%C3%A4nglerauthor=D.+Nadaauthor=G.+Hofnerauthor=S.+Maschauerauthor=B.+W%C3%A4nglerauthor=S.+Schneiderauthor=E.+Schirrmacherauthor=K.+T.+Wannerauthor=R.+Schirrmacherauthor=O.+Prante&title=In+vitro+and+initial+in+vivo+evaluation+of+68Ga-labeled+transferrin+receptor+%28TfR%29+binding+peptides+as+potential+carriers+for+enhanced+drug+transport+into+TfR+expressing+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and initial in vivo evaluation of (68)Ga-labeled transferrin receptor (TfR) binding peptides as potential carriers for enhanced drug transport into TfR expressing cells</span></div><div class="casAuthors">Wangler Carmen; Nada Dina; Hofner Georg; Maschauer Simone; Wangler Bjorn; Schneider Stephan; Schirrmacher Esther; Wanner Klaus T; Schirrmacher Ralf; Prante Olaf</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">332-41</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  The transferrin receptor (TfR) is one of the most attractive targets to overcome the blood-brain barrier (BBB).  It has recently been shown that THRPPMWSPVWP binds to the TfR and is subsequently internalized into TfR-expressing cells.  Here, we evaluated the ability of THRPPMWSPVWP to become internalized into human TfR-expressing cells via endocytosis to determine its potential to act as a carrier system for the transport of small molecules across the BBB.  PROCEDURES:  To validate the underlying concept of a conjugate consisting of a small brain imaging tracer and a large peptidic carrier molecule, a conjugate of the high affinity D2 receptor ligand fallypride and the TfR targeting peptide THRPPMWSPVWP has been synthesized.  Furthermore, two derivatives of THRPPMWSPVWP were labeled with (68)Ga in high radiochemical yields (>96%) and a radiochemical purity of 96-98% and evaluated in vitro and in vivo.  RESULTS:  The fallypride-THRPPMWSPVWP conjugate still displayed a K(i) of 27 nM.  The uptake of the (68)Ga-labeled peptides into TfR-bearing cells was investigated using U87MG and HT-29 cells to assess the capability of the peptide to act as a carrier molecule targeting the TfR.  The in vitro binding studies revealed negligible uptake of the tested (68)Ga-labeled conjugates ranging from 0.08% to 0.66% after 60 min incubation at 37°C.  Initial in vivo experiments with (68)Ga-DOTA-S-maleimido-THRPPMWSPVWP in two healthy rats showed a mean brain uptake of 0.037% injected dose per gram, confirming the results obtained in vitro.  CONCLUSION:  These results suggest that the accumulation of the (68)Ga-radiolabeled conjugates of the TfR-binding peptide THRPPMWSPVWP into TFR expressing human cell lines is nonspecific and too low to render this peptide suitable as a possible carrier molecule for a receptor-mediated transport of compounds across the BBB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTah1I4FHsD8QaK-_ZudimnfW6udTcc2eYdp7za8gTOj7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3kvVOluw%253D%253D&md5=52179bbb2a3c067dd354581366aff8f8</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1007%2Fs11307-010-0329-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-010-0329-6%26sid%3Dliteratum%253Aachs%26aulast%3DW%25C3%25A4ngler%26aufirst%3DC.%26aulast%3DNada%26aufirst%3DD.%26aulast%3DHofner%26aufirst%3DG.%26aulast%3DMaschauer%26aufirst%3DS.%26aulast%3DW%25C3%25A4ngler%26aufirst%3DB.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DSchirrmacher%26aufirst%3DE.%26aulast%3DWanner%26aufirst%3DK.%2BT.%26aulast%3DSchirrmacher%26aufirst%3DR.%26aulast%3DPrante%26aufirst%3DO.%26atitle%3DIn%2520vitro%2520and%2520initial%2520in%2520vivo%2520evaluation%2520of%252068Ga-labeled%2520transferrin%2520receptor%2520%2528TfR%2529%2520binding%2520peptides%2520as%2520potential%2520carriers%2520for%2520enhanced%2520drug%2520transport%2520into%2520TfR%2520expressing%2520cells%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2011%26volume%3D13%26spage%3D332%26epage%3D341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Schirrmacher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wängler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cypryk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradtmoller, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schäfer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurkschat, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirrmacher, R.</span><span> </span><span class="NLM_article-title">Synthesis of p-(di-tert-butyl[(18)f]fluorosilyl)benzaldehyde ([F-18]SiFA-A) with high specific activity by isotopic exchange: A convenient labeling synthon for the F-18-labeling of n-amino-oxy derivatized peptides</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2085</span><span class="NLM_x">–</span> <span class="NLM_lpage">2089</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc700195y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlKlurjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=2085-2089&author=E.+Schirrmacherauthor=B.+W%C3%A4nglerauthor=M.+Cyprykauthor=G.+Bradtmollerauthor=M.+Sch%C3%A4ferauthor=M.+Eisenhutauthor=K.+Jurkschatauthor=R.+Schirrmacher&title=Synthesis+of+p-%28di-tert-butyl%5B%2818%29f%5Dfluorosilyl%29benzaldehyde+%28%5BF-18%5DSiFA-A%29+with+high+specific+activity+by+isotopic+exchange%3A+A+convenient+labeling+synthon+for+the+F-18-labeling+of+n-amino-oxy+derivatized+peptides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of p-(Di-tert-butyl[18F]fluorosilyl)benzaldehyde ([18F]SiFA-A) with High Specific Activity by Isotopic Exchange: A Convenient Labeling Synthon for the 18F-Labeling of N-amino-oxy Derivatized Peptides</span></div><div class="casAuthors">Schirrmacher, Esther; Waengler, Bjoern; Cypryk, Marek; Bradtmoeller, Gerrit; Schaefer, Martin; Eisenhut, Michael; Jurkschat, Klaus; Schirrmacher, Ralf</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2085-2089</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The syntheses of different 18F-labeled peptides using the highly effective labeling synthon p-(di-tert-butylfluorosilyl)benzaldehyde ([18F]SiFA-A) for the development of 18F-radiopharmaceuticals for oncol. positron emission tomog. (PET) is reported.  The novel and mild labeling technique for the radiosynthesis of [18F]SiFA-A, based on an unexpectedly efficient isotopic 19F-18F exchange, yielded the 18F-synthon [18F]SiFA-A in almost quant. yields in high specific activities between 225 and 680 GBq/μmol (6081-18 378 Ci/mmol) without applying HPLC purifn.  The [18F]SiFA-A was finally used to label the N-terminal aminooxy (N-AO) derivatized peptides, AO-Tyr3-octreotate (AO-TATE), cyclo[fK(AO-N)]RGD and N-AO-PEG2-[D-Tyr-Gln-Trp-Ala-Val-βAla-His-Thi-Nle-NH2] (AO-BZH3, a bombesin deriv.) in high radiochem. yields.  D. functional theory (DFT) calcns. confirmed high efficiency of the isotopic exchange, which is predicted to proceed via a pentacoordinate siliconate intermediate dissocg. immediately to form the radiolabeled [18F]SiFA-A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgKANh1J7eRLVg90H21EOLACvtfcHk0lgzGrwDTJn9ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlKlurjK&md5=af8605837df40861aac17c9901afd6d2</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fbc700195y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc700195y%26sid%3Dliteratum%253Aachs%26aulast%3DSchirrmacher%26aufirst%3DE.%26aulast%3DW%25C3%25A4ngler%26aufirst%3DB.%26aulast%3DCypryk%26aufirst%3DM.%26aulast%3DBradtmoller%26aufirst%3DG.%26aulast%3DSch%25C3%25A4fer%26aufirst%3DM.%26aulast%3DEisenhut%26aufirst%3DM.%26aulast%3DJurkschat%26aufirst%3DK.%26aulast%3DSchirrmacher%26aufirst%3DR.%26atitle%3DSynthesis%2520of%2520p-%2528di-tert-butyl%255B%252818%2529f%255Dfluorosilyl%2529benzaldehyde%2520%2528%255BF-18%255DSiFA-A%2529%2520with%2520high%2520specific%2520activity%2520by%2520isotopic%2520exchange%253A%2520A%2520convenient%2520labeling%2520synthon%2520for%2520the%2520F-18-labeling%2520of%2520n-amino-oxy%2520derivatized%2520peptides%26jtitle%3DBioconjugate%2520Chem.%26date%3D2007%26volume%3D18%26spage%3D2085%26epage%3D2089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Wängler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waser, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iovkova, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niedermoser, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurkschat, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fottner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenstein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirrmacher, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reubi, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wester, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wängler, B.</span><span> </span><span class="NLM_article-title">One-step (18)F-labeling of carbohydrate-conjugated octreotate-derivatives containing a silicon-fluoride-acceptor (SiFA): in vitro and in vivo evaluation as tumor imaging agents for positron emission tomography (PET)</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2289</span><span class="NLM_x">–</span> <span class="NLM_lpage">2296</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc100316c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A280%3ADC%252BC3Mrks1Wkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=2289-2296&author=C.+W%C3%A4nglerauthor=B.+Waserauthor=A.+Alkeauthor=L.+Iovkovaauthor=H.+G.+Buchholzauthor=S.+Niedermoserauthor=K.+Jurkschatauthor=C.+Fottnerauthor=P.+Bartensteinauthor=R.+Schirrmacherauthor=J.+C.+Reubiauthor=H.+J.+Westerauthor=B.+W%C3%A4ngler&title=One-step+%2818%29F-labeling+of+carbohydrate-conjugated+octreotate-derivatives+containing+a+silicon-fluoride-acceptor+%28SiFA%29%3A+in+vitro+and+in+vivo+evaluation+as+tumor+imaging+agents+for+positron+emission+tomography+%28PET%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">One-step 18F-labeling of carbohydrate-conjugated octreotate-derivatives containing a silicon-fluoride-acceptor (SiFA): in vitro and in vivo evaluation as tumor imaging agents for positron emission tomography (PET)</span></div><div class="casAuthors">Wangler Carmen; Waser Beatrice; Alke Andrea; Iovkova Ljuba; Buchholz Hans-Georg; Niedermoser Sabrina; Jurkschat Klaus; Fottner Christian; Bartenstein Peter; Schirrmacher Ralf; Reubi Jean-Claude; Wester Hans-Jurgen; Wangler Bjorn</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2289-96</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The synthesis, radiolabeling, and initial evaluation of new silicon-fluoride acceptor (SiFA) derivatized octreotate derivatives is reported.  So far, the main drawback of the SiFA technology for the synthesis of PET-radiotracers is the high lipophilicity of the resulting radiopharmaceutical.  Consequently, we synthesized new SiFA-octreotate analogues derivatized with Fmoc-NH-PEG-COOH, Fmoc-Asn(Ac3AcNH-β-Glc)-OH, and SiFA-aldehyde (SIFA-A).  The substances could be labeled in high yields (38 ± 4%) and specific activities between 29 and 56 GBq/μmol in short synthesis times of less than 30 min (e.o.b.).  The in vitro evaluation of the synthesized conjugates displayed a sst2 receptor affinity (IC50 = 3.3 ± 0.3 nM) comparable to that of somatostatin-28.  As a measure of lipophilicity of the conjugates, the log P(ow) was determined and found to be 0.96 for SiFA-Asn(AcNH-β-Glc)-PEG-Tyr3-octreotate and 1.23 for SiFA-Asn(AcNH-β-Glc)-Tyr3-octreotate, which is considerably lower than for SiFA-Tyr3-octreotate (log P(ow) = 1.59).  The initial in vivo evaluation of [18F]SiFA-Asn(AcNH-β-Glc)-PEG-Tyr3-octreotate revealed a significant uptake of radiotracer in the tumor tissue of AR42J tumor-bearing nude mice of 7.7% ID/g tissue weight.  These results show that the high lipophilicity of the SiFA moiety can be compensated by applying hydrophilic moieties.  Using this approach, a tumor-affine SiFA-containing peptide could successfully be used for receptor imaging for the first time in this proof of concept study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQkefLj0Mu3yEEksK8CslK8fW6udTcc2ebWEIUrgcmpOLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mrks1Wkug%253D%253D&md5=c46ecf760ee9bc5092ebb480097e3b64</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fbc100316c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc100316c%26sid%3Dliteratum%253Aachs%26aulast%3DW%25C3%25A4ngler%26aufirst%3DC.%26aulast%3DWaser%26aufirst%3DB.%26aulast%3DAlke%26aufirst%3DA.%26aulast%3DIovkova%26aufirst%3DL.%26aulast%3DBuchholz%26aufirst%3DH.%2BG.%26aulast%3DNiedermoser%26aufirst%3DS.%26aulast%3DJurkschat%26aufirst%3DK.%26aulast%3DFottner%26aufirst%3DC.%26aulast%3DBartenstein%26aufirst%3DP.%26aulast%3DSchirrmacher%26aufirst%3DR.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DWester%26aufirst%3DH.%2BJ.%26aulast%3DW%25C3%25A4ngler%26aufirst%3DB.%26atitle%3DOne-step%2520%252818%2529F-labeling%2520of%2520carbohydrate-conjugated%2520octreotate-derivatives%2520containing%2520a%2520silicon-fluoride-acceptor%2520%2528SiFA%2529%253A%2520in%2520vitro%2520and%2520in%2520vivo%2520evaluation%2520as%2520tumor%2520imaging%2520agents%2520for%2520positron%2520emission%2520tomography%2520%2528PET%2529%26jtitle%3DBioconjugate%2520Chem.%26date%3D2010%26volume%3D21%26spage%3D2289%26epage%3D2296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Wessmann, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henriksen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wester, H. J.</span><span> </span><span class="NLM_article-title">Cryptate mediated nucleophilic F-18-fluorination without azeotropic drying</span> <span class="citation_source-journal">Nuklearmedizin</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=21989864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtlGlsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=1-8&author=S.+H.+Wessmannauthor=G.+Henriksenauthor=H.+J.+Wester&title=Cryptate+mediated+nucleophilic+F-18-fluorination+without+azeotropic+drying"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Cryptate mediated nucleophilic 18F-fluorination without azeotropic drying</span></div><div class="casAuthors">Wessmann, S. H.; Henriksen, G.; Wester, H.-J.</div><div class="citationInfo"><span class="NLM_cas:title">Nuklearmedizin</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">NMIMAX</span>;
        ISSN:<span class="NLM_cas:issn">0029-5566</span>.
    
            (<span class="NLM_cas:orgname">Schattauer GmbH</span>)
        </div><div class="casAbstract">The radiosynthesis of the vast majority of 18F-labeled tracers rely on azeotropic drying of [18F]fluoride and subsequent cryptate mediated introduction of [18F]fluoride by nucleophilic substitution.  The aim of this study was to develop a method for simplification of this process, based on prepn. of reactive [K+⊂2.2.2]18F- by solvent drying of [18F]fluoride adsorbed onto an anion exchange resin.  Methods: Aq. [18F]fluoride (0.5-1 mL) obtained from the 18O(p,n)18F nuclear reaction was trapped on a strong anion-exchange (SAX) cartridge.  After washing the cartridge with dry CH3CN, [18F]fluoride was eluted with an anhyd. soln. of [K+⊂2.2.2]OH- in CH3CN and directly used for nucleophilic fluorination reactions.  Results: [18F]Fluoride from target water was quant. retained by the SAX cartridge, and water-free [18F]-fluoride recovered in an overall yield of 92±5% (n = 10).  [18F]Fluoride obtained by this procedure led to radiochem. yields of 70-90% for [18F]FDG, [18F]FET, [18F]FLT, [18F]FAZA and [18F]Fallypride.  Conclusion: SAX-resin adsorbed [18F]fluoride can be dried with non-aq. solvents and eluted with [K+⊂2.2.2]OH- in CH3CN.  The reactivity of [K+⊂2.2.2]F- generated by the new method is comparable to that of [18F]fluoride obtained by azeotropic drying.  The described procedure facilitates the automated prodn. of 18F-radiopharmaceuticals in general, and may also simplify the use of microfluidic devices for 18F-radiotracer prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyM-RAbJbK-7Vg90H21EOLACvtfcHk0lhbTN7a1472JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtlGlsr0%253D&md5=7ef98d9c8b0d077f9ece3daaa4e5b6c6</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWessmann%26aufirst%3DS.%2BH.%26aulast%3DHenriksen%26aufirst%3DG.%26aulast%3DWester%26aufirst%3DH.%2BJ.%26atitle%3DCryptate%2520mediated%2520nucleophilic%2520F-18-fluorination%2520without%2520azeotropic%2520drying%26jtitle%3DNuklearmedizin%26date%3D2012%26volume%3D51%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Niessen, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Höfner, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanner, K. T.</span><span> </span><span class="NLM_article-title">Competitive MS binding assays for dopamine D-2 receptors employing spiperone as a native marker</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1769</span><span class="NLM_x">–</span> <span class="NLM_lpage">1775</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=1769-1775&author=K.+V.+Niessenauthor=G.+H%C3%B6fnerauthor=K.+T.+Wanner&title=Competitive+MS+binding+assays+for+dopamine+D-2+receptors+employing+spiperone+as+a+native+marker"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNiessen%26aufirst%3DK.%2BV.%26aulast%3DH%25C3%25B6fner%26aufirst%3DG.%26aulast%3DWanner%26aufirst%3DK.%2BT.%26atitle%3DCompetitive%2520MS%2520binding%2520assays%2520for%2520dopamine%2520D-2%2520receptors%2520employing%2520spiperone%2520as%2520a%2520native%2520marker%26jtitle%3DChemBioChem%26date%3D2005%26volume%3D6%26spage%3D1769%26epage%3D1775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Bubik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahringer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fricker, G.</span><span> </span><span class="NLM_article-title">Rapid assessment of p-glycoprotein-drug interactions at the blood-brain barrier</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2006&pages=51-58&author=M.+Bubikauthor=M.+Ottauthor=A.+Mahringerauthor=G.+Fricker&title=Rapid+assessment+of+p-glycoprotein-drug+interactions+at+the+blood-brain+barrier"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBubik%26aufirst%3DM.%26aulast%3DOtt%26aufirst%3DM.%26aulast%3DMahringer%26aufirst%3DA.%26aulast%3DFricker%26aufirst%3DG.%26atitle%3DRapid%2520assessment%2520of%2520p-glycoprotein-drug%2520interactions%2520at%2520the%2520blood-brain%2520barrier%26jtitle%3DAnal.%2520Biochem.%26date%3D2006%26volume%3D358%26spage%3D51%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Bauer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fricker, G.</span><span> </span><span class="NLM_article-title">Compound profiling for p-glycoprotein at the blood–brain barrier using a microplate screening system</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1170</span><span class="NLM_x">–</span> <span class="NLM_lpage">1176</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2003&pages=1170-1176&author=B.+Bauerauthor=D.+S.+Millerauthor=G.+Fricker&title=Compound+profiling+for+p-glycoprotein+at+the+blood%E2%80%93brain+barrier+using+a+microplate+screening+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBauer%26aufirst%3DB.%26aulast%3DMiller%26aufirst%3DD.%2BS.%26aulast%3DFricker%26aufirst%3DG.%26atitle%3DCompound%2520profiling%2520for%2520p-glycoprotein%2520at%2520the%2520blood%25E2%2580%2593brain%2520barrier%2520using%2520a%2520microplate%2520screening%2520system%26jtitle%3DPharm.%2520Res.%26date%3D2003%26volume%3D20%26spage%3D1170%26epage%3D1176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Weksler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couraud, P. O.</span><span> </span><span class="NLM_article-title">The hCMEC/D3 cell line as a model of the human blood brain barrier</span> <span class="citation_source-journal">Fluids Barriers CNS</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1186%2F2045-8118-10-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=23531482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A280%3ADC%252BC3svpvVGitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=16&author=B.+Wekslerauthor=I.+A.+Romeroauthor=P.+O.+Couraud&title=The+hCMEC%2FD3+cell+line+as+a+model+of+the+human+blood+brain+barrier"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">The hCMEC/D3 cell line as a model of the human blood brain barrier</span></div><div class="casAuthors">Weksler Babette; Romero Ignacio A; Couraud Pierre-Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Fluids and barriers of the CNS</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16</span>
        ISSN:<span class="NLM_cas:issn">2045-8118</span>.
    </div><div class="casAbstract">Since the first attempts in the 1970s to isolate cerebral microvessel endothelial cells (CECs) in order to model the blood-brain barrier (BBB) in vitro, the need for a human BBB model that closely mimics the in vivo phenotype and is reproducible and easy to grow, has been widely recognized by cerebrovascular researchers in both academia and industry.  While primary human CECs would ideally be the model of choice, the paucity of available fresh human cerebral tissue makes wide-scale studies impractical.  The brain microvascular endothelial cell line hCMEC/D3 represents one such model of the human BBB that can be easily grown and is amenable to cellular and molecular studies on pathological and drug transport mechanisms with relevance to the central nervous system (CNS).  Indeed, since the development of this cell line in 2005 over 100 studies on different aspects of cerebral endothelial biology and pharmacology have been published.  Here we review the suitability of this cell line as a human BBB model for pathogenic and drug transport studies and we critically consider its advantages and limitations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQqZ5q_j0vv4Q8IxFYvehhofW6udTcc2eZeAGNWh9m72bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3svpvVGitA%253D%253D&md5=66d3b2eaa9efb7cb0fb86bf740a941e6</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1186%2F2045-8118-10-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2045-8118-10-16%26sid%3Dliteratum%253Aachs%26aulast%3DWeksler%26aufirst%3DB.%26aulast%3DRomero%26aufirst%3DI.%2BA.%26aulast%3DCouraud%26aufirst%3DP.%2BO.%26atitle%3DThe%2520hCMEC%252FD3%2520cell%2520line%2520as%2520a%2520model%2520of%2520the%2520human%2520blood%2520brain%2520barrier%26jtitle%3DFluids%2520Barriers%2520CNS%26date%3D2013%26volume%3D10%26spage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Höfelschweiger, B.</span><span> </span><span class="NLM_article-title">The Pyrylium Dyes: A New Class of Biolabels. Synthesis, Spectroscopy, and Application as Labels and in General Protein Assay</span>, Ph.D. Thesis, <span class="NLM_publisher-name">University Regensburg</span>, <span class="NLM_publisher-loc">Regensburg, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=B.+H%C3%B6felschweiger&title=The+Pyrylium+Dyes%3A+A+New+Class+of+Biolabels.+Synthesis%2C+Spectroscopy%2C+and+Application+as+Labels+and+in+General+Protein+Assay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25B6felschweiger%26aufirst%3DB.%26atitle%3DThe%2520Pyrylium%2520Dyes%253A%2520A%2520New%2520Class%2520of%2520Biolabels.%2520Synthesis%252C%2520Spectroscopy%252C%2520and%2520Application%2520as%2520Labels%2520and%2520in%2520General%2520Protein%2520Assay%26pub%3DUniversity%2520Regensburg%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Wellings, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atherton, E.</span><span> </span><span class="NLM_article-title">Standard Fmoc protocols</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">44</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=1997&pages=44-67&author=D.+A.+Wellingsauthor=E.+Atherton&title=Standard+Fmoc+protocols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWellings%26aufirst%3DD.%2BA.%26aulast%3DAtherton%26aufirst%3DE.%26atitle%3DStandard%2520Fmoc%2520protocols%26jtitle%3DMethods%2520Enzymol.%26date%3D1997%26volume%3D289%26spage%3D44%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Iovkova-Berends, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wangler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofner, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanner, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rensch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenstein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostikov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirrmacher, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurkschat, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wangler, B.</span><span> </span><span class="NLM_article-title">t-Bu(2)SiF-derivatized D(2)-receptor ligands: the first SiFA-containing small molecule radiotracers for target-specific PET-imaging</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">7458</span><span class="NLM_x">–</span> <span class="NLM_lpage">7479</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=7458-7479&author=L.+Iovkova-Berendsauthor=C.+Wanglerauthor=T.+Zollerauthor=G.+Hofnerauthor=K.+T.+Wannerauthor=C.+Renschauthor=P.+Bartensteinauthor=A.+Kostikovauthor=R.+Schirrmacherauthor=K.+Jurkschatauthor=B.+Wangler&title=t-Bu%282%29SiF-derivatized+D%282%29-receptor+ligands%3A+the+first+SiFA-containing+small+molecule+radiotracers+for+target-specific+PET-imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIovkova-Berends%26aufirst%3DL.%26aulast%3DWangler%26aufirst%3DC.%26aulast%3DZoller%26aufirst%3DT.%26aulast%3DHofner%26aufirst%3DG.%26aulast%3DWanner%26aufirst%3DK.%2BT.%26aulast%3DRensch%26aufirst%3DC.%26aulast%3DBartenstein%26aufirst%3DP.%26aulast%3DKostikov%26aufirst%3DA.%26aulast%3DSchirrmacher%26aufirst%3DR.%26aulast%3DJurkschat%26aufirst%3DK.%26aulast%3DWangler%26aufirst%3DB.%26atitle%3Dt-Bu%25282%2529SiF-derivatized%2520D%25282%2529-receptor%2520ligands%253A%2520the%2520first%2520SiFA-containing%2520small%2520molecule%2520radiotracers%2520for%2520target-specific%2520PET-imaging%26jtitle%3DMolecules%26date%3D2011%26volume%3D16%26spage%3D7458%26epage%3D7479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 5 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vadim  Bernard-Gauthier</span>, <span class="hlFld-ContribAuthor ">Justin J.  Bailey</span>, <span class="hlFld-ContribAuthor ">Zhibo  Liu</span>, <span class="hlFld-ContribAuthor ">Björn  Wängler</span>, <span class="hlFld-ContribAuthor ">Carmen  Wängler</span>, <span class="hlFld-ContribAuthor ">Klaus  Jurkschat</span>, <span class="hlFld-ContribAuthor ">David M.  Perrin</span>, and <span class="hlFld-ContribAuthor ">Ralf  Schirrmacher</span>  . </span><span class="cited-content_cbyCitation_article-title">From Unorthodox to Established: The Current Status of 18F-Trifluoroborate- and 18F-SiFA-Based Radiopharmaceuticals in PET Nuclear Imaging. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2016,</strong> <em>27 </em>
                                    (2)
                                     , 267-279. <a href="https://doi.org/10.1021/acs.bioconjchem.5b00560" title="DOI URL">https://doi.org/10.1021/acs.bioconjchem.5b00560</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.bioconjchem.5b00560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.bioconjchem.5b00560%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DFrom%252BUnorthodox%252Bto%252BEstablished%25253A%252BThe%252BCurrent%252BStatus%252Bof%252B18F-Trifluoroborate-%252Band%252B18F-SiFA-Based%252BRadiopharmaceuticals%252Bin%252BPET%252BNuclear%252BImaging%26aulast%3DBernard-Gauthier%26aufirst%3DVadim%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D14102015%26date%3D10112015%26date%3D25112015%26date%3D17022016%26date%3D13112015%26volume%3D27%26issue%3D2%26spage%3D267%26epage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Balázs  Balogh</span>, <span class="hlFld-ContribAuthor ">Márton  Ivánczi</span>, <span class="hlFld-ContribAuthor ">Bilal  Nizami</span>, <span class="hlFld-ContribAuthor ">Tamás  Beke-Somfai</span>, <span class="hlFld-ContribAuthor ">István M  Mándity</span>. </span><span class="cited-content_cbyCitation_article-title">ConjuPepDB: a database of peptide–drug conjugates. </span><span class="cited-content_cbyCitation_journal-name">Nucleic Acids Research</span><span> <strong>2021,</strong> <em>49 </em>
                                    (D1)
                                     , D1102-D1112. <a href="https://doi.org/10.1093/nar/gkaa950" title="DOI URL">https://doi.org/10.1093/nar/gkaa950</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/nar/gkaa950&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fnar%2Fgkaa950%26sid%3Dliteratum%253Aachs%26jtitle%3DNucleic%2520Acids%2520Research%26atitle%3DConjuPepDB%25253A%252Ba%252Bdatabase%252Bof%252Bpeptide%2525E2%252580%252593drug%252Bconjugates%26aulast%3DBalogh%26aufirst%3DBal%25C3%25A1zs%26date%3D2021%26date%3D2020%26volume%3D49%26issue%3DD1%26spage%3DD1102%26epage%3DD1112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pol  Arranz-Gibert</span>, <span class="hlFld-ContribAuthor ">Bernat  Guixer</span>, <span class="hlFld-ContribAuthor ">Roger  Prades</span>, <span class="hlFld-ContribAuthor ">Sonia  Ciudad</span>, <span class="hlFld-ContribAuthor ">Ernest  Giralt</span>, <span class="hlFld-ContribAuthor ">Meritxell  Teixidó</span>. </span><span class="cited-content_cbyCitation_article-title">A MALDI-TOF-based Method for Studying the Transport of BBB Shuttles—Enhancing Sensitivity and Versatility of Cell-Based In Vitro Transport Models. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-019-40973-0" title="DOI URL">https://doi.org/10.1038/s41598-019-40973-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-019-40973-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-019-40973-0%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DA%252BMALDI-TOF-based%252BMethod%252Bfor%252BStudying%252Bthe%252BTransport%252Bof%252BBBB%252BShuttles%2525E2%252580%252594Enhancing%252BSensitivity%252Band%252BVersatility%252Bof%252BCell-Based%252BIn%252BVitro%252BTransport%252BModels%26aulast%3DArranz-Gibert%26aufirst%3DPol%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eric  Valeur</span>, <span class="hlFld-ContribAuthor ">Stéphanie M.  Guéret</span>, <span class="hlFld-ContribAuthor ">Hélène  Adihou</span>, <span class="hlFld-ContribAuthor ">Ranganath  Gopalakrishnan</span>, <span class="hlFld-ContribAuthor ">Malin  Lemurell</span>, <span class="hlFld-ContribAuthor ">Herbert  Waldmann</span>, <span class="hlFld-ContribAuthor ">Tom N.  Grossmann</span>, <span class="hlFld-ContribAuthor ">Alleyn T.  Plowright</span>. </span><span class="cited-content_cbyCitation_article-title">Neue Modalitäten für schwierige Zielstrukturen in der Wirkstoffentwicklung. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2017,</strong> <em>129 </em>
                                    (35)
                                     , 10428-10459. <a href="https://doi.org/10.1002/ange.201611914" title="DOI URL">https://doi.org/10.1002/ange.201611914</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201611914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201611914%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DNeue%252BModalit%2525C3%2525A4ten%252Bf%2525C3%2525BCr%252Bschwierige%252BZielstrukturen%252Bin%252Bder%252BWirkstoffentwicklung%26aulast%3DValeur%26aufirst%3DEric%26date%3D2017%26date%3D2017%26volume%3D129%26issue%3D35%26spage%3D10428%26epage%3D10459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eric  Valeur</span>, <span class="hlFld-ContribAuthor ">Stéphanie M.  Guéret</span>, <span class="hlFld-ContribAuthor ">Hélène  Adihou</span>, <span class="hlFld-ContribAuthor ">Ranganath  Gopalakrishnan</span>, <span class="hlFld-ContribAuthor ">Malin  Lemurell</span>, <span class="hlFld-ContribAuthor ">Herbert  Waldmann</span>, <span class="hlFld-ContribAuthor ">Tom N.  Grossmann</span>, <span class="hlFld-ContribAuthor ">Alleyn T.  Plowright</span>. </span><span class="cited-content_cbyCitation_article-title">New Modalities for Challenging Targets in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2017,</strong> <em>56 </em>
                                    (35)
                                     , 10294-10323. <a href="https://doi.org/10.1002/anie.201611914" title="DOI URL">https://doi.org/10.1002/anie.201611914</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201611914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201611914%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DNew%252BModalities%252Bfor%252BChallenging%252BTargets%252Bin%252BDrug%252BDiscovery%26aulast%3DValeur%26aufirst%3DEric%26date%3D2017%26date%3D2017%26volume%3D56%26issue%3D35%26spage%3D10294%26epage%3D10323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/medium/jm-2014-004123_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5004123&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/medium/jm-2014-004123_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic depiction of the different mechanisms of BBB function and transcytosis: hydrophilic drugs cannot enter the endothelium (A), some lipophilic drugs can enter the endothelium but get externalized by active drug transport (B), BBB crossing of receptor-binding substances such as transferrin and insulin by receptor-mediated transcytosis (C), unspecific BBB crossing of positively charged substances by adsorptive transcytosis (D), and specific or nonspecific BBB crossing of hydrophilic (blue) or lipophilic (orange) drugs using the molecular Trojan horse approach by receptor-mediated or adsorptive transcytosis (E).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5004123&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/medium/jm-2014-004123_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0010.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of FP-T (<b>1</b>) Starting from Tosyl-fallypride<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5004123&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) NaSH, DMF/H<sub>2</sub>O 3:1, rt; (ii) TCEP, DMF/H<sub>2</sub>O, rt.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/medium/jm-2014-004123_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0011.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. General Reaction Pathway for the Conjugation Reactions of Peptide Maleimides <b>2a</b>–<b>22a</b> to FP-T (<b>1</b>), Yielding Peptide–FP-T conjugates <b>2</b>–<b>22</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5004123&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: PB/MeCN, pH 6.7–7.2, rt.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/medium/jm-2014-004123_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Schematic depiction of the synthesized shuttle–cargo fusion molecules of subset <b>I</b> (carrier peptide–FP-T fusion molecules <b>2</b>–<b>9</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5004123&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/medium/jm-2014-004123_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of TfR-P<sub>s</sub>–PEG<sub><i>x</i></sub>–FP-T fusion molecules <b>4</b> and <b>10</b>–<b>16</b> (fusion molecule subset <b>II</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5004123&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/medium/jm-2014-004123_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structures of AngioPep–PEG<sub><i>x</i></sub>–FP-T fusion molecules <b>9</b> and <b>17</b>–<b>20</b> (fusion molecule subset <b>III</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5004123&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/medium/jm-2014-004123_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structures of TfR-P<sub>s</sub>–SiFA–PEG<sub>3</sub>–FP-T (<b>21</b>), TfR-P<sub>s</sub>–DOTA–PEG<sub>3</sub>–FP-T (<b>22</b>) and DOTA<sub>10</sub>–Py5<sub>15</sub>–AngioPep–FP-T (<b>24</b>) (fusion molecule subset <b>IV</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5004123&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/medium/jm-2014-004123_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structures PEG<sub>3</sub>–FP-T (<b>25</b>), TfR-P<sub>s</sub>–SiFA–PEG<sub>3</sub>–cysteine (<b>26</b>), and underivatized TfR-P<sub>s</sub> (<b>27</b>), TfR-P<sub>l</sub> (<b>28</b>), and TAT<sub>49–57</sub> (<b>29</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5004123&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/medium/jm-2014-004123_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0008.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) Predicted binding mode of <b>13</b> to the model hD<sub>2</sub> receptor obtained from 6 ns MD simulations. The fallypride part of compound <b>13</b> is depicted in original atom color, the linker part, in green, and the peptidic part (TfR-binding peptide), in yellow. (B) Overlay of the energy-minimized MD average structures of <b>25</b> (in cyan carbon atoms) and <b>13</b> (fallypride is depicted in original atom color, linker structure, in green, and peptide, in yellow) bound to the hD<sub>2</sub> receptor. The hD<sub>2</sub> receptor is displayed as a molecular surface in gray for improved clarity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5004123&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/medium/jm-2014-004123_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0009.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Results obtained from the Calcein assay to identify the interaction of the studied substances with P-gp. Intracellular fluorescence in the absence of test compounds was set as 100%. None of the substances showed any modulation of P-gp in the concentration range of 0.1–10 μM. At higher concentrations, fallypride as well as <b>21</b> showed an interaction with the applied esterase, disturbing the assay at concentrations >10 μM and resulting in the lower fluorescence values observed, which are not consequence of P-gp modulation by these compounds. Cyclosporine A was used as a positive control and showed an IC<sub>50</sub> value of 0.94 μM under the same conditions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm5004123/production/images/large/jm-2014-004123_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5004123&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i40">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51603" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51603" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 61 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Schirrmacher, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard-Gauthier, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reader, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soucy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirrmacher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wängler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wängler, C.</span><span> </span><span class="NLM_article-title">Design of brain imaging agents for positron emission tomography: do large bioconjugates provide an opportunity for in vivo brain imaging?</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1621</span><span class="NLM_x">–</span> <span class="NLM_lpage">1634</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.4155%2Ffmc.13.128" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVOgsb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=1621-1634&author=R.+Schirrmacherauthor=V.+Bernard-Gauthierauthor=A.+Readerauthor=J.+P.+Soucyauthor=E.+Schirrmacherauthor=B.+W%C3%A4nglerauthor=C.+W%C3%A4ngler&title=Design+of+brain+imaging+agents+for+positron+emission+tomography%3A+do+large+bioconjugates+provide+an+opportunity+for+in+vivo+brain+imaging%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Design of brain imaging agents for positron emission tomography: do large bioconjugates provide an opportunity for in vivo brain imaging?</span></div><div class="casAuthors">Schirrmacher, Ralf; Bernard-Gauthier, Vadim; Reader, Andrew; Soucy, Jean-Paul; Schirrmacher, Esther; Waengler, Bjoern; Waengler, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1621-1634</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">The development of brain imaging agents for positron emission tomog. and other in vivo imaging modalities mostly relies on small compds. of low MW as a result of the restricted transport of larger mols., such as peptides and proteins, across the blood-brain barrier.  Besides passive transport, only a few active carrier mechanisms, such as glucose transporters and amino acid transporters, have so far been exploited to mediate the accumulation of imaging probes in the brain.  An important question for the future is whether some of the abundant active carrier systems located at the blood-brain barrier can be used to shuttle potential, but non-crossing, imaging agents into the brain.  What are the biol. and chem. constrictions toward such bioconjugates and is it worthwhile to persue such a delivery strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4Z2wOe_zhr7Vg90H21EOLACvtfcHk0lhrzWWOegCByA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVOgsb7I&md5=1831933d19d453600d692d58ce7803c2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.4155%2Ffmc.13.128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.13.128%26sid%3Dliteratum%253Aachs%26aulast%3DSchirrmacher%26aufirst%3DR.%26aulast%3DBernard-Gauthier%26aufirst%3DV.%26aulast%3DReader%26aufirst%3DA.%26aulast%3DSoucy%26aufirst%3DJ.%2BP.%26aulast%3DSchirrmacher%26aufirst%3DE.%26aulast%3DW%25C3%25A4ngler%26aufirst%3DB.%26aulast%3DW%25C3%25A4ngler%26aufirst%3DC.%26atitle%3DDesign%2520of%2520brain%2520imaging%2520agents%2520for%2520positron%2520emission%2520tomography%253A%2520do%2520large%2520bioconjugates%2520provide%2520an%2520opportunity%2520for%2520in%2520vivo%2520brain%2520imaging%253F%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2013%26volume%3D5%26spage%3D1621%26epage%3D1634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Pardridge, W. M.</span><span> </span><span class="NLM_article-title">Re-engineering biopharmaceuticals for delivery to brain with molecular trojan horses</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1327</span><span class="NLM_x">–</span> <span class="NLM_lpage">1338</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc800148t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntVymsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=1327-1338&author=W.+M.+Pardridge&title=Re-engineering+biopharmaceuticals+for+delivery+to+brain+with+molecular+trojan+horses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Re-Engineering Biopharmaceuticals for Delivery to Brain with Molecular Trojan Horses</span></div><div class="casAuthors">Pardridge, William M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1327-1338</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Biopharmaceuticals, including recombinant proteins, monoclonal antibody therapeutics, and antisense or RNA interference drugs, cannot be developed as drugs for the brain, because these large mols. do not cross the blood-brain barrier (BBB).  Biopharmaceuticals must be re-engineered to cross the BBB, and this is possible with genetically engineered mol. Trojan horses.  A mol. Trojan horse is an endogenous peptide, or peptidomimetic monoclonal antibody (mAb), which enters brain from blood via receptor-mediated transport on endogenous BBB transporters.  Recombinant neurotrophins, single chain Fv antibodies, or therapeutic enzymes may be re-engineered as IgG fusion proteins.  The engineering of IgG-avidin fusion proteins enables the BBB delivery of biotinylated drugs.  The IgG fusion proteins are new chem. entities that are dual or triple function mols. that bind multiple receptors.  The fusion proteins are able both to enter the brain, by binding an endogenous BBB receptor, and to induce the desired pharmacol. effect in brain, by binding target receptors in the brain behind the BBB.  The development of mol. Trojan horses for BBB drug delivery allows the re-engineering of biopharmaceuticals that, owing to the BBB problem, could not otherwise be developed as new drugs for the human brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWMtDrX08sBLVg90H21EOLACvtfcHk0ljES-N6bR4V3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntVymsr8%253D&md5=33a66171dd5ee634a5270169e9b28669</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fbc800148t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc800148t%26sid%3Dliteratum%253Aachs%26aulast%3DPardridge%26aufirst%3DW.%2BM.%26atitle%3DRe-engineering%2520biopharmaceuticals%2520for%2520delivery%2520to%2520brain%2520with%2520molecular%2520trojan%2520horses%26jtitle%3DBioconjugate%2520Chem.%26date%3D2008%26volume%3D19%26spage%3D1327%26epage%3D1338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Pardridge, W. M.</span><span> </span><span class="NLM_article-title">Drug transport across the blood-brain barrier</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1959</span><span class="NLM_x">–</span> <span class="NLM_lpage">1972</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1038%2Fjcbfm.2012.126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=22929442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1akurfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=1959-1972&author=W.+M.+Pardridge&title=Drug+transport+across+the+blood-brain+barrier"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Drug transport across the blood-brain barrier</span></div><div class="casAuthors">Pardridge, William M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow & Metabolism</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1959-1972</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The blood-brain barrier (BBB) prevents the brain uptake of most pharmaceuticals.  This property arises from the epithelial-like tight junctions within the brain capillary endothelium.  The BBB is anatomically and functionally distinct from the blood-cerebrospinal fluid barrier at the choroid plexus.  Certain small mol. drugs may cross the BBB via lipid-mediated free diffusion, providing the drug has a mol. wt. <400 Da and forms <8 hydrogen bonds.  These chem. properties are lacking in the majority of small mol. drugs, and all large mol. drugs.  Nevertheless, drugs can be reengineered for BBB transport, based on the knowledge of the endogenous transport systems within the BBB.  Small mol. drugs can be synthesized that access carrier-mediated transport (CMT) systems within the BBB.  Large mol. drugs can be reengineered with mol. Trojan horse delivery systems to access receptor-mediated transport (RMT) systems within the BBB.  Peptide and antisense radiopharmaceuticals are made brain-penetrating with the combined use of RMT-based delivery systems and avidin-biotin technol.  Knowledge on the endogenous CMT and RMT systems expressed at the BBB enable new solns. to the problem of BBB drug transport.  Journal of Cerebral Blood Flow & Metab. (2012) 32, 1959-1972; doi:10.1038/jcbfm.2012.126; published online 29 August 2012.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8BKNlB45nSrVg90H21EOLACvtfcHk0ljES-N6bR4V3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1akurfJ&md5=f05b190f1e4373fdaf8e3cba794a587c</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fjcbfm.2012.126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjcbfm.2012.126%26sid%3Dliteratum%253Aachs%26aulast%3DPardridge%26aufirst%3DW.%2BM.%26atitle%3DDrug%2520transport%2520across%2520the%2520blood-brain%2520barrier%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2012%26volume%3D32%26spage%3D1959%26epage%3D1972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Pardridge, W. M.</span><span> </span><span class="NLM_article-title">Biopharmaceutical drug targeting to the brain</span> <span class="citation_source-journal">J. Drug Targeting</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">167</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.3109%2F10611860903548354" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=20064077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivFeks78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=157-167&author=W.+M.+Pardridge&title=Biopharmaceutical+drug+targeting+to+the+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Biopharmaceutical drug targeting to the brain</span></div><div class="casAuthors">Pardridge, William M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Targeting</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">157-167</span>CODEN:
                <span class="NLM_cas:coden">JDTAEH</span>;
        ISSN:<span class="NLM_cas:issn">1061-186X</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Biopharmaceuticals are large mol. drugs that do not cross the blood-brain barrier (BBB).  The limiting factor in the drug development of biopharmaceuticals as new drugs for the human brain is the engineering of effective brain drug targeting technol. platforms.  Recombinant proteins, enzymes, and monoclonal antibodies can be re-engineered for transport across the human BBB with the mol. Trojan horse technol.  The most active BBB mol. Trojan horse is a monoclonal antibody to the human insulin receptor.  The genetic engineering of IgG fusion proteins was demonstrated for neurotrophic factors, decoy receptors, therapeutic enzymes, single chain Fv antibodies, and avidin.  The IgG fusion proteins are not toxic on repeated administration in high doses to primates and do not interfere with glycemic control in plasma or brain.  IgG fusion proteins contain amino acid sequences that induce immune tolerance, and show low immunogenicity in primates.  The IgG fusion proteins are new bifunctional biopharmaceuticals that are both targeted to brain via transport on endogenous BBB receptors, and exert pharmacol. effects in brain at the cognate receptor, ligand, or enzyme substrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRWOOTMvV4QbVg90H21EOLACvtfcHk0ljES-N6bR4V3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivFeks78%253D&md5=d043c468777e8ed37cba3e08708faf96</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.3109%2F10611860903548354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10611860903548354%26sid%3Dliteratum%253Aachs%26aulast%3DPardridge%26aufirst%3DW.%2BM.%26atitle%3DBiopharmaceutical%2520drug%2520targeting%2520to%2520the%2520brain%26jtitle%3DJ.%2520Drug%2520Targeting%26date%3D2010%26volume%3D18%26spage%3D157%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Patel, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goyal, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhadada, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatt, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amin, A. F.</span><span> </span><span class="NLM_article-title">Getting into the brain: approaches to enhance brain drug delivery</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2009&pages=35-58&author=M.+M.+Patelauthor=B.+R.+Goyalauthor=S.+V.+Bhadadaauthor=J.+S.+Bhattauthor=A.+F.+Amin&title=Getting+into+the+brain%3A+approaches+to+enhance+brain+drug+delivery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DM.%2BM.%26aulast%3DGoyal%26aufirst%3DB.%2BR.%26aulast%3DBhadada%26aufirst%3DS.%2BV.%26aulast%3DBhatt%26aufirst%3DJ.%2BS.%26aulast%3DAmin%26aufirst%3DA.%2BF.%26atitle%3DGetting%2520into%2520the%2520brain%253A%2520approaches%2520to%2520enhance%2520brain%2520drug%2520delivery%26jtitle%3DCNS%2520Drugs%26date%3D2009%26volume%3D23%26spage%3D35%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Smith, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gumbleton, M.</span><span> </span><span class="NLM_article-title">Endocytosis at the blood–brain barrier: from basic understanding to drug delivery strategies</span> <span class="citation_source-journal">J. Drug Targeting</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">–</span> <span class="NLM_lpage">214</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1080%2F10611860600650086" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=16777679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsFyru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=191-214&author=M.+W.+Smithauthor=M.+Gumbleton&title=Endocytosis+at+the+blood%E2%80%93brain+barrier%3A+from+basic+understanding+to+drug+delivery+strategies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Endocytosis at the blood-brain barrier: from basic understanding to drug delivery strategies</span></div><div class="casAuthors">Smith, Mathew W.; Gumbleton, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Targeting</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">191-214</span>CODEN:
                <span class="NLM_cas:coden">JDTAEH</span>;
        ISSN:<span class="NLM_cas:issn">1061-186X</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  The blood-brain barrier (BBB) protects the central nervous system (CNS) from potentially harmful xenobiotics and endogenous mols.  Anatomically, it comprises the brain microvasculature whose functionality is nevertheless influenced by assocd. astrocyte, pericyte and neuronal cells.  The highly restrictive paracellular pathway within brain microvasculature restricts significant CNS penetration to only those drugs whose physicochem. properties afford ready penetration into hydrophobic cell membranes or are capable of exploiting endogenous active transport processes such as solute carriers or endocytosis pathways.  Endocytosis at the BBB is an essential pathway by which the brain obtains its nutrients and affords communication with the periphery.  The development of strategies to exploit these endocytic pathways for the purposes of drug delivery to the CNS is still an immature field although some impressive results were documented with the targeting of particular receptors.  This current article initially provides an overview of general endocytosis processes and pathways showing evidence of their functional existence within the BBB.  Subsequent sections provide, in an entity-specific manner, comprehensive reviews on BBB transport investigations of endocytosis involving: transferrin and the targeting of the transferrin receptor; hormones; cytokines; cell penetrating peptides; microorganisms and toxins, and nanoparticles aimed at more effectively delivering drugs to the CNS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzIwFBgV4FlLVg90H21EOLACvtfcHk0ljcUp2FdUVfTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsFyru7o%253D&md5=31776a86a3b6ca21c5540b131457786f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1080%2F10611860600650086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10611860600650086%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DM.%2BW.%26aulast%3DGumbleton%26aufirst%3DM.%26atitle%3DEndocytosis%2520at%2520the%2520blood%25E2%2580%2593brain%2520barrier%253A%2520from%2520basic%2520understanding%2520to%2520drug%2520delivery%2520strategies%26jtitle%3DJ.%2520Drug%2520Targeting%26date%3D2006%26volume%3D14%26spage%3D191%26epage%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Pardridge, W. M.</span><span> </span><span class="NLM_article-title">Blood–brain barrier delivery of protein and non-viral gene therapeutics with molecular trojan horses</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">345</span><span class="NLM_x">–</span> <span class="NLM_lpage">348</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2007&pages=345-348&author=W.+M.+Pardridge&title=Blood%E2%80%93brain+barrier+delivery+of+protein+and+non-viral+gene+therapeutics+with+molecular+trojan+horses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPardridge%26aufirst%3DW.%2BM.%26atitle%3DBlood%25E2%2580%2593brain%2520barrier%2520delivery%2520of%2520protein%2520and%2520non-viral%2520gene%2520therapeutics%2520with%2520molecular%2520trojan%2520horses%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2007%26volume%3D122%26spage%3D345%26epage%3D348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Pardridge, W. M.</span><span> </span><span class="NLM_article-title">Drug targeting to the brain</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1733</span><span class="NLM_x">–</span> <span class="NLM_lpage">1744</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1007%2Fs11095-007-9324-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=17554607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BD2sXosVKgtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2007&pages=1733-1744&author=W.+M.+Pardridge&title=Drug+targeting+to+the+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Drug Targeting to the Brain</span></div><div class="casAuthors">Pardridge, William M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1733-1744</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The goal of brain drug targeting technol. is the delivery of therapeutics across the blood-brain barrier (BBB), including the human BBB.  This is accomplished by re-engineering pharmaceuticals to cross the BBB via specific endogenous transporters localized within the brain capillary endothelium.  Certain endogenous peptides, such as insulin or transferrin, undergo receptor-mediated transport across the BBB in vivo.  In addn., peptidomimetic monoclonal antibodies (MAb) may also cross the BBB via RMT on the endogenous transporters.  The MAb may be used as a mol. Trojan horse to ferry across the BBB large mol. pharmaceuticals, including recombinant proteins, antibodies, RNA interference drugs, or non-viral gene medicines.  Fusion proteins of the mol. Trojan horse and either neurotrophins or single chain Fv antibodies have been genetically engineered.  The fusion proteins retain bi-functional properties, and both bind the BBB receptor, to trigger transport into brain, and bind the cognate receptor inside brain to induce the pharmacol. effect.  Trojan horse liposome technol. enables the brain targeting of non-viral plasmid DNA.  Mol. Trojan horses may be formulated with fusion protein technol., avidin-biotin technol., or Trojan horse liposomes to target to brain virtually any large mol. pharmaceutical.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuz680fGNiBLVg90H21EOLACvtfcHk0ljcUp2FdUVfTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXosVKgtrk%253D&md5=1240d9a47eb361850e8a76ee76ce0413</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs11095-007-9324-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-007-9324-2%26sid%3Dliteratum%253Aachs%26aulast%3DPardridge%26aufirst%3DW.%2BM.%26atitle%3DDrug%2520targeting%2520to%2520the%2520brain%26jtitle%3DPharm.%2520Res.%26date%3D2007%26volume%3D24%26spage%3D1733%26epage%3D1744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Gabathuler, R.</span><span> </span><span class="NLM_article-title">Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1016%2Fj.nbd.2009.07.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=19664710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGms7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2010&pages=48-57&author=R.+Gabathuler&title=Approaches+to+transport+therapeutic+drugs+across+the+blood%E2%80%93brain+barrier+to+treat+brain+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases</span></div><div class="casAuthors">Gabathuler, Reinhard</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-57</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The central nervous system is protected by barriers which control the entry of compds. into the brain, thereby regulating brain homeostasis.  The blood-brain barrier, formed by the endothelial cells of the brain capillaries, restricts access to brain cells of blood-borne compds. and facilitates nutrients essential for normal metab. to reach brain cells.  This very tight regulation of the brain homeostasis results in the inability of some small and large therapeutic compds. to cross the blood-brain barrier (BBB).  Therefore, various strategies are being developed to enhance the amt. and concn. of therapeutic compds. in the brain.  In this review, we will address the different approaches used to increase the transport of therapeutics from blood into the brain parenchyma.  We will mainly conc. on the physiol. approach which takes advantage of specific receptors already expressed on the capillary endothelial cells forming the BBB and necessary for the survival of brain cells.  Among all the approaches used for increasing brain delivery of therapeutics, the most accepted method is the use of the physiol. approach which takes advantage of the transcytosis capacity of specific receptors expressed at the BBB.  The low d. lipoprotein receptor related protein (LRP) is the most adapted for such use with the engineered peptide compd. (EPiC) platform incorporating the Angiopep peptide in new therapeutics the most advanced with promising data in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXnM4hn2vGGrVg90H21EOLACvtfcHk0ljcUp2FdUVfTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGms7jE&md5=ede4d80cd5fabc1080289b5446072d07</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2009.07.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2009.07.028%26sid%3Dliteratum%253Aachs%26aulast%3DGabathuler%26aufirst%3DR.%26atitle%3DApproaches%2520to%2520transport%2520therapeutic%2520drugs%2520across%2520the%2520blood%25E2%2580%2593brain%2520barrier%2520to%2520treat%2520brain%2520diseases%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2010%26volume%3D37%26spage%3D48%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engler, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collawn, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, B. A.</span><span> </span><span class="NLM_article-title">Receptor mediated uptake of peptides that bind the human transferrin receptor</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">2004</span><span class="NLM_x">–</span> <span class="NLM_lpage">2012</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1046%2Fj.1432-1327.2001.02073.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=11277922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivVarsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=2001&pages=2004-2012&author=J.+H.+Leeauthor=J.+A.+Englerauthor=J.+F.+Collawnauthor=B.+A.+Moore&title=Receptor+mediated+uptake+of+peptides+that+bind+the+human+transferrin+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor mediated uptake of peptides that bind the human transferrin receptor</span></div><div class="casAuthors">Lee, Jae H.; Engler, Jeffrey A.; Collawn, James F.; Moore, Bryan A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2004-2012</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">A biopanning process designed to find peptide epitopes specific for cell surface receptors has been used in this study to select seven- and 12-amino-acid peptides capable of binding to and internalizing with the human transferrin receptor (hTfR).  Through sequential rounds of neg. and pos. selection, two peptide sequences were identified that specifically bind to the hTfR.  Phage contg. the sequences HAIYPRH or THRPPMWSPVWP were inhibited from binding the hTfR in a dose-dependent fashion when peptides of the same sequence were present in a competition assay.  Interestingly, transferrin did not compete with either of these sequences for receptor binding, suggesting that these peptides bind a site on the hTfR distinct from the transferrin binding site.  When either of these sequences was expressed as a fusion to green fluorescent protein (GFP), the recombinant GFP mol. was internalized in cells expressing the hTfR.  These studies suggest that the two peptides can be used to target other proteins into the endosomal pathway.  Further, they provide a strategy for identifying peptides that bind to other cell surface receptors that can be used for both diagnostic and therapeutic purposes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZqmkWYuxavbVg90H21EOLACvtfcHk0lhOMBtLCitHEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivVarsrc%253D&md5=8071d3918d869523d8693c68b7056637</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1327.2001.02073.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1327.2001.02073.x%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DEngler%26aufirst%3DJ.%2BA.%26aulast%3DCollawn%26aufirst%3DJ.%2BF.%26aulast%3DMoore%26aufirst%3DB.%2BA.%26atitle%3DReceptor%2520mediated%2520uptake%2520of%2520peptides%2520that%2520bind%2520the%2520human%2520transferrin%2520receptor%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2001%26volume%3D268%26spage%3D2004%26epage%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Boules, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredrickson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richelson, E.</span><span> </span><span class="NLM_article-title">Bioactive analogs of neurotensin: focus on CNS effects</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">2523</span><span class="NLM_x">–</span> <span class="NLM_lpage">2533</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1016%2Fj.peptides.2005.12.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=16882457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvV2gs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=2523-2533&author=M.+Boulesauthor=P.+Fredricksonauthor=E.+Richelson&title=Bioactive+analogs+of+neurotensin%3A+focus+on+CNS+effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactive analogs of neurotensin: Focus on CNS effects</span></div><div class="casAuthors">Boules, Mona; Fredrickson, Paul; Richelson, Elliott</div><div class="citationInfo"><span class="NLM_cas:title">Peptides (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2523-2533</span>CODEN:
                <span class="NLM_cas:coden">PPTDD5</span>;
        ISSN:<span class="NLM_cas:issn">0196-9781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Neurotensin (NT) is a 13-amino acid neuropeptide found in the central nervous system and in the gastrointestinal tract.  It is closely assocd. anatomically with dopaminergic and other neurotransmitter systems, and evidence supports a role for NT agonists in the treatment of various neuropsychiatric disorders.  However, NT is readily degraded by peptidases, so there is much interest in the development of stable NT agonists, that can be injected systemically, cross the blood-brain barrier (BBB), yet retains the pharmacol. characteristics of native NT for therapeutic use in the treatment of diseases such as schizophrenia, Parkinson's disease and addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUdzePDOc0p7Vg90H21EOLACvtfcHk0lhOMBtLCitHEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvV2gs7k%253D&md5=a78d008b6c62190144780ad3c4c667d5</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.peptides.2005.12.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.peptides.2005.12.018%26sid%3Dliteratum%253Aachs%26aulast%3DBoules%26aufirst%3DM.%26aulast%3DFredrickson%26aufirst%3DP.%26aulast%3DRichelson%26aufirst%3DE.%26atitle%3DBioactive%2520analogs%2520of%2520neurotensin%253A%2520focus%2520on%2520CNS%2520effects%26jtitle%3DPeptides%26date%3D2006%26volume%3D27%26spage%3D2523%26epage%3D2533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">McGonigle, P.</span><span> </span><span class="NLM_article-title">Peptide therapeutics for CNS indications</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">559</span><span class="NLM_x">–</span> <span class="NLM_lpage">566</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2012&pages=559-566&author=P.+McGonigle&title=Peptide+therapeutics+for+CNS+indications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcGonigle%26aufirst%3DP.%26atitle%3DPeptide%2520therapeutics%2520for%2520CNS%2520indications%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D83%26spage%3D559%26epage%3D566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Cano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merino, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ezquerra, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somoza, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz-Gayo, M.</span><span> </span><span class="NLM_article-title">A cholecystokinin-1 receptor agonist (CCK-8) mediates increased permeability of brain barriers to leptin</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">1009</span><span class="NLM_x">–</span> <span class="NLM_lpage">1015</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1038%2Fbjp.2008.149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=18587446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvVGrurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2008&pages=1009-1015&author=V.+Canoauthor=B.+Merinoauthor=L.+Ezquerraauthor=B.+Somozaauthor=M.+Ruiz-Gayo&title=A+cholecystokinin-1+receptor+agonist+%28CCK-8%29+mediates+increased+permeability+of+brain+barriers+to+leptin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A cholecystokinin-1 receptor agonist (CCK-8) mediates increased permeability of brain barriers to leptin</span></div><div class="casAuthors">Cano, V.; Merino, B.; Ezquerra, L.; Somoza, B.; Ruiz-Gayo, M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1009-1015</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background and purpose: Leptin regulates energy expenditure and body wt. by acting both on the hypothalamus and on peripheral targets.  Central actions of leptin are enhanced by cholecystokinin (CCK).  The interaction between leptin and CCK makes physiol. sense, as rats lacking CCK1 receptors are resistant to peripheral leptin but not to leptin directly infused into the brain.  We have recently reported that CCK enhances leptin effects by increasing the entry of leptin into the CNS.  The aim of this work was to further characterize the effect of CCK (10 μg/kg) on leptin kinetics as well as the CCK receptor subtype involved in the interaction between CCK and leptin.  Exptl. approach: Expts. were carried out both in free-feeding and in fasted rats receiving a single dose of leptin (100 μg/kg; i.p.).  Parameters analyzed over the next 6 h were plasma and cerebrospinal fluid concns. of leptin.  Key results: We obsd. that CCK-8 depressed the increase in plasma leptin that followed the i.p. injection and simultaneously increased leptin concn. in the cerebrospinal fluid from 92 to 230 pg/mL.  The effect of CCK-8 was totally prevented by the CCK1 receptor antagonist, SR-27897 (0.3 mg/kg, s.c.), but not by the CCK2 receptor antagonist, L-365260 (1 mg/kg).  Conclusions and implications: These results show that CCK plays a role in regulating the access of leptin to the brain and suggest that CCK analogs, acting on CCK1 receptors, might be useful drugs in improving leptin actions within the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr03XGmm0KQybVg90H21EOLACvtfcHk0lhOMBtLCitHEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvVGrurk%253D&md5=3bc77eb9d0a6eb06943d903a82077b3e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fbjp.2008.149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjp.2008.149%26sid%3Dliteratum%253Aachs%26aulast%3DCano%26aufirst%3DV.%26aulast%3DMerino%26aufirst%3DB.%26aulast%3DEzquerra%26aufirst%3DL.%26aulast%3DSomoza%26aufirst%3DB.%26aulast%3DRuiz-Gayo%26aufirst%3DM.%26atitle%3DA%2520cholecystokinin-1%2520receptor%2520agonist%2520%2528CCK-8%2529%2520mediates%2520increased%2520permeability%2520of%2520brain%2520barriers%2520to%2520leptin%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D154%26spage%3D1009%26epage%3D1015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Kastin, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akerstrom, V.</span><span> </span><span class="NLM_article-title">Nonsaturable entry of neuropeptide Y into brain</span> <span class="citation_source-journal">Am. J. Physiol.: Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">E479</span><span class="NLM_x">–</span> <span class="NLM_lpage">E482</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=1999&pages=E479-E482&author=A.+J.+Kastinauthor=V.+Akerstrom&title=Nonsaturable+entry+of+neuropeptide+Y+into+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKastin%26aufirst%3DA.%2BJ.%26aulast%3DAkerstrom%26aufirst%3DV.%26atitle%3DNonsaturable%2520entry%2520of%2520neuropeptide%2520Y%2520into%2520brain%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Endocrinol.%2520Metab.%26date%3D1999%26volume%3D276%26spage%3DE479%26epage%3DE482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Chappa, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audus, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunte, S. M.</span><span> </span><span class="NLM_article-title">Characteristics of substance P transport across the blood–brain barrier</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1201</span><span class="NLM_x">–</span> <span class="NLM_lpage">1208</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2006&pages=1201-1208&author=A.+K.+Chappaauthor=K.+L.+Audusauthor=S.+M.+Lunte&title=Characteristics+of+substance+P+transport+across+the+blood%E2%80%93brain+barrier"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChappa%26aufirst%3DA.%2BK.%26aulast%3DAudus%26aufirst%3DK.%2BL.%26aulast%3DLunte%26aufirst%3DS.%2BM.%26atitle%3DCharacteristics%2520of%2520substance%2520P%2520transport%2520across%2520the%2520blood%25E2%2580%2593brain%2520barrier%26jtitle%3DPharm.%2520Res.%26date%3D2006%26volume%3D23%26spage%3D1201%26epage%3D1208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Thomas, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taskar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudraraju, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorsheim, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaasch, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mittapalli, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmieri, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steeg, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockman, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, Q. R.</span><span> </span><span class="NLM_article-title">Uptake of ANG1005, a novel paclitaxel derivative, through the blood–brain barrier into brain and experimental brain metastases of breast cancer</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">2486</span><span class="NLM_x">–</span> <span class="NLM_lpage">2494</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2009&pages=2486-2494&author=F.+C.+Thomasauthor=K.+Taskarauthor=V.+Rudrarajuauthor=S.+Godaauthor=H.+R.+Thorsheimauthor=J.+A.+Gaaschauthor=R.+K.+Mittapalliauthor=D.+Palmieriauthor=P.+S.+Steegauthor=P.+R.+Lockmanauthor=Q.+R.+Smith&title=Uptake+of+ANG1005%2C+a+novel+paclitaxel+derivative%2C+through+the+blood%E2%80%93brain+barrier+into+brain+and+experimental+brain+metastases+of+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DF.%2BC.%26aulast%3DTaskar%26aufirst%3DK.%26aulast%3DRudraraju%26aufirst%3DV.%26aulast%3DGoda%26aufirst%3DS.%26aulast%3DThorsheim%26aufirst%3DH.%2BR.%26aulast%3DGaasch%26aufirst%3DJ.%2BA.%26aulast%3DMittapalli%26aufirst%3DR.%2BK.%26aulast%3DPalmieri%26aufirst%3DD.%26aulast%3DSteeg%26aufirst%3DP.%2BS.%26aulast%3DLockman%26aufirst%3DP.%2BR.%26aulast%3DSmith%26aufirst%3DQ.%2BR.%26atitle%3DUptake%2520of%2520ANG1005%252C%2520a%2520novel%2520paclitaxel%2520derivative%252C%2520through%2520the%2520blood%25E2%2580%2593brain%2520barrier%2520into%2520brain%2520and%2520experimental%2520brain%2520metastases%2520of%2520breast%2520cancer%26jtitle%3DPharm.%2520Res.%26date%3D2009%26volume%3D26%26spage%3D2486%26epage%3D2494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Bertrand, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Currie, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demeule, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abulrob, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fatehi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartelet, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabathuler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaigne, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanimirovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beliveau, R.</span><span> </span><span class="NLM_article-title">Transport characteristics of a novel peptide platform for CNS therapeutics</span> <span class="citation_source-journal">J. Cell. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2827</span><span class="NLM_x">–</span> <span class="NLM_lpage">2839</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1111%2Fj.1582-4934.2009.00930.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=19818094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlansrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2010&pages=2827-2839&author=Y.+Bertrandauthor=J.+C.+Currieauthor=M.+Demeuleauthor=A.+Reginaauthor=C.+Cheauthor=A.+Abulrobauthor=D.+Fatehiauthor=H.+Sarteletauthor=R.+Gabathulerauthor=J.+P.+Castaigneauthor=D.+Stanimirovicauthor=R.+Beliveau&title=Transport+characteristics+of+a+novel+peptide+platform+for+CNS+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Transport characteristics of a novel peptide platform for CNS therapeutics</span></div><div class="casAuthors">Bertrand, Yanick; Currie, Jean-Christophe; Demeule, Michel; Regina, Anthony; Che, Christian; Abulrob, Abedelnasser; Fatehi, Dorothy; Sartelet, Herve; Gabathuler, Reinhard; Castaigne, Jean-Paul; Stanimirovic, Danica; Beliveau, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular and Molecular Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2827-2839</span>CODEN:
                <span class="NLM_cas:coden">JCMMC9</span>;
        ISSN:<span class="NLM_cas:issn">1582-1838</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">New and effective therapeutics that cross the blood-brain barrier (BBB) are critically needed for treatment of many brain diseases.  We characterize here a novel drug development platform that is broadly applicable for the development of new therapeutics with increased brain penetration.  The platform is based on the Angiopep-2 peptide, a sequence derived from ligands that bind to low-d. lipoprotein receptor-related protein-1 (LRP-1), a receptor expressed on the BBB.  Fluorescent imaging studies of a Cy5.5 Angiopep-2 conjugate and immunohistochem. studies of injected Angiopep-2 in mice demonstrated efficient transport across the BBB into brain parenchyma and subsequent co-localization with the neuronal nuclei-selective marker NeuN and the glial marker glial fibrillary acidic protein (GFAP).  Uptake of [125I]-Angiopep-2 into brain endothelial cells occurred by a saturable mechanism involving LRP-1.  The primary sequence and charge of Angiopep-2 were crucial for its passage across the BBB.  Overall, the results demonstrate the significant potential of this platform for the development of novel neurotherapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorb_5glvZU4LVg90H21EOLACvtfcHk0li_jSG-NRPHyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlansrk%253D&md5=8a934864d86940a15d203cc7228fa00e</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1111%2Fj.1582-4934.2009.00930.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1582-4934.2009.00930.x%26sid%3Dliteratum%253Aachs%26aulast%3DBertrand%26aufirst%3DY.%26aulast%3DCurrie%26aufirst%3DJ.%2BC.%26aulast%3DDemeule%26aufirst%3DM.%26aulast%3DRegina%26aufirst%3DA.%26aulast%3DChe%26aufirst%3DC.%26aulast%3DAbulrob%26aufirst%3DA.%26aulast%3DFatehi%26aufirst%3DD.%26aulast%3DSartelet%26aufirst%3DH.%26aulast%3DGabathuler%26aufirst%3DR.%26aulast%3DCastaigne%26aufirst%3DJ.%2BP.%26aulast%3DStanimirovic%26aufirst%3DD.%26aulast%3DBeliveau%26aufirst%3DR.%26atitle%3DTransport%2520characteristics%2520of%2520a%2520novel%2520peptide%2520platform%2520for%2520CNS%2520therapeutics%26jtitle%3DJ.%2520Cell.%2520Mol.%2520Med.%26date%3D2010%26volume%3D14%26spage%3D2827%26epage%3D2839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Che, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacoste, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Currie, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demeule, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beliveau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaigne, J. P.</span><span> </span><span class="NLM_article-title">New angiopep-modified doxorubicin (ANG1007) and etoposide (ANG1009) chemotherapeutics with increased brain penetration</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2814</span><span class="NLM_x">–</span> <span class="NLM_lpage">2824</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9016637" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2814-2824&author=C.+Cheauthor=G.+Q.+Yangauthor=C.+Thiotauthor=M.+C.+Lacosteauthor=J.+C.+Currieauthor=M.+Demeuleauthor=A.+Reginaauthor=R.+Beliveauauthor=J.+P.+Castaigne&title=New+angiopep-modified+doxorubicin+%28ANG1007%29+and+etoposide+%28ANG1009%29+chemotherapeutics+with+increased+brain+penetration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm9016637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9016637%26sid%3Dliteratum%253Aachs%26aulast%3DChe%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DG.%2BQ.%26aulast%3DThiot%26aufirst%3DC.%26aulast%3DLacoste%26aufirst%3DM.%2BC.%26aulast%3DCurrie%26aufirst%3DJ.%2BC.%26aulast%3DDemeule%26aufirst%3DM.%26aulast%3DRegina%26aufirst%3DA.%26aulast%3DBeliveau%26aufirst%3DR.%26aulast%3DCastaigne%26aufirst%3DJ.%2BP.%26atitle%3DNew%2520angiopep-modified%2520doxorubicin%2520%2528ANG1007%2529%2520and%2520etoposide%2520%2528ANG1009%2529%2520chemotherapeutics%2520with%2520increased%2520brain%2520penetration%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2814%26epage%3D2824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Regina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demeule, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavallee, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabathuler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beliveau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaigne, J. P.</span><span> </span><span class="NLM_article-title">Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector angiopep-2</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1038%2Fbjp.2008.260" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=18574456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVygtL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2008&pages=185-197&author=A.+Reginaauthor=M.+Demeuleauthor=C.+Cheauthor=I.+Lavalleeauthor=J.+Poirierauthor=R.+Gabathulerauthor=R.+Beliveauauthor=J.+P.+Castaigne&title=Antitumour+activity+of+ANG1005%2C+a+conjugate+between+paclitaxel+and+the+new+brain+delivery+vector+angiopep-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2</span></div><div class="casAuthors">Regina, A.; Demeule, M.; Che, C.; Lavallee, I.; Poirier, J.; Gabathuler, R.; Beliveau, R.; Castaigne, J-P.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-197</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background and purpose: Paclitaxel is highly efficacious in the treatment of breast, head and neck, non-small cell lung cancers and ovarian carcinoma.  For malignant gliomas, paclitaxel is prevented from reaching its target by the presence of the efflux pump P-glycoprotein (P-gp) at the blood-brain barrier.  We investigated the utilization of a new drug delivery system to increase brain delivery of paclitaxel.  Exptl. approach: Paclitaxel mols. were conjugated to a brain peptide vector, Angiopep-2, to provide a paclitaxel-Angiopep-2 conjugate named ANG1005.  We detd. the brain uptake capacity, intracellular effects and antitumor properties of ANG1005 in vitro against human tumor cell lines and in vivo in human xenografts.  We then detd. ANG1005 activity on brain tumors with intracerebral human tumor models in nude mice.  Key results: We show by in situ brain perfusion that ANG1005 enters the brain to a greater extent than paclitaxel and bypasses the P-gp.  ANG1005 has an antineoplastic potency similar to that of paclitaxel against human cancer cell lines.  We also demonstrate that ANG1005 caused a more potent inhibition of human tumor xenografts than paclitaxel.  Finally, ANG1005 administration led to a significant increase in the survival of mice with intracerebral implantation of U87 MG glioblastoma cells or NCI-H460 lung carcinoma cells.  Conclusions and implications: These results demonstrate the antitumor potential of a new drug, ANG1005, and establish that conjugation of anticancer agents with the Angiopep-2 peptide vector could increase their efficacy in the treatment of brain cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf7gdI2T8jHbVg90H21EOLACvtfcHk0liFxWp9ZuOwwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVygtL3N&md5=3c86b5d1a64c5754d439dfa787f16637</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fbjp.2008.260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjp.2008.260%26sid%3Dliteratum%253Aachs%26aulast%3DRegina%26aufirst%3DA.%26aulast%3DDemeule%26aufirst%3DM.%26aulast%3DChe%26aufirst%3DC.%26aulast%3DLavallee%26aufirst%3DI.%26aulast%3DPoirier%26aufirst%3DJ.%26aulast%3DGabathuler%26aufirst%3DR.%26aulast%3DBeliveau%26aufirst%3DR.%26aulast%3DCastaigne%26aufirst%3DJ.%2BP.%26atitle%3DAntitumour%2520activity%2520of%2520ANG1005%252C%2520a%2520conjugate%2520between%2520paclitaxel%2520and%2520the%2520new%2520brain%2520delivery%2520vector%2520angiopep-2%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D155%26spage%3D185%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Malcor, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payrot, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faucon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abouzid, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacquot, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floquet, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debarbieux, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rougon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khrestchatisky, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlieghe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lisowski, V.</span><span> </span><span class="NLM_article-title">Chemical optimization of new ligands of the low-density lipoprotein receptor as potential vectors for central nervous system targeting</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2227</span><span class="NLM_x">–</span> <span class="NLM_lpage">2241</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2014919" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2227-2241&author=J.+D.+Malcorauthor=N.+Payrotauthor=M.+Davidauthor=A.+Fauconauthor=K.+Abouzidauthor=G.+Jacquotauthor=N.+Floquetauthor=F.+Debarbieuxauthor=G.+Rougonauthor=J.+Martinezauthor=M.+Khrestchatiskyauthor=P.+Vliegheauthor=V.+Lisowski&title=Chemical+optimization+of+new+ligands+of+the+low-density+lipoprotein+receptor+as+potential+vectors+for+central+nervous+system+targeting"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm2014919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2014919%26sid%3Dliteratum%253Aachs%26aulast%3DMalcor%26aufirst%3DJ.%2BD.%26aulast%3DPayrot%26aufirst%3DN.%26aulast%3DDavid%26aufirst%3DM.%26aulast%3DFaucon%26aufirst%3DA.%26aulast%3DAbouzid%26aufirst%3DK.%26aulast%3DJacquot%26aufirst%3DG.%26aulast%3DFloquet%26aufirst%3DN.%26aulast%3DDebarbieux%26aufirst%3DF.%26aulast%3DRougon%26aufirst%3DG.%26aulast%3DMartinez%26aufirst%3DJ.%26aulast%3DKhrestchatisky%26aufirst%3DM.%26aulast%3DVlieghe%26aufirst%3DP.%26aulast%3DLisowski%26aufirst%3DV.%26atitle%3DChemical%2520optimization%2520of%2520new%2520ligands%2520of%2520the%2520low-density%2520lipoprotein%2520receptor%2520as%2520potential%2520vectors%2520for%2520central%2520nervous%2520system%2520targeting%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2227%26epage%3D2241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Tian, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, L.</span><span> </span><span class="NLM_article-title">In vitro and in vivo studies on gelatin–siloxane nanoparticles conjugated with SynB peptide to increase drug delivery to the brain</span> <span class="citation_source-journal">Int. J. Nanomed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1031</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=22403486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BC38XjvFWrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1031-41&author=X.+H.+Tianauthor=F.+Weiauthor=T.+X.+Wangauthor=P.+Wangauthor=X.+N.+Linauthor=J.+Wangauthor=D.+Wangauthor=L.+Ren&title=In+vitro+and+in+vivo+studies+on+gelatin%E2%80%93siloxane+nanoparticles+conjugated+with+SynB+peptide+to+increase+drug+delivery+to+the+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo studies on gelatin-siloxane nanoparticles conjugated with SynB peptide to increase drug delivery to the brain</span></div><div class="casAuthors">Tian, Xin-Hua; Wei, Feng; Wang, Tian-Xiao; Wang, Peng; Lin, Xiao-Ning; Wang, Jun; Wang, Dong; Ren, Lei</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Nanomedicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1031-1041</span>CODEN:
                <span class="NLM_cas:coden">IJNNHQ</span>;
        ISSN:<span class="NLM_cas:issn">1178-2013</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Background: Nanobiotechnol. can provide more efficient tools for diagnosis, targeted and personalized therapy, and increase the chances of brain tumor treatment being successful.  Use of nanoparticles is a promising strategy for overcoming the blood-brain barrier and delivering drugs to the brain.  Gelatin-siloxane (GS) nanoparticles modified with Tat peptide can enhance plasmid DNA transfection efficiency compared with a com. reagent.  Methods: SynB-PEG-GS nanoparticles are membrane-penetrable, and can cross the blood-brain barrier and deliver a drug to its target site in the brain.  The efficiency of delivery was investigated in vivo and in vitro using brain capillary endothelial cells, a cocultured blood-brain barrier model, and a normal mouse model.  Results: Our study demonstrated that both SynB-PEG-GS and PEG-GS nanoparticles had a spherical shape and an av. diam. of 150-200 nm.  It was shown by MTT assay that SynB-PEG-GS nanoparticles had good biocompatibility with brain capillary endothelial cells.  Cellular uptake by SynB-PEG-GS nanoparticles was higher than that for PEG-GS nanoparticles for all incubation periods.  The amt. of SynB-PEG-GS nanoparticles crossing the cocultured blood-brain barrier model was significantly higher than that of PEG-GS nanoparticles at all time points measured (P < 0.05).  In animal testing, SynB-PEG-GS nanoparticle levels in the brain were significantly higher than those of PEG-GS nanoparticles at all time points measured (P < 0.01).  In contrast with localization in the brain, PEG-GS nanoparticle levels were significantly higher than those of SynB-PEG-GS nanoparticles (P < 0.01) in the liver.  Conclusion: This study indicates that SynB-PEG-GS nanoparticles have favorable properties with regard to morphol., size distribution, and toxicity.  Moreover, the SynB-PEG-GS nanoparticles exhibited more efficient brain capillary endothelial cell uptake and improved crossing of the blood-brain barrier.  Further, biodistribution studies of rhodamine-loaded nanoparticles demonstrated that modification with the SynB peptide could not only improve the ability of PEG-GS nanoparticles to evade capture in the reticuloendothelial system but also enhance their efficiency in crossing the blood-brain barrier.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQoFHPbbbugLVg90H21EOLACvtfcHk0lirTOCEenWjkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjvFWrsLc%253D&md5=12c3b0832b6f1ec93b2d528349dc413d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DX.%2BH.%26aulast%3DWei%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DT.%2BX.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DX.%2BN.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DRen%26aufirst%3DL.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520studies%2520on%2520gelatin%25E2%2580%2593siloxane%2520nanoparticles%2520conjugated%2520with%2520SynB%2520peptide%2520to%2520increase%2520drug%2520delivery%2520to%2520the%2520brain%26jtitle%3DInt.%2520J.%2520Nanomed.%26date%3D2012%26volume%3D7%26spage%3D1031%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Temsamani, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnafous, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rousselle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraisse, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clair, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Granier, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaczorek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherrmann, J. M.</span><span> </span><span class="NLM_article-title">Improved brain uptake and pharmacological activity profile of morphine-6-glucuronide using a peptide vector-mediated strategy</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">313</span><span class="NLM_x">, </span> <span class="NLM_fpage">712</span><span class="NLM_x">–</span> <span class="NLM_lpage">719</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1124%2Fjpet.104.081000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=15647327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktFemsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2005&pages=712-719&author=J.+Temsamaniauthor=C.+Bonnafousauthor=C.+Rousselleauthor=Y.+Fraisseauthor=P.+Clairauthor=L.+A.+Granierauthor=A.+R.+Reesauthor=M.+Kaczorekauthor=J.+M.+Scherrmann&title=Improved+brain+uptake+and+pharmacological+activity+profile+of+morphine-6-glucuronide+using+a+peptide+vector-mediated+strategy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Improved brain uptake and pharmacological activity profile of Morphine-6-glucuronide using a peptide vector-mediated strategy</span></div><div class="casAuthors">Temsamani, Jamal; Bonnafous, Cecile; Rousselle, Christophe; Fraisse, Yannik; Clair, Philippe; Granier, Luc-Andre; Rees, Anthony R.; Kaczorek, Michel; Scherrmann, Jean-Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">712-719</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Morphine-6-glucuronide (M6G), an active metabolite of morphine, has been shown to have significantly attenuated brain penetration relative to that of morphine.  Recently, we have demonstrated that conjugation of various drugs to peptide vectors significantly enhances their brain uptake.  In this study, we have conjugated morphine-6-glucuronide to a peptide vector SynB3 to enhance its brain uptake and its analgesic potency after systemic administration.  We show by in situ brain perfusion that vectorization of M6G (Syn1001) markedly enhances the brain uptake of M6G.  This enhancement results in a significant improvement in the pharmacol. activity of M6G in several models of nociception.  Syn1001 was about 4 times more potent than free M6G (ED50 of 1.87 vs. 8.74 μmol/kg).  Syn1001 showed also a prolonged duration of action compared with free M6G (300 and 120 min, resp.).  Furthermore, the conjugation of M6G results in a lowered respiratory depression, as measured in a rat model.  Taken together, these data strongly support the utility of peptide-mediated strategies for improving the efficacy of drugs such as M6G for the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrrHR8h0dYyrVg90H21EOLACvtfcHk0lirTOCEenWjkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktFemsLY%253D&md5=436b2ad8faf1339f4b459fdac1f6c416</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.081000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.081000%26sid%3Dliteratum%253Aachs%26aulast%3DTemsamani%26aufirst%3DJ.%26aulast%3DBonnafous%26aufirst%3DC.%26aulast%3DRousselle%26aufirst%3DC.%26aulast%3DFraisse%26aufirst%3DY.%26aulast%3DClair%26aufirst%3DP.%26aulast%3DGranier%26aufirst%3DL.%2BA.%26aulast%3DRees%26aufirst%3DA.%2BR.%26aulast%3DKaczorek%26aufirst%3DM.%26aulast%3DScherrmann%26aufirst%3DJ.%2BM.%26atitle%3DImproved%2520brain%2520uptake%2520and%2520pharmacological%2520activity%2520profile%2520of%2520morphine-6-glucuronide%2520using%2520a%2520peptide%2520vector-mediated%2520strategy%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D313%26spage%3D712%26epage%3D719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Mazel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clair, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rousselle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherrmann, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Temsamani, J.</span><span> </span><span class="NLM_article-title">Doxorubicin–peptide conjugates overcome multidrug resistance</span> <span class="citation_source-journal">Anticancer Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2001&pages=107-16&author=M.+Mazelauthor=P.+Clairauthor=C.+Rousselleauthor=P.+Vidalauthor=J.+M.+Scherrmannauthor=D.+Mathieuauthor=J.+Temsamani&title=Doxorubicin%E2%80%93peptide+conjugates+overcome+multidrug+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMazel%26aufirst%3DM.%26aulast%3DClair%26aufirst%3DP.%26aulast%3DRousselle%26aufirst%3DC.%26aulast%3DVidal%26aufirst%3DP.%26aulast%3DScherrmann%26aufirst%3DJ.%2BM.%26aulast%3DMathieu%26aufirst%3DD.%26aulast%3DTemsamani%26aufirst%3DJ.%26atitle%3DDoxorubicin%25E2%2580%2593peptide%2520conjugates%2520overcome%2520multidrug%2520resistance%26jtitle%3DAnticancer%2520Drugs%26date%3D2001%26volume%3D12%26spage%3D107%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Rousselle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clair, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefauconnier, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaczorek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherrmann, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Temsamani, J.</span><span> </span><span class="NLM_article-title">New advances in the transport of doxorubicin through the blood–brain barrier by a peptide vector-mediated strategy</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">679</span><span class="NLM_x">–</span> <span class="NLM_lpage">686</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2000&pages=679-686&author=C.+Rousselleauthor=P.+Clairauthor=J.+M.+Lefauconnierauthor=M.+Kaczorekauthor=J.+M.+Scherrmannauthor=J.+Temsamani&title=New+advances+in+the+transport+of+doxorubicin+through+the+blood%E2%80%93brain+barrier+by+a+peptide+vector-mediated+strategy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRousselle%26aufirst%3DC.%26aulast%3DClair%26aufirst%3DP.%26aulast%3DLefauconnier%26aufirst%3DJ.%2BM.%26aulast%3DKaczorek%26aufirst%3DM.%26aulast%3DScherrmann%26aufirst%3DJ.%2BM.%26aulast%3DTemsamani%26aufirst%3DJ.%26atitle%3DNew%2520advances%2520in%2520the%2520transport%2520of%2520doxorubicin%2520through%2520the%2520blood%25E2%2580%2593brain%2520barrier%2520by%2520a%2520peptide%2520vector-mediated%2520strategy%26jtitle%3DMol.%2520Pharmacol.%26date%3D2000%26volume%3D57%26spage%3D679%26epage%3D686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Dogrukol-Ak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuncel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuncel, M.</span><span> </span><span class="NLM_article-title">Passage of vasoactive intestinal peptide across the blood–brain barrier</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">–</span> <span class="NLM_lpage">444</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2003&pages=437-444&author=D.+Dogrukol-Akauthor=W.+A.+Banksauthor=N.+Tuncelauthor=M.+Tuncel&title=Passage+of+vasoactive+intestinal+peptide+across+the+blood%E2%80%93brain+barrier"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDogrukol-Ak%26aufirst%3DD.%26aulast%3DBanks%26aufirst%3DW.%2BA.%26aulast%3DTuncel%26aufirst%3DN.%26aulast%3DTuncel%26aufirst%3DM.%26atitle%3DPassage%2520of%2520vasoactive%2520intestinal%2520peptide%2520across%2520the%2520blood%25E2%2580%2593brain%2520barrier%26jtitle%3DPeptides%26date%3D2003%26volume%3D24%26spage%3D437%26epage%3D444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Lindgren, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallbrink, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmquist, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langel, U.</span><span> </span><span class="NLM_article-title">Passage of cell-penetrating peptides across a human epithelial cell layer in vitro</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">377</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=2004&pages=69-76&author=M.+E.+Lindgrenauthor=M.+M.+Hallbrinkauthor=A.+M.+Elmquistauthor=U.+Langel&title=Passage+of+cell-penetrating+peptides+across+a+human+epithelial+cell+layer+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLindgren%26aufirst%3DM.%2BE.%26aulast%3DHallbrink%26aufirst%3DM.%2BM.%26aulast%3DElmquist%26aufirst%3DA.%2BM.%26aulast%3DLangel%26aufirst%3DU.%26atitle%3DPassage%2520of%2520cell-penetrating%2520peptides%2520across%2520a%2520human%2520epithelial%2520cell%2520layer%2520in%2520vitro%26jtitle%3DBiochem.%2520J.%26date%3D2004%26volume%3D377%26spage%3D69%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Qin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Q.</span><span> </span><span class="NLM_article-title">Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery</span> <span class="citation_source-journal">Int. J. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">419</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1016%2Fj.ijpharm.2011.07.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=21807083" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1CltbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=419&publication_year=2011&pages=85-95&author=Y.+Qinauthor=H.+L.+Chenauthor=W.+M.+Yuanauthor=R.+Kuaiauthor=Q.+Y.+Zhangauthor=F.+L.+Xieauthor=L.+Zhangauthor=Z.+R.+Zhangauthor=J.+Liuauthor=Q.+He&title=Liposome+formulated+with+TAT-modified+cholesterol+for+enhancing+the+brain+delivery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery</span></div><div class="casAuthors">Qin, Yao; Chen, Huali; Yuan, Wenmin; Kuai, Rui; Zhang, Qianyu; Xie, Fulan; Zhang, Li; Zhang, Zhirong; Liu, Ji; He, Qin</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">419</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">85-95</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Delivery of drugs to the brain is a major challenge due to the presence of the blood-brain barrier (BBB).  The cell penetrating peptide TAT, which appears to enter cells with alacrity, can pass through the BBB efficiently.  With this in mind, a novel TAT-modified liposome (TAT-LIP) was developed for overcoming the ineffective delivery of normal drug formulation to the brain.  Targeting liposomal formulations are always composed of modified phospholipids as an anchor.  However, cholesterol, another liposomal component, which was more stable and cheaper, has not been fully investigated as an alternative anchor.  In this study, TAT was covalently conjugated with the cholesterol to prep. the liposome.  The cellular uptake by brain capillary endothelial cells (BCECs) of rats and the mechanism of TAT-LIP pathway of endocytosis was explored.  The blood brain barrier model in vitro was established to evaluate the transendothelial ability crossing the BBB and its transport mechanism.  The biodistribution of each formulation was further identified.  The results showed that the pos. charge of the TAT-LIP played an important role in enhancing its brain delivery.  The absorptive endocytosis might be one of the mechanisms of TAT-LIP crossing the BBB.  In conclusion, the exptl. data in vitro and in vivo indicated that the TAT-LIP was a promising brain drug delivery system due to its high delivery efficiency across the BBB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7Vs9iIz7ezLVg90H21EOLACvtfcHk0ljDR7sJ_yPDlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1CltbbF&md5=2044ef7c599023479256fb53963253b2</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2011.07.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2011.07.021%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%2BL.%26aulast%3DYuan%26aufirst%3DW.%2BM.%26aulast%3DKuai%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DQ.%2BY.%26aulast%3DXie%26aufirst%3DF.%2BL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DZ.%2BR.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DQ.%26atitle%3DLiposome%2520formulated%2520with%2520TAT-modified%2520cholesterol%2520for%2520enhancing%2520the%2520brain%2520delivery%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2011%26volume%3D419%26spage%3D85%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Qin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Q.</span><span> </span><span class="NLM_article-title">Liposome formulated with TAT-modified cholesterol for improving brain delivery and therapeutic efficacy on brain glioma in animals</span> <span class="citation_source-journal">Int. J. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">420</span><span class="NLM_x">, </span> <span class="NLM_fpage">304</span><span class="NLM_x">–</span> <span class="NLM_lpage">312</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1016%2Fj.ijpharm.2011.09.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=21945185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlWmtL3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=420&publication_year=2011&pages=304-312&author=Y.+Qinauthor=H.+L.+Chenauthor=Q.+Y.+Zhangauthor=X.+X.+Wangauthor=W.+M.+Yuanauthor=R.+Kuaiauthor=J.+Tangauthor=L.+Zhangauthor=Z.+R.+Zhangauthor=Q.+Zhangauthor=J.+Liuauthor=Q.+He&title=Liposome+formulated+with+TAT-modified+cholesterol+for+improving+brain+delivery+and+therapeutic+efficacy+on+brain+glioma+in+animals"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Liposome formulated with TAT-modified cholesterol for improving brain delivery and therapeutic efficacy on brain glioma in animals</span></div><div class="casAuthors">Qin, Yao; Chen, Huali; Zhang, Qianyu; Wang, Xiaoxiao; Yuan, Wenmin; Kuai, Rui; Tang, Jie; Zhang, Li; Zhang, Zhirong; Zhang, Qiang; Liu, Ji; He, Qin</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">420</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">304-312</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The treatment of central nervous system diseases such as brain glioma is a major challenge due to the presence of the blood-brain barrier (BBB).  A cell-penetrating peptide TAT (AYGRKKRRQRRR), which appears to enter cells with alacrity, was employed to enhance the delivery efficiency of normal drug formulation to the brain.  Targeting liposomal formulations often apply modified phospholipids as anchors.  However, cholesterol, another liposomal component more stable and cheaper, has not been fully investigated as an alternative anchor.  In our study, TAT was covalently conjugated with cholesterol for prepg. doxorubicin-loaded liposome for brain glioma therapy.  Cellular uptake by brain capillary endothelial cells (BCECs) and C6 glioma cells was explored.  The anti-proliferative activity against C6s confirmed strong inhibitory effect of the liposomes modified with doxorubicin-loaded TAT.  The bio-distribution findings in brains and hearts were evident of higher efficiency of brain delivery and lower cardiotoxic risk.  The results on survival of the brain glioma-bearing animals indicate that survival time of the glioma-bearing rats treated with TAT-modified liposome was much longer than in the other groups.  In conclusion, the potency of the TAT-modified liposome to enter the BBB appears to be related with the TAT on the liposome's surface.  The TAT-modified liposome may improve the therapeutic efficacy on brain glioma in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3xqE3ThQsrVg90H21EOLACvtfcHk0ljDR7sJ_yPDlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlWmtL3P&md5=bf97e2dd3d8ed11f0fe7e467653315ff</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2011.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2011.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%2BL.%26aulast%3DZhang%26aufirst%3DQ.%2BY.%26aulast%3DWang%26aufirst%3DX.%2BX.%26aulast%3DYuan%26aufirst%3DW.%2BM.%26aulast%3DKuai%26aufirst%3DR.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DZ.%2BR.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DQ.%26atitle%3DLiposome%2520formulated%2520with%2520TAT-modified%2520cholesterol%2520for%2520improving%2520brain%2520delivery%2520and%2520therapeutic%2520efficacy%2520on%2520brain%2520glioma%2520in%2520animals%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2011%26volume%3D420%26spage%3D304%26epage%3D312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Rao, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horning, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labhasetwar, V.</span><span> </span><span class="NLM_article-title">TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs</span> <span class="citation_source-journal">Biomaterials</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">4429</span><span class="NLM_x">–</span> <span class="NLM_lpage">4438</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=4429-4438&author=K.+S.+Raoauthor=M.+K.+Reddyauthor=J.+L.+Horningauthor=V.+Labhasetwar&title=TAT-conjugated+nanoparticles+for+the+CNS+delivery+of+anti-HIV+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DK.%2BS.%26aulast%3DReddy%26aufirst%3DM.%2BK.%26aulast%3DHorning%26aufirst%3DJ.%2BL.%26aulast%3DLabhasetwar%26aufirst%3DV.%26atitle%3DTAT-conjugated%2520nanoparticles%2520for%2520the%2520CNS%2520delivery%2520of%2520anti-HIV%2520drugs%26jtitle%3DBiomaterials%26date%3D2008%26volume%3D29%26spage%3D4429%26epage%3D4438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Nam, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, I. S.</span><span> </span><span class="NLM_article-title">Intracellular drug delivery using poly(<span class="smallcaps smallerCapital">d</span>,<span class="smallcaps smallerCapital">l</span>-lactide-co-glycolide) nanoparticles derivatized with a peptide from a transcriptional activator protein of HIV-1</span> <span class="citation_source-journal">Biotechnol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2093</span><span class="NLM_x">–</span> <span class="NLM_lpage">2098</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2002&pages=2093-2098&author=Y.+S.+Namauthor=J.+Y.+Parkauthor=S.+H.+Hanauthor=I.+S.+Chang&title=Intracellular+drug+delivery+using+poly%28d%2Cl-lactide-co-glycolide%29+nanoparticles+derivatized+with+a+peptide+from+a+transcriptional+activator+protein+of+HIV-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNam%26aufirst%3DY.%2BS.%26aulast%3DPark%26aufirst%3DJ.%2BY.%26aulast%3DHan%26aufirst%3DS.%2BH.%26aulast%3DChang%26aufirst%3DI.%2BS.%26atitle%3DIntracellular%2520drug%2520delivery%2520using%2520poly%2528d%252Cl-lactide-co-glycolide%2529%2520nanoparticles%2520derivatized%2520with%2520a%2520peptide%2520from%2520a%2520transcriptional%2520activator%2520protein%2520of%2520HIV-1%26jtitle%3DBiotechnol.%2520Lett.%26date%3D2002%26volume%3D24%26spage%3D2093%26epage%3D2098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Sharma, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modgil, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, J.</span><span> </span><span class="NLM_article-title">Grafting of cell-penetrating peptide to receptor-targeted liposomes improves their transfection efficiency and transport across blood–brain barrier model</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">2468</span><span class="NLM_x">–</span> <span class="NLM_lpage">2478</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2012&pages=2468-2478&author=G.+Sharmaauthor=A.+Modgilauthor=C.+W.+Sunauthor=J.+Singh&title=Grafting+of+cell-penetrating+peptide+to+receptor-targeted+liposomes+improves+their+transfection+efficiency+and+transport+across+blood%E2%80%93brain+barrier+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DG.%26aulast%3DModgil%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DC.%2BW.%26aulast%3DSingh%26aufirst%3DJ.%26atitle%3DGrafting%2520of%2520cell-penetrating%2520peptide%2520to%2520receptor-targeted%2520liposomes%2520improves%2520their%2520transfection%2520efficiency%2520and%2520transport%2520across%2520blood%25E2%2580%2593brain%2520barrier%2520model%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2012%26volume%3D101%26spage%3D2468%26epage%3D2478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Meade, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meloni, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mastaglia, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knuckey, N. W.</span><span> </span><span class="NLM_article-title">The application of cell penetrating peptides for the delivery of neuroprotective peptides/proteins in experimental cerebral ischemia studies</span> <span class="citation_source-journal">J. Exp. Stroke Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.6030%2F1939-067X-2.1.21" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVKjs7zF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2009&pages=22-40&author=A.+J.+Meadeauthor=B.+P.+Meloniauthor=F.+L.+Mastagliaauthor=N.+W.+Knuckey&title=The+application+of+cell+penetrating+peptides+for+the+delivery+of+neuroprotective+peptides%2Fproteins+in+experimental+cerebral+ischemia+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The application of cell penetrating peptides for the delivery of neuroprotective peptides/proteins in experimental cerebral ischaemia studies</span></div><div class="casAuthors">Meade, Amanda J.; Meloni, Bruno P.; Mastaglia, Frank L.; Knuckey, Neville W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Stroke & Translational Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-40</span>CODEN:
                <span class="NLM_cas:coden">JESTD7</span>;
        ISSN:<span class="NLM_cas:issn">1939-067X</span>.
    
            (<span class="NLM_cas:orgname">Society for Experimental Stroke</span>)
        </div><div class="casAbstract">A review.  The restricted ability of most proteins and peptides to cross the blood-brain barrier and/or plasma membrane limits their use as therapeutics following cerebral ischemia.  However, the discovery of cell-penetrating peptides has provided a means by which such mols. can be transported across the blood-brain barrier and plasma membrane.  Many proteins/peptides have already been shown to have neuroprotective properties, and, due to their ability to block protein-protein interactions, provide a potentially rich source of new therapeutic compds. to prevent cell death following cerebral ischemia.  In this review, we give an overview of cell-penetrating peptides and their use exptl. to deliver neuroprotectant proteins/peptides into the brain following cerebral ischemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyZ4xC7kvAXLVg90H21EOLACvtfcHk0liWkZOOZh0h4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVKjs7zF&md5=dde3d406d73fc3223ac74deab19600e7</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.6030%2F1939-067X-2.1.21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.6030%252F1939-067X-2.1.21%26sid%3Dliteratum%253Aachs%26aulast%3DMeade%26aufirst%3DA.%2BJ.%26aulast%3DMeloni%26aufirst%3DB.%2BP.%26aulast%3DMastaglia%26aufirst%3DF.%2BL.%26aulast%3DKnuckey%26aufirst%3DN.%2BW.%26atitle%3DThe%2520application%2520of%2520cell%2520penetrating%2520peptides%2520for%2520the%2520delivery%2520of%2520neuroprotective%2520peptides%252Fproteins%2520in%2520experimental%2520cerebral%2520ischemia%2520studies%26jtitle%3DJ.%2520Exp.%2520Stroke%2520Transl.%2520Med.%26date%3D2009%26volume%3D2%26spage%3D22%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Malakotikhah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teixido, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giralt, E.</span><span> </span><span class="NLM_article-title">Toward an optimal blood–brain barrier shuttle by synthesis and evaluation of peptide libraries</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4881</span><span class="NLM_x">–</span> <span class="NLM_lpage">4889</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4881-4889&author=M.+Malakotikhahauthor=M.+Teixidoauthor=E.+Giralt&title=Toward+an+optimal+blood%E2%80%93brain+barrier+shuttle+by+synthesis+and+evaluation+of+peptide+libraries"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalakotikhah%26aufirst%3DM.%26aulast%3DTeixido%26aufirst%3DM.%26aulast%3DGiralt%26aufirst%3DE.%26atitle%3DToward%2520an%2520optimal%2520blood%25E2%2580%2593brain%2520barrier%2520shuttle%2520by%2520synthesis%2520and%2520evaluation%2520of%2520peptide%2520libraries%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4881%26epage%3D4889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Swift, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cramb, D. T.</span><span> </span><span class="NLM_article-title">Nanoparticles as fluorescence labels: Is size all that matters?</span> <span class="citation_source-journal">Biophys. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">865</span><span class="NLM_x">–</span> <span class="NLM_lpage">876</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2008&pages=865-876&author=J.+L.+Swiftauthor=D.+T.+Cramb&title=Nanoparticles+as+fluorescence+labels%3A+Is+size+all+that+matters%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwift%26aufirst%3DJ.%2BL.%26aulast%3DCramb%26aufirst%3DD.%2BT.%26atitle%3DNanoparticles%2520as%2520fluorescence%2520labels%253A%2520Is%2520size%2520all%2520that%2520matters%253F%26jtitle%3DBiophys.%2520J.%26date%3D2008%26volume%3D95%26spage%3D865%26epage%3D876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Swift, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heuff, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cramb, D. T.</span><span> </span><span class="NLM_article-title">A two-photon excitation fluorescence cross-correlation assay for a model ligand–receptor binding system using quantum dots</span> <span class="citation_source-journal">Biophys. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">1396</span><span class="NLM_x">–</span> <span class="NLM_lpage">1410</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2006&pages=1396-1410&author=J.+L.+Swiftauthor=R.+Heuffauthor=D.+T.+Cramb&title=A+two-photon+excitation+fluorescence+cross-correlation+assay+for+a+model+ligand%E2%80%93receptor+binding+system+using+quantum+dots"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwift%26aufirst%3DJ.%2BL.%26aulast%3DHeuff%26aufirst%3DR.%26aulast%3DCramb%26aufirst%3DD.%2BT.%26atitle%3DA%2520two-photon%2520excitation%2520fluorescence%2520cross-correlation%2520assay%2520for%2520a%2520model%2520ligand%25E2%2580%2593receptor%2520binding%2520system%2520using%2520quantum%2520dots%26jtitle%3DBiophys.%2520J.%26date%3D2006%26volume%3D90%26spage%3D1396%26epage%3D1410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Ceccarini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrieze, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koole, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muylle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bormans, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Laere, K.</span><span> </span><span class="NLM_article-title">Optimized in vivo detection of dopamine release using F-18-fallypride PET</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1565</span><span class="NLM_x">–</span> <span class="NLM_lpage">1572</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=1565-1572&author=J.+Ceccariniauthor=E.+Vriezeauthor=M.+Kooleauthor=T.+Muylleauthor=G.+Bormansauthor=S.+Claesauthor=K.+Van+Laere&title=Optimized+in+vivo+detection+of+dopamine+release+using+F-18-fallypride+PET"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCeccarini%26aufirst%3DJ.%26aulast%3DVrieze%26aufirst%3DE.%26aulast%3DKoole%26aufirst%3DM.%26aulast%3DMuylle%26aufirst%3DT.%26aulast%3DBormans%26aufirst%3DG.%26aulast%3DClaes%26aufirst%3DS.%26aulast%3DVan%2BLaere%26aufirst%3DK.%26atitle%3DOptimized%2520in%2520vivo%2520detection%2520of%2520dopamine%2520release%2520using%2520F-18-fallypride%2520PET%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2012%26volume%3D53%26spage%3D1565%26epage%3D1572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Rominger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koller, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boning, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wulff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwergal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forster, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilhac, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munk, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soyka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wangler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenstein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">la Fougere, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pogarell, O.</span><span> </span><span class="NLM_article-title">[F-18]fallypride PET measurement of striatal and extrastriatal dopamine D-2/3 receptor availability in recently abstinent alcoholics</span> <span class="citation_source-journal">Addict. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">490</span><span class="NLM_x">–</span> <span class="NLM_lpage">503</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1111%2Fj.1369-1600.2011.00355.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=22023291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BC38XltV2ktbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=490-503&author=A.+Romingerauthor=P.+Cummingauthor=G.+M.+Xiongauthor=G.+Kollerauthor=G.+Boningauthor=M.+Wulffauthor=A.+Zwergalauthor=S.+Forsterauthor=A.+Reilhacauthor=O.+Munkauthor=M.+Soykaauthor=B.+Wanglerauthor=P.+Bartensteinauthor=C.+la+Fougereauthor=O.+Pogarell&title=%5BF-18%5Dfallypride+PET+measurement+of+striatal+and+extrastriatal+dopamine+D-2%2F3+receptor+availability+in+recently+abstinent+alcoholics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">[18F]fallypride PET measurement of striatal and extrastriatal dopamine D2/3 receptor availability in recently abstinent alcoholics</span></div><div class="casAuthors">Rominger, Axel; Cumming, Paul; Xiong, Guoming; Koller, Gabriele; Boening, Guido; Wulff, Melanie; Zwergal, Andreas; Foerster, Stefan; Reilhac, Anthonin; Munk, Ole; Soyka, Michael; Waengler, Bjoern; Bartenstein, Peter; La Fougere, Christian; Pogarell, Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Addiction Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">490-503</span>CODEN:
                <span class="NLM_cas:coden">ADBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1369-1600</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Positron emission tomog. (PET) shows reduced binding of the dopamine D2/3 antagonist [11C]raclopride in striatum of withdrawn psychostimulant abusers, but not consistently in patients with alc. dependence (AD).  We make first use of the high affinity ligand [18F]fallypride to obtain serial measures of D2/3 receptor availability in striatal and extrastriatal regions of AD patients undergoing detoxification.  Seventeen patients (mean age 44 ± 5y) with AD and 14 age-matched healthy volunteers participated.  Each patient underwent [18F]fallypride PET upon hospital admission, and again 1-2 wk later: two patients achieving abstinence, and two with substantial harm redn. had addnl. PET follow-up at 1 yr.  Dynamic 180-min PET recordings were used for vol. of interest (VOI)-based and voxel-wise anal. of [18F]fallypride binding potential (BPND).  Mean baseline BPND in striatum of the AD patients (15.7 ± 3.6) was unaltered during short-term follow-up, and did not differ from that in healthy controls (16.8 ± 3.0); however, BPND was 10-20% lower in thalamus, hippocampus, and insular and temporal cortex of the AD patients (P < 0.05).  Age-dependent declines in BPND were very small in controls, but more pronounced and widespread in the AD group.  Striatal and thalamic BPND increased by 30% in four patients with long-term abstinence or reduced alc. consumption.  VOI-based [18F]fallypride PET analyses revealed group differences in D2/3 receptor availability primarily in extra-striatal regions.  Age-related loss of dopamine D2/3 receptors was more pronounced in AD patients.  Receptor availability was unaltered by acute withdrawal, but increased in the subgroup of patients with long-term follow-up, suggesting reversibility of receptor changes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4E_AxSPnZfbVg90H21EOLACvtfcHk0liHPEF4AqP73w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltV2ktbk%253D&md5=052784627f551b0281d70a377986709b</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1111%2Fj.1369-1600.2011.00355.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1369-1600.2011.00355.x%26sid%3Dliteratum%253Aachs%26aulast%3DRominger%26aufirst%3DA.%26aulast%3DCumming%26aufirst%3DP.%26aulast%3DXiong%26aufirst%3DG.%2BM.%26aulast%3DKoller%26aufirst%3DG.%26aulast%3DBoning%26aufirst%3DG.%26aulast%3DWulff%26aufirst%3DM.%26aulast%3DZwergal%26aufirst%3DA.%26aulast%3DForster%26aufirst%3DS.%26aulast%3DReilhac%26aufirst%3DA.%26aulast%3DMunk%26aufirst%3DO.%26aulast%3DSoyka%26aufirst%3DM.%26aulast%3DWangler%26aufirst%3DB.%26aulast%3DBartenstein%26aufirst%3DP.%26aulast%3Dla%2BFougere%26aufirst%3DC.%26aulast%3DPogarell%26aufirst%3DO.%26atitle%3D%255BF-18%255Dfallypride%2520PET%2520measurement%2520of%2520striatal%2520and%2520extrastriatal%2520dopamine%2520D-2%252F3%2520receptor%2520availability%2520in%2520recently%2520abstinent%2520alcoholics%26jtitle%3DAddict.%2520Biol.%26date%3D2012%26volume%3D17%26spage%3D490%26epage%3D503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Kegeles, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slifstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moadel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harkavy-Friedman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gil, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laruelle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abi-Dargham, A.</span><span> </span><span class="NLM_article-title">Striatal and extrastriatal dopamine D-2/D-3 receptors in schizophrenia evaluated with [F-18]fallypride positron emission tomography</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">634</span><span class="NLM_x">–</span> <span class="NLM_lpage">641</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1016%2Fj.biopsych.2010.05.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=20673873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFOntb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2010&pages=634-641&author=L.+S.+Kegelesauthor=M.+Slifsteinauthor=X.+Y.+Xuauthor=N.+Urbanauthor=J.+L.+Thompsonauthor=T.+Moadelauthor=J.+M.+Harkavy-Friedmanauthor=R.+Gilauthor=M.+Laruelleauthor=A.+Abi-Dargham&title=Striatal+and+extrastriatal+dopamine+D-2%2FD-3+receptors+in+schizophrenia+evaluated+with+%5BF-18%5Dfallypride+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Striatal and Extrastriatal Dopamine D2/D3 Receptors in Schizophrenia Evaluated With [18F]fallypride Positron Emission Tomography</span></div><div class="casAuthors">Kegeles, Lawrence S.; Slifstein, Mark; Xu, Xiaoyan; Urban, Nina; Thompson, Judy L.; Moadel, Tiffany; Harkavy-Friedman, Jill M.; Gil, Roberto; Laruelle, Marc; Abi-Dargham, Anissa</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">634-641</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Alterations in dopamine D2/D3 receptor binding have been reported in schizophrenia, and a meta-anal. of imaging studies has shown a modest elevation in striatum.  Newer radioligands now allow the assessment of these receptors in extrastriatal regions.  We used positron emission tomog. with [18F]fallypride to evaluate D2/D3 receptors in both striatal and extrastriatal regions in schizophrenia.  21 Patients with schizophrenia and 22 matched healthy control subjects were scanned with an ECAT EXACT HR+ camera.  Two-tissue compartment modeling and the ref. tissue method gave binding potentials relative to nondisplaceable uptake, total plasma concn., and free plasma concn.  These were compared between groups in five striatal and eight extrastriatal regions.  Several regional vols. were lower in the patient group, and positron emission tomog. data were cor. for partial vol. effects.  Binding potential values differed in three regions between groups.  Values for binding potential relative to nondisplaceable uptake from two-tissue compartment modeling in patients and control subjects, resp., were 28.7 ± 6.8 and 25.3 ± 4.3 in postcommissural caudate, 2.9 ± .7 and 2.6 ± .4 in thalamus, and 1.8 ± .5 and 2.1 ± .7 in uncus.  Loss of D2/D3 receptors with age was found in striatal and extrastriatal regions and was greater in neocortex.  Our study found selective alterations in D2/D3 receptors in striatal and extrastriatal regions, consistent with some but not all previously published reports.  As previously shown for the striatum, a more sensitive imaging approach for studying the role of dopamine in the pathophysiol. of schizophrenia might be assessment of neurotransmitter levels rather than D2/D3 receptor levels in extrastriatal regions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTExw0oYsWerVg90H21EOLACvtfcHk0liHPEF4AqP73w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFOntb%252FN&md5=699f4816ad045009c1679fd95f52b6f3</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2010.05.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2010.05.027%26sid%3Dliteratum%253Aachs%26aulast%3DKegeles%26aufirst%3DL.%2BS.%26aulast%3DSlifstein%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DX.%2BY.%26aulast%3DUrban%26aufirst%3DN.%26aulast%3DThompson%26aufirst%3DJ.%2BL.%26aulast%3DMoadel%26aufirst%3DT.%26aulast%3DHarkavy-Friedman%26aufirst%3DJ.%2BM.%26aulast%3DGil%26aufirst%3DR.%26aulast%3DLaruelle%26aufirst%3DM.%26aulast%3DAbi-Dargham%26aufirst%3DA.%26atitle%3DStriatal%2520and%2520extrastriatal%2520dopamine%2520D-2%252FD-3%2520receptors%2520in%2520schizophrenia%2520evaluated%2520with%2520%255BF-18%255Dfallypride%2520positron%2520emission%2520tomography%26jtitle%3DBiol.%2520Psychiatry%26date%3D2010%26volume%3D68%26spage%3D634%26epage%3D641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Gao, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mock, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glick-Wilson, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoder, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchins, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Q. H.</span><span> </span><span class="NLM_article-title">An improved synthesis of dopamine D-2/D-3 receptor radioligands [C-11]fallypride and [F-18]fallypride</span> <span class="citation_source-journal">Appl. Radiat. Isot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">1079</span><span class="NLM_x">–</span> <span class="NLM_lpage">1086</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1016%2Fj.apradiso.2009.09.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=20167502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtFGqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2010&pages=1079-1086&author=M.+Z.+Gaoauthor=M.+Wangauthor=B.+H.+Mockauthor=B.+E.+Glick-Wilsonauthor=K.+K.+Yoderauthor=G.+D.+Hutchinsauthor=Q.+H.+Zheng&title=An+improved+synthesis+of+dopamine+D-2%2FD-3+receptor+radioligands+%5BC-11%5Dfallypride+and+%5BF-18%5Dfallypride"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">An improved synthesis of dopamine D2/D3 receptor radioligands [11C]fallypride and [18F]fallypride</span></div><div class="casAuthors">Gao, Mingzhang; Wang, Min; Mock, Bruce H.; Glick-Wilson, Barbara E.; Yoder, Karmen K.; Hutchins, Gary D.; Zheng, Qi-Huang</div><div class="citationInfo"><span class="NLM_cas:title">Applied Radiation and Isotopes</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1079-1086</span>CODEN:
                <span class="NLM_cas:coden">ARISEF</span>;
        ISSN:<span class="NLM_cas:issn">0969-8043</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Improved syntheses of dopamine D2/D3 receptor radioligands [11C]Fallypride and [18F]Fallypride are reported.  The phenolic precursor (9) for C-11 labeling and the Fallypride (10) ref. std. were synthesized from the starting material 2-hydroxy-3-methoxy-5-(2-propenyl)benzoic acid Me ester (1) in 7 and 8 steps with 16% and 5% overall chem. yields, resp.  The tosylated precursor (15) for F-18 labeling was synthesized from compd. 1 in 5 steps with 32% overall chem. yield.  An alternate synthetic approach for Fallypride has been developed using the same starting material 1 in 5 steps with 26% overall chem. yield. [11C]Fallypride ([11C]10) was prepd. by O-[11C]methylation of the phenolic precursor with [11C]methyl triflate and purified with a semi-preparative HPLC method in 50-60% radiochem. yield, decay cor. to end of bombardment (EOB), based on [11C]CO2, and 370±185 GBq/μmol specific radioactivity at EOB. [18F]Fallypride ([18F]10) was prepd. by nucleophilic substitution of the tosylated precursor with K[18F]F/Kryptofix 2.2.2 and HPLC combined with solid-phase extn. (SPE) purifn. in variable (up to 50%) decay cor. radiochem. yield from K[18F]F and 111-222 GBq/μmol specific activity at EOB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXobetfyLezrVg90H21EOLACvtfcHk0liHPEF4AqP73w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtFGqsbk%253D&md5=ba0dc8a4c0ff13c93873742a4afb47e0</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.apradiso.2009.09.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apradiso.2009.09.071%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DM.%2BZ.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DMock%26aufirst%3DB.%2BH.%26aulast%3DGlick-Wilson%26aufirst%3DB.%2BE.%26aulast%3DYoder%26aufirst%3DK.%2BK.%26aulast%3DHutchins%26aufirst%3DG.%2BD.%26aulast%3DZheng%26aufirst%3DQ.%2BH.%26atitle%3DAn%2520improved%2520synthesis%2520of%2520dopamine%2520D-2%252FD-3%2520receptor%2520radioligands%2520%255BC-11%255Dfallypride%2520and%2520%255BF-18%255Dfallypride%26jtitle%3DAppl.%2520Radiat.%2520Isot.%26date%3D2010%26volume%3D68%26spage%3D1079%26epage%3D1086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Majumdar, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muhuri, S.</span><span> </span><span class="NLM_article-title">Regioselective synthesis of pyrone-annulated sulfur heterocycles by aryl radical cyclization</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">2725</span><span class="NLM_x">–</span> <span class="NLM_lpage">2730</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1055%2Fs-2006-942499" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1SisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=2725-2730&author=K.+C.+Majumdarauthor=S.+Muhuri&title=Regioselective+synthesis+of+pyrone-annulated+sulfur+heterocycles+by+aryl+radical+cyclization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Regioselective synthesis of pyrone-annulated sulfur heterocycles by aryl radical cyclization</span></div><div class="casAuthors">Majumdar, K. C.; Muhuri, S.</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2725-2730</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">The tributyltin hydride-mediated cyclization of a no. of 4-(2-bromophenoxymethyl)-7-methylthiopyrano[3,2-c]pyran-5-ones was carried out to afford tetracyclic [6,6]pyranothiopyrans I [R, R1, R2 = H; R = Me, R1 = R2 = H; R1 = OMe, R = R2 = H; RR1 = (CH)4, R2 = H; R1 = Me, R = R2 = H; R = H, R1 = R2 = Me] in 70-80% yield and with good to excellent diastereoselectivity.  The substrate ethers were obtained by a thio-Claisen rearrangement of the corresponding 4-(4-aryloxybut-2-ynyl)-6-methylpyran-2-ones.  The cis stereochem. of the predominant diastereomer was corroborated by single crystal x-ray anal. of I [R1 = Me, R = R2 = H: monoclinic, space group, P21/c, a 8.2785(7), b 10.7418(9), c 16.3304(14) Å, β 101.008(2)°, V 1425.5(2) Å3, Z 4].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdyUtQ7EjGqrVg90H21EOLACvtfcHk0liLvMwr2iNmCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1SisLk%253D&md5=4720c055449d9e0c860b7f8c9be70246</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1055%2Fs-2006-942499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2006-942499%26sid%3Dliteratum%253Aachs%26aulast%3DMajumdar%26aufirst%3DK.%2BC.%26aulast%3DMuhuri%26aufirst%3DS.%26atitle%3DRegioselective%2520synthesis%2520of%2520pyrone-annulated%2520sulfur%2520heterocycles%2520by%2520aryl%2520radical%2520cyclization%26jtitle%3DSynthesis%26date%3D2006%26spage%3D2725%26epage%3D2730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Majumdar, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafique-ul-Islam</span><span> </span><span class="NLM_article-title">Chemoselective synthesis of thieno [3,2-c] [1,8]naphthyridin-4(5H-ones by tandem cyclization</span> <span class="citation_source-journal">Heteroat. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1002%2Fhc.20234" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsVymtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=87-92&author=K.+C.+Majumdarauthor=+Rafique-ul-Islam&title=Chemoselective+synthesis+of+thieno+%5B3%2C2-c%5D+%5B1%2C8%5Dnaphthyridin-4%285H-ones+by+tandem+cyclization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoselective synthesis of thieno[3,2-c][1,8]naphthyridin-4(5H)-ones by tandem cyclization</span></div><div class="casAuthors">Majumdar, Krishna C.; Rafique-ul-Islam</div><div class="citationInfo"><span class="NLM_cas:title">Heteroatom Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-92</span>CODEN:
                <span class="NLM_cas:coden">HETCE8</span>;
        ISSN:<span class="NLM_cas:issn">1042-7163</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A no. of the thieno[3,2-c][1,8]naphthyridin-4(5H)-ones are chemoselectively synthesized from 4-(4'-aryloxybut-2'-ynylthio)-1-phenyl-1,8-naphthyridin-2(1H)-ones in 82-90% yield by the formation of sulfoxide, followed by [2,3] and [3,3]sigmatropic rearrangement and an intramol. Michael addn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDYFbS7CgRC7Vg90H21EOLACvtfcHk0liLvMwr2iNmCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsVymtA%253D%253D&md5=63801e2719d5c5d1c75a5dd1ce1b1668</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fhc.20234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhc.20234%26sid%3Dliteratum%253Aachs%26aulast%3DMajumdar%26aufirst%3DK.%2BC.%26aulast%3DRafique-ul-Islam%26atitle%3DChemoselective%2520synthesis%2520of%2520thieno%2520%255B3%252C2-c%255D%2520%255B1%252C8%255Dnaphthyridin-4%25285H-ones%2520by%2520tandem%2520cyclization%26jtitle%3DHeteroat.%2520Chem.%26date%3D2007%26volume%3D18%26spage%3D87%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Liu, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, R. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuang, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, C.</span><span> </span><span class="NLM_article-title">Gene and doxorubicin co-delivery system for targeting therapy of glioma</span> <span class="citation_source-journal">Biomaterials</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">4907</span><span class="NLM_x">–</span> <span class="NLM_lpage">4916</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1016%2Fj.biomaterials.2012.03.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=22484049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1aht7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=4907-4916&author=S.+H.+Liuauthor=Y.+B.+Guoauthor=R.+Q.+Huangauthor=J.+F.+Liauthor=S.+X.+Huangauthor=Y.+Y.+Kuangauthor=L.+Hanauthor=C.+Jiang&title=Gene+and+doxorubicin+co-delivery+system+for+targeting+therapy+of+glioma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Gene and doxorubicin co-delivery system for targeting therapy of glioma</span></div><div class="casAuthors">Liu, Shuhuan; Guo, Yubo; Huang, Rongqin; Li, Jianfeng; Huang, Shixian; Kuang, Yuyang; Han, Liang; Jiang, Chen</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4907-4916</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The combination of gene therapy and chemotherapy is a promising treatment strategy for brain gliomas.  In this paper, we designed a co-delivery system (DGDPT/pORF-hTRAIL) loading chemotherapeutic drug doxorubicin and gene agent pORF-hTRAIL, and with functions of pH-trigger and cancer targeting.  Peptide HAIYPRH (T7), a transferrin receptor-specific peptide, was chosen as the ligand to target the co-delivery system to the tumor cells expressing transferrin receptors.  T7-modified co-delivery system showed higher efficiency in cellular uptake and gene expression than unmodified co-delivery system in U87 MG cells, and accumulated in tumor more efficiently in vivo.  DOX was covalently conjugated to carrier though pH-triggered hydrazone bond.  In vitro incubation of the conjugates in buffers led to a fast DOX release at pH 5.0 (intracellular environment) while at pH 7.4 (blood) the conjugates are relatively stable.  The combination treatment resulted in a synergistic growth inhibition (combination index, CI < 1) in U87 MG cells.  The synergism effect of DGDPT/pORF-hTRAIL was verified in vitro and in vivo.  In vivo anti-glioma efficacy study confirmed that DGDPT/pORF-hTRAIL displayed anti-glioma activity but was less toxic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVV0K9FZSitbVg90H21EOLACvtfcHk0liLvMwr2iNmCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1aht7w%253D&md5=16941e794801046db903e62779932e79</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2012.03.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2012.03.031%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DS.%2BH.%26aulast%3DGuo%26aufirst%3DY.%2BB.%26aulast%3DHuang%26aufirst%3DR.%2BQ.%26aulast%3DLi%26aufirst%3DJ.%2BF.%26aulast%3DHuang%26aufirst%3DS.%2BX.%26aulast%3DKuang%26aufirst%3DY.%2BY.%26aulast%3DHan%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DC.%26atitle%3DGene%2520and%2520doxorubicin%2520co-delivery%2520system%2520for%2520targeting%2520therapy%2520of%2520glioma%26jtitle%3DBiomaterials%26date%3D2012%26volume%3D33%26spage%3D4907%26epage%3D4916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Oh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, T.</span><span> </span><span class="NLM_article-title">Synthesis and anti-cancer activity of covalent conjugates of artemisinin and a transferrin-receptor targeting peptide</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1016%2Fj.canlet.2008.08.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=18838215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFCmsLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=2009&pages=33-39&author=S.+Ohauthor=B.+J.+Kimauthor=N.+P.+Singhauthor=H.+Laiauthor=T.+Sasaki&title=Synthesis+and+anti-cancer+activity+of+covalent+conjugates+of+artemisinin+and+a+transferrin-receptor+targeting+peptide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and anti-cancer activity of covalent conjugates of artemisinin and a transferrin-receptor targeting peptide</span></div><div class="casAuthors">Oh, Steve; Kim, Byung Ju; Singh, Narendra P.; Lai, Henry; Sasaki, Tomikazu</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-39</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Artemisinin, a natural product isolated from Artemisia annua L., shows a unique anti-cancer activity by an iron dependent mechanism.  Artemisinin was covalently conjugated to a transferrin-receptor targeting peptide, HAIYPRH that binds to a cavity on the surface of transferrin receptor.  This enables artemisinin to be co-internalized with receptor-bound transferrin.  The iron released from transferrin can activate artemisinin to generate toxic radical species to kill cells.  The artemisinin-peptide conjugates showed potent anti-cancer activity against Molt-4 leukemia cells with a significantly improved cancer/normal cells selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfTf4ms6hIp7Vg90H21EOLACvtfcHk0lgbjGyRXjbWdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFCmsLrL&md5=00d017bc7bd19a5846984c6f75fcc634</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2008.08.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2008.08.031%26sid%3Dliteratum%253Aachs%26aulast%3DOh%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DB.%2BJ.%26aulast%3DSingh%26aufirst%3DN.%2BP.%26aulast%3DLai%26aufirst%3DH.%26aulast%3DSasaki%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520anti-cancer%2520activity%2520of%2520covalent%2520conjugates%2520of%2520artemisinin%2520and%2520a%2520transferrin-receptor%2520targeting%2520peptide%26jtitle%3DCancer%2520Lett.%26date%3D2009%26volume%3D274%26spage%3D33%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Demeule, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Currie, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabathuler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaigne, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beliveau, R.</span><span> </span><span class="NLM_article-title">Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector aAngiopep-2</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">1534</span><span class="NLM_x">–</span> <span class="NLM_lpage">1544</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1111%2Fj.1471-4159.2008.05492.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=18489712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVegtL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2008&pages=1534-1544&author=M.+Demeuleauthor=J.+C.+Currieauthor=Y.+Bertrandauthor=C.+Cheauthor=T.+Nguyenauthor=A.+Reginaauthor=R.+Gabathulerauthor=J.+P.+Castaigneauthor=R.+Beliveau&title=Involvement+of+the+low-density+lipoprotein+receptor-related+protein+in+the+transcytosis+of+the+brain+delivery+vector+aAngiopep-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2</span></div><div class="casAuthors">Demeule, Michel; Currie, Jean-Christophe; Bertrand, Yanick; Che, Christian; Nguyen, Tran; Regina, Anthony; Gabathuler, Reinhard; Castaigne, Jean-Paul; Beliveau, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1534-1544</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The blood-brain barrier (BBB) restricts the entry of proteins as well as potential drugs to cerebral tissues.  We previously reported that a family of Kunitz domain-derived peptides called Angiopeps can be used as a drug delivery system for the brain.  Here, we further characterize the transcytosis ability of these peptides using an in vitro model of the BBB and in situ brain perfusion.  These peptides, and in particular Angiopep-2, exhibited higher transcytosis capacity and parenchymal accumulation than do transferrin, lactoferrin, and avidin.  Angiopep-2 transport and accumulation in brain endothelial cells were unaffected by the P-glycoprotein inhibitor, cyclosporin A, indicating that this peptide is not a substrate for the efflux pump P-glycoprotein.  However, competition studies show that activated α2-macroglobulin, a specific ligand for the low-d. lipoprotein receptor-related protein-1 (LRP1) and Angiopep-2 can share the same receptor.  In addn., LRP1 was detected in glioblastomas and brain metastases from lung and skin cancers.  Fluorescent microscopy also revealed that Alexa488-Angiopep-2 co-localized with LRP1 in brain endothelial cell monolayers.  Overall, these results suggest that Angiopep-2 transport across the BBB is, in part, mediated by LRP1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMFu69WDcG1bVg90H21EOLACvtfcHk0lgbjGyRXjbWdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVegtL3L&md5=c36a424070e833dfc60329e397065a3b</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2008.05492.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2008.05492.x%26sid%3Dliteratum%253Aachs%26aulast%3DDemeule%26aufirst%3DM.%26aulast%3DCurrie%26aufirst%3DJ.%2BC.%26aulast%3DBertrand%26aufirst%3DY.%26aulast%3DChe%26aufirst%3DC.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DRegina%26aufirst%3DA.%26aulast%3DGabathuler%26aufirst%3DR.%26aulast%3DCastaigne%26aufirst%3DJ.%2BP.%26aulast%3DBeliveau%26aufirst%3DR.%26atitle%3DInvolvement%2520of%2520the%2520low-density%2520lipoprotein%2520receptor-related%2520protein%2520in%2520the%2520transcytosis%2520of%2520the%2520brain%2520delivery%2520vector%2520aAngiopep-2%26jtitle%3DJ.%2520Neurochem.%26date%3D2008%26volume%3D106%26spage%3D1534%26epage%3D1544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Bertrand, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Currie, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demeule, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abulrob, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fatehi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanimirovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartelet, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaigne, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beliveau, R.</span><span> </span><span class="NLM_article-title">Influence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">1697</span><span class="NLM_x">–</span> <span class="NLM_lpage">1707</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1038%2Fbjc.2011.427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=22027709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFWqs7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2011&pages=1697-1707&author=Y.+Bertrandauthor=J.+C.+Currieauthor=J.+Poirierauthor=M.+Demeuleauthor=A.+Abulrobauthor=D.+Fatehiauthor=D.+Stanimirovicauthor=H.+Sarteletauthor=J.+P.+Castaigneauthor=R.+Beliveau&title=Influence+of+glioma+tumour+microenvironment+on+the+transport+of+ANG1005+via+low-density+lipoprotein+receptor-related+protein+1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1</span></div><div class="casAuthors">Bertrand, Y.; Currie, J.-C.; Poirier, J.; Demeule, M.; Abulrob, A.; Fatehi, D.; Stanimirovic, D.; Sartelet, H.; Castaigne, J.-P.; Beliveau, R.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1697-1707</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: ANG1005 consists of three mols. of paclitaxel conjugated via ester bonds to the 19-amino-acid peptide Angiopep-2.  The new chem. agent has been shown to cross the blood-brain barrier (BBB) by receptor-mediated transcytosis via low-d. lipoprotein receptor-related protein 1 (LRP1).  The expts. here examd. the role of LRP1 in the subsequent endocytosis of drug into cancer cells.  Methods: Localisation of ANG1005 and Angiopep-2 was examd. by immunohistochem. and in-vivo near-IR fluorescence imaging in mice carrying orthotopic glioma tumors.  Transport of ANG1005 and Angiopep-2 was examd. in U87 glioblastoma cell lines.  Results: Systemically administered ANG1005 and Cy5.5Angiopep-2 localized to orthotopic glioma tumors in mice.  The glioma transplants correlated with high expression levels of LRP1.  Decreasing LRP1 activity, by RNA silencing or LRP1 competitors, decreased uptake of ANG1005 and Angiopep-2 into U87 glioblastoma cells.  Conversely, LRP1 expression and endocytosis rates for ANG1005 and Angiopep-2 increased in U87 cells under conditions that mimicked the microenvironment near aggressive tumors, i.e., hypoxic and acidic conditions.  Conclusion: ANG1005 might be a particularly effective chemotherapeutic agent for the wide array of known LRP1-expressing brain and non-brain cancers, in particular those with an aggressive phenotype.  British Journal of Cancer (2011) 105, 1697-1707; doi:10.1038/bjc.2011.427; published online 25 Oct. 2011; www.bjcancer.com.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGm0tJMDHmObVg90H21EOLACvtfcHk0lgbjGyRXjbWdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFWqs7fN&md5=4c4fe96279d122af99a53d0f72f71c30</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2011.427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2011.427%26sid%3Dliteratum%253Aachs%26aulast%3DBertrand%26aufirst%3DY.%26aulast%3DCurrie%26aufirst%3DJ.%2BC.%26aulast%3DPoirier%26aufirst%3DJ.%26aulast%3DDemeule%26aufirst%3DM.%26aulast%3DAbulrob%26aufirst%3DA.%26aulast%3DFatehi%26aufirst%3DD.%26aulast%3DStanimirovic%26aufirst%3DD.%26aulast%3DSartelet%26aufirst%3DH.%26aulast%3DCastaigne%26aufirst%3DJ.%2BP.%26aulast%3DBeliveau%26aufirst%3DR.%26atitle%3DInfluence%2520of%2520glioma%2520tumour%2520microenvironment%2520on%2520the%2520transport%2520of%2520ANG1005%2520via%2520low-density%2520lipoprotein%2520receptor-related%2520protein%25201%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2011%26volume%3D105%26spage%3D1697%26epage%3D1707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Kostikov, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orchowski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirrmacher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niedermoser, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurkschat, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iovkova-Berends, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wängler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wängler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirrmacher, R.</span><span> </span><span class="NLM_article-title">Synthesis of [F-18]SiFB: a prosthetic group for direct protein radiolabeling for application in positron emission tomography</span> <span class="citation_source-journal">Nat. Protoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1956</span><span class="NLM_x">–</span> <span class="NLM_lpage">1963</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1956-1963&author=A.+P.+Kostikovauthor=J.+S.+Chinauthor=K.+Orchowskiauthor=E.+Schirrmacherauthor=S.+Niedermoserauthor=K.+Jurkschatauthor=L.+Iovkova-Berendsauthor=C.+W%C3%A4nglerauthor=B.+W%C3%A4nglerauthor=R.+Schirrmacher&title=Synthesis+of+%5BF-18%5DSiFB%3A+a+prosthetic+group+for+direct+protein+radiolabeling+for+application+in+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKostikov%26aufirst%3DA.%2BP.%26aulast%3DChin%26aufirst%3DJ.%2BS.%26aulast%3DOrchowski%26aufirst%3DK.%26aulast%3DSchirrmacher%26aufirst%3DE.%26aulast%3DNiedermoser%26aufirst%3DS.%26aulast%3DJurkschat%26aufirst%3DK.%26aulast%3DIovkova-Berends%26aufirst%3DL.%26aulast%3DW%25C3%25A4ngler%26aufirst%3DC.%26aulast%3DW%25C3%25A4ngler%26aufirst%3DB.%26aulast%3DSchirrmacher%26aufirst%3DR.%26atitle%3DSynthesis%2520of%2520%255BF-18%255DSiFB%253A%2520a%2520prosthetic%2520group%2520for%2520direct%2520protein%2520radiolabeling%2520for%2520application%2520in%2520positron%2520emission%2520tomography%26jtitle%3DNat.%2520Protoc.%26date%3D2012%26volume%3D7%26spage%3D1956%26epage%3D1963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Wängler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostikov, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niedermoser, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orchowski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirrmacher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iovkova-Berends, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurkschat, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wängler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirrmacher, R.</span><span> </span><span class="NLM_article-title">Protein labeling with the labeling precursor [F-18]SiFA-SH for positron emission tomography</span> <span class="citation_source-journal">Nat. Protoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1964</span><span class="NLM_x">–</span> <span class="NLM_lpage">1969</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1964-1969&author=B.+W%C3%A4nglerauthor=A.+P.+Kostikovauthor=S.+Niedermoserauthor=J.+S.+Chinauthor=K.+Orchowskiauthor=E.+Schirrmacherauthor=L.+Iovkova-Berendsauthor=K.+Jurkschatauthor=C.+W%C3%A4nglerauthor=R.+Schirrmacher&title=Protein+labeling+with+the+labeling+precursor+%5BF-18%5DSiFA-SH+for+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DW%25C3%25A4ngler%26aufirst%3DB.%26aulast%3DKostikov%26aufirst%3DA.%2BP.%26aulast%3DNiedermoser%26aufirst%3DS.%26aulast%3DChin%26aufirst%3DJ.%2BS.%26aulast%3DOrchowski%26aufirst%3DK.%26aulast%3DSchirrmacher%26aufirst%3DE.%26aulast%3DIovkova-Berends%26aufirst%3DL.%26aulast%3DJurkschat%26aufirst%3DK.%26aulast%3DW%25C3%25A4ngler%26aufirst%3DC.%26aulast%3DSchirrmacher%26aufirst%3DR.%26atitle%3DProtein%2520labeling%2520with%2520the%2520labeling%2520precursor%2520%255BF-18%255DSiFA-SH%2520for%2520positron%2520emission%2520tomography%26jtitle%3DNat.%2520Protoc.%26date%3D2012%26volume%3D7%26spage%3D1964%26epage%3D1969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Wängler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niedermoser, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orchowski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirrmacher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurkschat, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iovkova-Berends, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostikov, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirrmacher, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wängler, B.</span><span> </span><span class="NLM_article-title">One-step F-18-labeling of peptides for positron emission tomography imaging using the SiFA methodology</span> <span class="citation_source-journal">Nat. Protoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1946</span><span class="NLM_x">–</span> <span class="NLM_lpage">1955</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1946-1955&author=C.+W%C3%A4nglerauthor=S.+Niedermoserauthor=J.+S.+Chinauthor=K.+Orchowskiauthor=E.+Schirrmacherauthor=K.+Jurkschatauthor=L.+Iovkova-Berendsauthor=A.+P.+Kostikovauthor=R.+Schirrmacherauthor=B.+W%C3%A4ngler&title=One-step+F-18-labeling+of+peptides+for+positron+emission+tomography+imaging+using+the+SiFA+methodology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DW%25C3%25A4ngler%26aufirst%3DC.%26aulast%3DNiedermoser%26aufirst%3DS.%26aulast%3DChin%26aufirst%3DJ.%2BS.%26aulast%3DOrchowski%26aufirst%3DK.%26aulast%3DSchirrmacher%26aufirst%3DE.%26aulast%3DJurkschat%26aufirst%3DK.%26aulast%3DIovkova-Berends%26aufirst%3DL.%26aulast%3DKostikov%26aufirst%3DA.%2BP.%26aulast%3DSchirrmacher%26aufirst%3DR.%26aulast%3DW%25C3%25A4ngler%26aufirst%3DB.%26atitle%3DOne-step%2520F-18-labeling%2520of%2520peptides%2520for%2520positron%2520emission%2520tomography%2520imaging%2520using%2520the%2520SiFA%2520methodology%26jtitle%3DNat.%2520Protoc.%26date%3D2012%26volume%3D7%26spage%3D1946%26epage%3D1955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Wetzl, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarmoluk, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craig, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfbeis, O. S.</span><span> </span><span class="NLM_article-title">Chameleon labels for staining and quantifying proteins</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">5400</span><span class="NLM_x">–</span> <span class="NLM_lpage">5402</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1002%2Fanie.200460508" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptValu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=5400-5402&author=B.+K.+Wetzlauthor=S.+M.+Yarmolukauthor=D.+B.+Craigauthor=O.+S.+Wolfbeis&title=Chameleon+labels+for+staining+and+quantifying+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Chameleon labels for staining and quantifying proteins</span></div><div class="casAuthors">Wetzl, Bianca K.; Yarmoluk, Sergiy M.; Craig, Douglas B.; Wolfbeis, Otto S.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">5400-5402</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Glowing marks: A new class of protein stains, the pyrylium dyes, undergo a strong color change (typically from blue to red) on covalently binding to proteins.  While the free stains are almost nonfluorescent, the protein-conjugated forms are highly fluorescent.  The dyes do not alter the charge of a protein, and thus do not change its electrophoretic properties.  The stains also can be used in quant. protein assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYw-9981yr5rVg90H21EOLACvtfcHk0ljlOLpwPan3gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptValu74%253D&md5=b63ed2a572d46b54d72fa9e667de80ac</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1002%2Fanie.200460508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200460508%26sid%3Dliteratum%253Aachs%26aulast%3DWetzl%26aufirst%3DB.%2BK.%26aulast%3DYarmoluk%26aufirst%3DS.%2BM.%26aulast%3DCraig%26aufirst%3DD.%2BB.%26aulast%3DWolfbeis%26aufirst%3DO.%2BS.%26atitle%3DChameleon%2520labels%2520for%2520staining%2520and%2520quantifying%2520proteins%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2004%26volume%3D43%26spage%3D5400%26epage%3D5402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Iovkova, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wängler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirrmacher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirrmacher, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quandt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boening, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schurmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurkschat, K.</span><span> </span><span class="NLM_article-title">Para-functionalized aryl-di-tert-butylfluorosilanes as potential labeling synthons for F-18 radiopharmaceuticals</span> <span class="citation_source-journal">Chem.—Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2140</span><span class="NLM_x">–</span> <span class="NLM_lpage">2147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1002%2Fchem.200802266" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=19156812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisVagurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=2140-2147&author=L.+Iovkovaauthor=B.+W%C3%A4nglerauthor=E.+Schirrmacherauthor=R.+Schirrmacherauthor=G.+Quandtauthor=G.+Boeningauthor=M.+Schurmannauthor=K.+Jurkschat&title=Para-functionalized+aryl-di-tert-butylfluorosilanes+as+potential+labeling+synthons+for+F-18+radiopharmaceuticals"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">para-functionalized aryl-di-tert-butylfluorosilanes as potential labeling synthons for 18F radiopharmaceuticals</span></div><div class="casAuthors">Iovkova, Ljuba; Waengler, Bjoern; Schirrmacher, Esther; Schirrmacher, Ralf; Quandt, Gabriele; Boening, Buido; Schuermann, Markus; Jurkschat, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry--A European Journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2140-2147</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The syntheses of the functionalized triorganofluorosilanes tBu2-(p-XC6H4)SiF (3a, X = SH; 4a, X = NCS; 4b, X = NCO; 5, X = NC4H2O2; 7, X = COOH; 8a, X = COONC4H4O2; 8b, X = COOC6F5) are reported.  These compds. display potential as silicon-based fluoride acceptors (SiFAs).  The mol. structures of compds. 5, 7, and 8a have been detd. by single-crystal X-ray diffraction studies.  With the exception of compds. 8a and 8b, all of the compds. could be 18F-labeled by isotopic exchange in good to high radiochem. yields (RCY) with good to excellent specific activities.  As proof of applicability, the maleimido-functionalized SiFA deriv. 5, which is specific for thiol groups, has been used for the labeling of rat serum albumin (RSA) that had been derivatized with 2-iminothiolane.  The incorporation of [18F]5 into the derivatized RSA reached a max. yield after 30 min at ambient temp.  After purifn., the [18F]RSA was evaluated in a healthy rat by means of μPET and displayed an expedient in vivo stability over 180 min.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_35-B6hKV3rVg90H21EOLACvtfcHk0li8PfniuAM2eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisVagurc%253D&md5=f365f79d276db6b12d2ff7228f91089e</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1002%2Fchem.200802266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.200802266%26sid%3Dliteratum%253Aachs%26aulast%3DIovkova%26aufirst%3DL.%26aulast%3DW%25C3%25A4ngler%26aufirst%3DB.%26aulast%3DSchirrmacher%26aufirst%3DE.%26aulast%3DSchirrmacher%26aufirst%3DR.%26aulast%3DQuandt%26aufirst%3DG.%26aulast%3DBoening%26aufirst%3DG.%26aulast%3DSchurmann%26aufirst%3DM.%26aulast%3DJurkschat%26aufirst%3DK.%26atitle%3DPara-functionalized%2520aryl-di-tert-butylfluorosilanes%2520as%2520potential%2520labeling%2520synthons%2520for%2520F-18%2520radiopharmaceuticals%26jtitle%3DChem.%25E2%2580%2594Eur.%2520J.%26date%3D2009%26volume%3D15%26spage%3D2140%26epage%3D2147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Wängler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nada, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofner, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maschauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wängler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirrmacher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanner, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirrmacher, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prante, O.</span><span> </span><span class="NLM_article-title">In vitro and initial in vivo evaluation of <sup>68</sup>Ga-labeled transferrin receptor (TfR) binding peptides as potential carriers for enhanced drug transport into TfR expressing cells</span> <span class="citation_source-journal">Mol. Imaging Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">332</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1007%2Fs11307-010-0329-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=20473573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A280%3ADC%252BC3M3kvVOluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=332-341&author=C.+W%C3%A4nglerauthor=D.+Nadaauthor=G.+Hofnerauthor=S.+Maschauerauthor=B.+W%C3%A4nglerauthor=S.+Schneiderauthor=E.+Schirrmacherauthor=K.+T.+Wannerauthor=R.+Schirrmacherauthor=O.+Prante&title=In+vitro+and+initial+in+vivo+evaluation+of+68Ga-labeled+transferrin+receptor+%28TfR%29+binding+peptides+as+potential+carriers+for+enhanced+drug+transport+into+TfR+expressing+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and initial in vivo evaluation of (68)Ga-labeled transferrin receptor (TfR) binding peptides as potential carriers for enhanced drug transport into TfR expressing cells</span></div><div class="casAuthors">Wangler Carmen; Nada Dina; Hofner Georg; Maschauer Simone; Wangler Bjorn; Schneider Stephan; Schirrmacher Esther; Wanner Klaus T; Schirrmacher Ralf; Prante Olaf</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">332-41</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  The transferrin receptor (TfR) is one of the most attractive targets to overcome the blood-brain barrier (BBB).  It has recently been shown that THRPPMWSPVWP binds to the TfR and is subsequently internalized into TfR-expressing cells.  Here, we evaluated the ability of THRPPMWSPVWP to become internalized into human TfR-expressing cells via endocytosis to determine its potential to act as a carrier system for the transport of small molecules across the BBB.  PROCEDURES:  To validate the underlying concept of a conjugate consisting of a small brain imaging tracer and a large peptidic carrier molecule, a conjugate of the high affinity D2 receptor ligand fallypride and the TfR targeting peptide THRPPMWSPVWP has been synthesized.  Furthermore, two derivatives of THRPPMWSPVWP were labeled with (68)Ga in high radiochemical yields (>96%) and a radiochemical purity of 96-98% and evaluated in vitro and in vivo.  RESULTS:  The fallypride-THRPPMWSPVWP conjugate still displayed a K(i) of 27 nM.  The uptake of the (68)Ga-labeled peptides into TfR-bearing cells was investigated using U87MG and HT-29 cells to assess the capability of the peptide to act as a carrier molecule targeting the TfR.  The in vitro binding studies revealed negligible uptake of the tested (68)Ga-labeled conjugates ranging from 0.08% to 0.66% after 60 min incubation at 37°C.  Initial in vivo experiments with (68)Ga-DOTA-S-maleimido-THRPPMWSPVWP in two healthy rats showed a mean brain uptake of 0.037% injected dose per gram, confirming the results obtained in vitro.  CONCLUSION:  These results suggest that the accumulation of the (68)Ga-radiolabeled conjugates of the TfR-binding peptide THRPPMWSPVWP into TFR expressing human cell lines is nonspecific and too low to render this peptide suitable as a possible carrier molecule for a receptor-mediated transport of compounds across the BBB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTah1I4FHsD8QaK-_ZudimnfW6udTcc2eZc5RvWqbvtorntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3kvVOluw%253D%253D&md5=52179bbb2a3c067dd354581366aff8f8</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1007%2Fs11307-010-0329-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-010-0329-6%26sid%3Dliteratum%253Aachs%26aulast%3DW%25C3%25A4ngler%26aufirst%3DC.%26aulast%3DNada%26aufirst%3DD.%26aulast%3DHofner%26aufirst%3DG.%26aulast%3DMaschauer%26aufirst%3DS.%26aulast%3DW%25C3%25A4ngler%26aufirst%3DB.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DSchirrmacher%26aufirst%3DE.%26aulast%3DWanner%26aufirst%3DK.%2BT.%26aulast%3DSchirrmacher%26aufirst%3DR.%26aulast%3DPrante%26aufirst%3DO.%26atitle%3DIn%2520vitro%2520and%2520initial%2520in%2520vivo%2520evaluation%2520of%252068Ga-labeled%2520transferrin%2520receptor%2520%2528TfR%2529%2520binding%2520peptides%2520as%2520potential%2520carriers%2520for%2520enhanced%2520drug%2520transport%2520into%2520TfR%2520expressing%2520cells%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2011%26volume%3D13%26spage%3D332%26epage%3D341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Schirrmacher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wängler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cypryk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradtmoller, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schäfer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurkschat, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirrmacher, R.</span><span> </span><span class="NLM_article-title">Synthesis of p-(di-tert-butyl[(18)f]fluorosilyl)benzaldehyde ([F-18]SiFA-A) with high specific activity by isotopic exchange: A convenient labeling synthon for the F-18-labeling of n-amino-oxy derivatized peptides</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2085</span><span class="NLM_x">–</span> <span class="NLM_lpage">2089</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc700195y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlKlurjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=2085-2089&author=E.+Schirrmacherauthor=B.+W%C3%A4nglerauthor=M.+Cyprykauthor=G.+Bradtmollerauthor=M.+Sch%C3%A4ferauthor=M.+Eisenhutauthor=K.+Jurkschatauthor=R.+Schirrmacher&title=Synthesis+of+p-%28di-tert-butyl%5B%2818%29f%5Dfluorosilyl%29benzaldehyde+%28%5BF-18%5DSiFA-A%29+with+high+specific+activity+by+isotopic+exchange%3A+A+convenient+labeling+synthon+for+the+F-18-labeling+of+n-amino-oxy+derivatized+peptides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of p-(Di-tert-butyl[18F]fluorosilyl)benzaldehyde ([18F]SiFA-A) with High Specific Activity by Isotopic Exchange: A Convenient Labeling Synthon for the 18F-Labeling of N-amino-oxy Derivatized Peptides</span></div><div class="casAuthors">Schirrmacher, Esther; Waengler, Bjoern; Cypryk, Marek; Bradtmoeller, Gerrit; Schaefer, Martin; Eisenhut, Michael; Jurkschat, Klaus; Schirrmacher, Ralf</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2085-2089</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The syntheses of different 18F-labeled peptides using the highly effective labeling synthon p-(di-tert-butylfluorosilyl)benzaldehyde ([18F]SiFA-A) for the development of 18F-radiopharmaceuticals for oncol. positron emission tomog. (PET) is reported.  The novel and mild labeling technique for the radiosynthesis of [18F]SiFA-A, based on an unexpectedly efficient isotopic 19F-18F exchange, yielded the 18F-synthon [18F]SiFA-A in almost quant. yields in high specific activities between 225 and 680 GBq/μmol (6081-18 378 Ci/mmol) without applying HPLC purifn.  The [18F]SiFA-A was finally used to label the N-terminal aminooxy (N-AO) derivatized peptides, AO-Tyr3-octreotate (AO-TATE), cyclo[fK(AO-N)]RGD and N-AO-PEG2-[D-Tyr-Gln-Trp-Ala-Val-βAla-His-Thi-Nle-NH2] (AO-BZH3, a bombesin deriv.) in high radiochem. yields.  D. functional theory (DFT) calcns. confirmed high efficiency of the isotopic exchange, which is predicted to proceed via a pentacoordinate siliconate intermediate dissocg. immediately to form the radiolabeled [18F]SiFA-A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgKANh1J7eRLVg90H21EOLACvtfcHk0lijEPtdW-loXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlKlurjK&md5=af8605837df40861aac17c9901afd6d2</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fbc700195y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc700195y%26sid%3Dliteratum%253Aachs%26aulast%3DSchirrmacher%26aufirst%3DE.%26aulast%3DW%25C3%25A4ngler%26aufirst%3DB.%26aulast%3DCypryk%26aufirst%3DM.%26aulast%3DBradtmoller%26aufirst%3DG.%26aulast%3DSch%25C3%25A4fer%26aufirst%3DM.%26aulast%3DEisenhut%26aufirst%3DM.%26aulast%3DJurkschat%26aufirst%3DK.%26aulast%3DSchirrmacher%26aufirst%3DR.%26atitle%3DSynthesis%2520of%2520p-%2528di-tert-butyl%255B%252818%2529f%255Dfluorosilyl%2529benzaldehyde%2520%2528%255BF-18%255DSiFA-A%2529%2520with%2520high%2520specific%2520activity%2520by%2520isotopic%2520exchange%253A%2520A%2520convenient%2520labeling%2520synthon%2520for%2520the%2520F-18-labeling%2520of%2520n-amino-oxy%2520derivatized%2520peptides%26jtitle%3DBioconjugate%2520Chem.%26date%3D2007%26volume%3D18%26spage%3D2085%26epage%3D2089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Wängler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waser, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iovkova, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niedermoser, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurkschat, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fottner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenstein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirrmacher, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reubi, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wester, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wängler, B.</span><span> </span><span class="NLM_article-title">One-step (18)F-labeling of carbohydrate-conjugated octreotate-derivatives containing a silicon-fluoride-acceptor (SiFA): in vitro and in vivo evaluation as tumor imaging agents for positron emission tomography (PET)</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2289</span><span class="NLM_x">–</span> <span class="NLM_lpage">2296</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc100316c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A280%3ADC%252BC3Mrks1Wkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=2289-2296&author=C.+W%C3%A4nglerauthor=B.+Waserauthor=A.+Alkeauthor=L.+Iovkovaauthor=H.+G.+Buchholzauthor=S.+Niedermoserauthor=K.+Jurkschatauthor=C.+Fottnerauthor=P.+Bartensteinauthor=R.+Schirrmacherauthor=J.+C.+Reubiauthor=H.+J.+Westerauthor=B.+W%C3%A4ngler&title=One-step+%2818%29F-labeling+of+carbohydrate-conjugated+octreotate-derivatives+containing+a+silicon-fluoride-acceptor+%28SiFA%29%3A+in+vitro+and+in+vivo+evaluation+as+tumor+imaging+agents+for+positron+emission+tomography+%28PET%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">One-step 18F-labeling of carbohydrate-conjugated octreotate-derivatives containing a silicon-fluoride-acceptor (SiFA): in vitro and in vivo evaluation as tumor imaging agents for positron emission tomography (PET)</span></div><div class="casAuthors">Wangler Carmen; Waser Beatrice; Alke Andrea; Iovkova Ljuba; Buchholz Hans-Georg; Niedermoser Sabrina; Jurkschat Klaus; Fottner Christian; Bartenstein Peter; Schirrmacher Ralf; Reubi Jean-Claude; Wester Hans-Jurgen; Wangler Bjorn</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2289-96</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The synthesis, radiolabeling, and initial evaluation of new silicon-fluoride acceptor (SiFA) derivatized octreotate derivatives is reported.  So far, the main drawback of the SiFA technology for the synthesis of PET-radiotracers is the high lipophilicity of the resulting radiopharmaceutical.  Consequently, we synthesized new SiFA-octreotate analogues derivatized with Fmoc-NH-PEG-COOH, Fmoc-Asn(Ac3AcNH-β-Glc)-OH, and SiFA-aldehyde (SIFA-A).  The substances could be labeled in high yields (38 ± 4%) and specific activities between 29 and 56 GBq/μmol in short synthesis times of less than 30 min (e.o.b.).  The in vitro evaluation of the synthesized conjugates displayed a sst2 receptor affinity (IC50 = 3.3 ± 0.3 nM) comparable to that of somatostatin-28.  As a measure of lipophilicity of the conjugates, the log P(ow) was determined and found to be 0.96 for SiFA-Asn(AcNH-β-Glc)-PEG-Tyr3-octreotate and 1.23 for SiFA-Asn(AcNH-β-Glc)-Tyr3-octreotate, which is considerably lower than for SiFA-Tyr3-octreotate (log P(ow) = 1.59).  The initial in vivo evaluation of [18F]SiFA-Asn(AcNH-β-Glc)-PEG-Tyr3-octreotate revealed a significant uptake of radiotracer in the tumor tissue of AR42J tumor-bearing nude mice of 7.7% ID/g tissue weight.  These results show that the high lipophilicity of the SiFA moiety can be compensated by applying hydrophilic moieties.  Using this approach, a tumor-affine SiFA-containing peptide could successfully be used for receptor imaging for the first time in this proof of concept study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQkefLj0Mu3yEEksK8CslK8fW6udTcc2eaqF7CREdcJvrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mrks1Wkug%253D%253D&md5=c46ecf760ee9bc5092ebb480097e3b64</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fbc100316c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc100316c%26sid%3Dliteratum%253Aachs%26aulast%3DW%25C3%25A4ngler%26aufirst%3DC.%26aulast%3DWaser%26aufirst%3DB.%26aulast%3DAlke%26aufirst%3DA.%26aulast%3DIovkova%26aufirst%3DL.%26aulast%3DBuchholz%26aufirst%3DH.%2BG.%26aulast%3DNiedermoser%26aufirst%3DS.%26aulast%3DJurkschat%26aufirst%3DK.%26aulast%3DFottner%26aufirst%3DC.%26aulast%3DBartenstein%26aufirst%3DP.%26aulast%3DSchirrmacher%26aufirst%3DR.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DWester%26aufirst%3DH.%2BJ.%26aulast%3DW%25C3%25A4ngler%26aufirst%3DB.%26atitle%3DOne-step%2520%252818%2529F-labeling%2520of%2520carbohydrate-conjugated%2520octreotate-derivatives%2520containing%2520a%2520silicon-fluoride-acceptor%2520%2528SiFA%2529%253A%2520in%2520vitro%2520and%2520in%2520vivo%2520evaluation%2520as%2520tumor%2520imaging%2520agents%2520for%2520positron%2520emission%2520tomography%2520%2528PET%2529%26jtitle%3DBioconjugate%2520Chem.%26date%3D2010%26volume%3D21%26spage%3D2289%26epage%3D2296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Wessmann, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henriksen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wester, H. J.</span><span> </span><span class="NLM_article-title">Cryptate mediated nucleophilic F-18-fluorination without azeotropic drying</span> <span class="citation_source-journal">Nuklearmedizin</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=21989864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtlGlsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=1-8&author=S.+H.+Wessmannauthor=G.+Henriksenauthor=H.+J.+Wester&title=Cryptate+mediated+nucleophilic+F-18-fluorination+without+azeotropic+drying"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Cryptate mediated nucleophilic 18F-fluorination without azeotropic drying</span></div><div class="casAuthors">Wessmann, S. H.; Henriksen, G.; Wester, H.-J.</div><div class="citationInfo"><span class="NLM_cas:title">Nuklearmedizin</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">NMIMAX</span>;
        ISSN:<span class="NLM_cas:issn">0029-5566</span>.
    
            (<span class="NLM_cas:orgname">Schattauer GmbH</span>)
        </div><div class="casAbstract">The radiosynthesis of the vast majority of 18F-labeled tracers rely on azeotropic drying of [18F]fluoride and subsequent cryptate mediated introduction of [18F]fluoride by nucleophilic substitution.  The aim of this study was to develop a method for simplification of this process, based on prepn. of reactive [K+⊂2.2.2]18F- by solvent drying of [18F]fluoride adsorbed onto an anion exchange resin.  Methods: Aq. [18F]fluoride (0.5-1 mL) obtained from the 18O(p,n)18F nuclear reaction was trapped on a strong anion-exchange (SAX) cartridge.  After washing the cartridge with dry CH3CN, [18F]fluoride was eluted with an anhyd. soln. of [K+⊂2.2.2]OH- in CH3CN and directly used for nucleophilic fluorination reactions.  Results: [18F]Fluoride from target water was quant. retained by the SAX cartridge, and water-free [18F]-fluoride recovered in an overall yield of 92±5% (n = 10).  [18F]Fluoride obtained by this procedure led to radiochem. yields of 70-90% for [18F]FDG, [18F]FET, [18F]FLT, [18F]FAZA and [18F]Fallypride.  Conclusion: SAX-resin adsorbed [18F]fluoride can be dried with non-aq. solvents and eluted with [K+⊂2.2.2]OH- in CH3CN.  The reactivity of [K+⊂2.2.2]F- generated by the new method is comparable to that of [18F]fluoride obtained by azeotropic drying.  The described procedure facilitates the automated prodn. of 18F-radiopharmaceuticals in general, and may also simplify the use of microfluidic devices for 18F-radiotracer prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyM-RAbJbK-7Vg90H21EOLACvtfcHk0lijEPtdW-loXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtlGlsr0%253D&md5=7ef98d9c8b0d077f9ece3daaa4e5b6c6</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWessmann%26aufirst%3DS.%2BH.%26aulast%3DHenriksen%26aufirst%3DG.%26aulast%3DWester%26aufirst%3DH.%2BJ.%26atitle%3DCryptate%2520mediated%2520nucleophilic%2520F-18-fluorination%2520without%2520azeotropic%2520drying%26jtitle%3DNuklearmedizin%26date%3D2012%26volume%3D51%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Niessen, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Höfner, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanner, K. T.</span><span> </span><span class="NLM_article-title">Competitive MS binding assays for dopamine D-2 receptors employing spiperone as a native marker</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1769</span><span class="NLM_x">–</span> <span class="NLM_lpage">1775</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=1769-1775&author=K.+V.+Niessenauthor=G.+H%C3%B6fnerauthor=K.+T.+Wanner&title=Competitive+MS+binding+assays+for+dopamine+D-2+receptors+employing+spiperone+as+a+native+marker"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNiessen%26aufirst%3DK.%2BV.%26aulast%3DH%25C3%25B6fner%26aufirst%3DG.%26aulast%3DWanner%26aufirst%3DK.%2BT.%26atitle%3DCompetitive%2520MS%2520binding%2520assays%2520for%2520dopamine%2520D-2%2520receptors%2520employing%2520spiperone%2520as%2520a%2520native%2520marker%26jtitle%3DChemBioChem%26date%3D2005%26volume%3D6%26spage%3D1769%26epage%3D1775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Bubik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahringer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fricker, G.</span><span> </span><span class="NLM_article-title">Rapid assessment of p-glycoprotein-drug interactions at the blood-brain barrier</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2006&pages=51-58&author=M.+Bubikauthor=M.+Ottauthor=A.+Mahringerauthor=G.+Fricker&title=Rapid+assessment+of+p-glycoprotein-drug+interactions+at+the+blood-brain+barrier"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBubik%26aufirst%3DM.%26aulast%3DOtt%26aufirst%3DM.%26aulast%3DMahringer%26aufirst%3DA.%26aulast%3DFricker%26aufirst%3DG.%26atitle%3DRapid%2520assessment%2520of%2520p-glycoprotein-drug%2520interactions%2520at%2520the%2520blood-brain%2520barrier%26jtitle%3DAnal.%2520Biochem.%26date%3D2006%26volume%3D358%26spage%3D51%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Bauer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fricker, G.</span><span> </span><span class="NLM_article-title">Compound profiling for p-glycoprotein at the blood–brain barrier using a microplate screening system</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1170</span><span class="NLM_x">–</span> <span class="NLM_lpage">1176</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2003&pages=1170-1176&author=B.+Bauerauthor=D.+S.+Millerauthor=G.+Fricker&title=Compound+profiling+for+p-glycoprotein+at+the+blood%E2%80%93brain+barrier+using+a+microplate+screening+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBauer%26aufirst%3DB.%26aulast%3DMiller%26aufirst%3DD.%2BS.%26aulast%3DFricker%26aufirst%3DG.%26atitle%3DCompound%2520profiling%2520for%2520p-glycoprotein%2520at%2520the%2520blood%25E2%2580%2593brain%2520barrier%2520using%2520a%2520microplate%2520screening%2520system%26jtitle%3DPharm.%2520Res.%26date%3D2003%26volume%3D20%26spage%3D1170%26epage%3D1176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Weksler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couraud, P. O.</span><span> </span><span class="NLM_article-title">The hCMEC/D3 cell line as a model of the human blood brain barrier</span> <span class="citation_source-journal">Fluids Barriers CNS</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm5004123&amp;key=10.1186%2F2045-8118-10-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm5004123&amp;key=23531482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm5004123&amp;key=1%3ACAS%3A280%3ADC%252BC3svpvVGitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=16&author=B.+Wekslerauthor=I.+A.+Romeroauthor=P.+O.+Couraud&title=The+hCMEC%2FD3+cell+line+as+a+model+of+the+human+blood+brain+barrier"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">The hCMEC/D3 cell line as a model of the human blood brain barrier</span></div><div class="casAuthors">Weksler Babette; Romero Ignacio A; Couraud Pierre-Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Fluids and barriers of the CNS</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16</span>
        ISSN:<span class="NLM_cas:issn">2045-8118</span>.
    </div><div class="casAbstract">Since the first attempts in the 1970s to isolate cerebral microvessel endothelial cells (CECs) in order to model the blood-brain barrier (BBB) in vitro, the need for a human BBB model that closely mimics the in vivo phenotype and is reproducible and easy to grow, has been widely recognized by cerebrovascular researchers in both academia and industry.  While primary human CECs would ideally be the model of choice, the paucity of available fresh human cerebral tissue makes wide-scale studies impractical.  The brain microvascular endothelial cell line hCMEC/D3 represents one such model of the human BBB that can be easily grown and is amenable to cellular and molecular studies on pathological and drug transport mechanisms with relevance to the central nervous system (CNS).  Indeed, since the development of this cell line in 2005 over 100 studies on different aspects of cerebral endothelial biology and pharmacology have been published.  Here we review the suitability of this cell line as a human BBB model for pathogenic and drug transport studies and we critically consider its advantages and limitations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQqZ5q_j0vv4Q8IxFYvehhofW6udTcc2eaX27pktGJO8rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3svpvVGitA%253D%253D&md5=66d3b2eaa9efb7cb0fb86bf740a941e6</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1186%2F2045-8118-10-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2045-8118-10-16%26sid%3Dliteratum%253Aachs%26aulast%3DWeksler%26aufirst%3DB.%26aulast%3DRomero%26aufirst%3DI.%2BA.%26aulast%3DCouraud%26aufirst%3DP.%2BO.%26atitle%3DThe%2520hCMEC%252FD3%2520cell%2520line%2520as%2520a%2520model%2520of%2520the%2520human%2520blood%2520brain%2520barrier%26jtitle%3DFluids%2520Barriers%2520CNS%26date%3D2013%26volume%3D10%26spage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Höfelschweiger, B.</span><span> </span><span class="NLM_article-title">The Pyrylium Dyes: A New Class of Biolabels. Synthesis, Spectroscopy, and Application as Labels and in General Protein Assay</span>, Ph.D. Thesis, <span class="NLM_publisher-name">University Regensburg</span>, <span class="NLM_publisher-loc">Regensburg, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=B.+H%C3%B6felschweiger&title=The+Pyrylium+Dyes%3A+A+New+Class+of+Biolabels.+Synthesis%2C+Spectroscopy%2C+and+Application+as+Labels+and+in+General+Protein+Assay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25B6felschweiger%26aufirst%3DB.%26atitle%3DThe%2520Pyrylium%2520Dyes%253A%2520A%2520New%2520Class%2520of%2520Biolabels.%2520Synthesis%252C%2520Spectroscopy%252C%2520and%2520Application%2520as%2520Labels%2520and%2520in%2520General%2520Protein%2520Assay%26pub%3DUniversity%2520Regensburg%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Wellings, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atherton, E.</span><span> </span><span class="NLM_article-title">Standard Fmoc protocols</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">44</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=1997&pages=44-67&author=D.+A.+Wellingsauthor=E.+Atherton&title=Standard+Fmoc+protocols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWellings%26aufirst%3DD.%2BA.%26aulast%3DAtherton%26aufirst%3DE.%26atitle%3DStandard%2520Fmoc%2520protocols%26jtitle%3DMethods%2520Enzymol.%26date%3D1997%26volume%3D289%26spage%3D44%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Iovkova-Berends, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wangler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofner, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanner, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rensch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenstein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostikov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirrmacher, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurkschat, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wangler, B.</span><span> </span><span class="NLM_article-title">t-Bu(2)SiF-derivatized D(2)-receptor ligands: the first SiFA-containing small molecule radiotracers for target-specific PET-imaging</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">7458</span><span class="NLM_x">–</span> <span class="NLM_lpage">7479</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=7458-7479&author=L.+Iovkova-Berendsauthor=C.+Wanglerauthor=T.+Zollerauthor=G.+Hofnerauthor=K.+T.+Wannerauthor=C.+Renschauthor=P.+Bartensteinauthor=A.+Kostikovauthor=R.+Schirrmacherauthor=K.+Jurkschatauthor=B.+Wangler&title=t-Bu%282%29SiF-derivatized+D%282%29-receptor+ligands%3A+the+first+SiFA-containing+small+molecule+radiotracers+for+target-specific+PET-imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIovkova-Berends%26aufirst%3DL.%26aulast%3DWangler%26aufirst%3DC.%26aulast%3DZoller%26aufirst%3DT.%26aulast%3DHofner%26aufirst%3DG.%26aulast%3DWanner%26aufirst%3DK.%2BT.%26aulast%3DRensch%26aufirst%3DC.%26aulast%3DBartenstein%26aufirst%3DP.%26aulast%3DKostikov%26aufirst%3DA.%26aulast%3DSchirrmacher%26aufirst%3DR.%26aulast%3DJurkschat%26aufirst%3DK.%26aulast%3DWangler%26aufirst%3DB.%26atitle%3Dt-Bu%25282%2529SiF-derivatized%2520D%25282%2529-receptor%2520ligands%253A%2520the%2520first%2520SiFA-containing%2520small%2520molecule%2520radiotracers%2520for%2520target-specific%2520PET-imaging%26jtitle%3DMolecules%26date%3D2011%26volume%3D16%26spage%3D7458%26epage%3D7479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBL" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBL','PDB','3PBL'); return false;">PDB: 3PBL</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i35"><a href="/doi/suppl/10.1021/jm5004123">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_45632"></div></div></div></div></div><hr /></hr><p class="last">Detailed description of the homology modeling of the hD<sub>2</sub> receptor; the model prediction, docking studies, molecular dynamics simulations, and results of these in silico studies; and a detailed description of the cytotoxicity and Calcein assays. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm5004123/suppl_file/jm5004123_si_001.pdf">jm5004123_si_001.pdf (877.56 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB ID for protein hD<sub>3</sub> receptor in complex with antagonist eticlopride: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBL">3PBL</a>.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm5004123&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm5004123%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-10" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm5004123" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67998257d8c52390","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
